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 Abstract   
It is known that some individuals with chronic pain go on to develop high blood 
pressure. Indeed, patients with post-surgical chronic pain have nearly twice the 
prevalence of clinical hypertension than medical patients without pain (Bruehl, Chung, 
Jirjis, & Biridepalli, 2005). Accordingly, we could postulate that a person who 
consistently exhibited increases in muscle sympathetic nerve activity (MSNA), blood 
pressure and heart rate during experimental muscle pain may – if he or she developed 
chronic pain from an injury in the future – go on to develop hypertension (Bruehl et 
al., 2005). Interestingly, long-lasting experimental muscle pain induced by hypertonic 
saline solution in humans causes a sustained and consistent increase in muscle 
vasoconstrictor drive and blood pressure in some subjects, and a sustained decrease in 
others (Fazalbhoy, Birznieks, & Macefield, 2012, 2014).  
To further our understanding of the complex physiological changes that bring about 
these divergent responses, this thesis has explored the association of baseline 
physiological and psychological levels with the direction of the sympathetic response 
during tonic muscle pain. Furthermore, this project included combined 
microneurography and neuroimaging techniques to identify areas of the brain involved 
in generating sustained increases or decreases in sympathetic nerve activity to muscle, 
as well as changes in the brain associated with the generation of MSNA bursts during 
experimental muscle pain. The final chapter explored the effects of an audio-visual 
stimulus on the direction of the response.  
The results reported in this thesis highlight the fact that the muscle sympathetic 
responses to experimental muscle pain are not based on baseline physiological or 
psychological parameters but are associated with different signal intensity changes in 
 14 
important autonomic brain regions. Furthermore, distraction from the painful stimulus 
through audio-visual distraction does not influence the direction of the response. While 
this series of experiments has shed light on the neurophysiological mechanism through 
which the divergent sympathetic response to experimental muscle pain arises, many 
questions remain to be answered. For instance, it is unknown why such divergent 
responses would occur in humans. Furthermore, whether these responses remain 
sustained over a longer period of time needs to be determined. 
 
 CHAPTER 1   Introduction 
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1.1. Autonomic nervous system  
The nervous system is divided into the central nervous system (CNS) and the 
peripheral nervous system (PNS). The CNS comprises the brain, the brainstem, the 
cerebellum, and the spinal cord. The PNS is composed of the cranial nerves III through 
XII, which supply the head, and the spinal nerves, which derive from the spinal cord 
and innervate the torso and limbs. The PNS is further subdivided into somatic and 
autonomic. The somatic PNS works under conscious control and is comprised of two 
types of fibres (axons): the efferent (motor) fibres innervate skeletal muscles via the 
ventral roots and spinal nerves, while the afferent (sensory) axons convey sensory 
information to the CNS via the spinal nerves and dorsal roots (Catala & Kubis, 2013). 
The autonomic nervous system acts without conscious control – although it can be 
accessed by higher-order cognitive or emotional functions - and is accountable for 
motor functions of the visceral organs, which are critical for the maintenance of 
homeostasis (Loewy & Spyer, 1990). It targets the smooth muscles in the organs 
throughout the body, as well as the blood vessels and glands (Loewy & Spyer, 1990). 
It is subdivided into the sympathetic, parasympathetic, and enteric branches (Darby, 
2014). The enteric branch is located within the gastrointestinal tract and is exclusively 
involved in control of gastrointestinal secretions and motility; it shall not be considered 
further here. The sympathetic and parasympathetic branches each work as a two-
motor-neuron system: a pre-ganglionic neuron, and a post-ganglionic neuron, and for 
those organs that receive both sympathetic and parasympathetic innervation, the two 
branches operate antagonistically (Chase & Clemente, 1968). 
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1.1.1. Sympathetic nervous system 
The sympathetic nervous system is the main player during periods of stress and 
adversity. Also called ‘the fight or flight system,’ it is responsible for increased cardiac 
and respiratory rates, as well as increases in blood pressure (Guyenet, 2006).  The 
preganglionic neurons are located in the lateral grey column (or intermediolateral cell 
column) of the spinal cord between the first thoracic (T1) and second lumbar (L2) 
vertebrae (Loewy & Spyer, 1990). It is therefore often called the thoracolumbar 
outflow. The preganglionic neurons receive inputs from premotor neurons in the 
brainstem via the dorsolateral funiculus, in addition to input from spinal and 
propriospinal interneurons (Charkoudian & Wallin, 2014). Preganglionic sympathetic 
neurons are thinly myelinated and conduct at velocities of up to 15m/s (Darby, 2014). 
Once they leave the spinal cord via the anterior roots they synapse with ganglia located 
in the sympathetic chain or with prevertebral ganglia that are located close to large 
blood vessels (Darby, 2014). The primary neurotransmitter they release onto these 
post-ganglionic sympathetic neurons is acetylcholine (ACh; Loewy & Spyer, 1990). 
The post-ganglionic sympathetic neurons lie within the ganglia comprising the 
sympathetic chain (the paravertebral ganglia), located parallel to the spinal cord on 
either side, as well as  within the prevertebral ganglia (Chase & Clemente, 1968). In 
contrast to the preganglionic neurons, these are unmyelinated and therefore conduct at 
a much slower rate (~0.5 to 1m/s). With the exception of post-ganglionic sudomotor  
neurons, which use acetylcholine as the neurotransmitter (Jänig, Krauspe, & 
Wiedersatz, 1982), all post-ganglionic sympathetic neurons release noradrenaline 
(NA) onto their target organs; the chromaffin cells of the adrenal medulla are 
considered to be modified post-ganglionic cells and release adrenaline and 
noradrenaline (Loewy & Spyer, 1990). These include the salivary glands, as well as 
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the heart and blood vessels. Sympathetic innervation to the smooth muscles 
surrounding blood vessels causes vasoconstriction (Charkoudian & Wallin, 2014). The 
sympathetic division of the autonomic nervous system is illustrated in Figure 1.1. 
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Figure 1.1: Sympathetic division of the autonomic nervous system (Buijs & Swaab, 2013). 
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1.1.2. Parasympathetic nervous system 
The parasympathetic nervous system differs from the sympathetic nervous system in 
its arrangement, as well as in its function. It plays a major role during periods of rest 
and digestion. It is responsible for slowing down the heart, lowering the blood pressure, 
and promoting digestion. The first neuron of the parasympathetic nervous system 
originates from the brainstem nuclei of cranial nerves III, VII, IX and X, as well as 
from the intermediolateral cell column of the second, third and fourth sacral spinal 
segments (S2-S4; Chase & Clemente, 1968). From these craniosacral sites these 
neurons synapse with postganglionic parasympathetic neurons located within ganglia 
close to or within the walls of the viscera; as such their preganglionic axons are longer, 
and postganglionic axons shorter, than those of the sympathetic nervous system 
(Loewy & Spyer, 1990). All parasympathetic postganglionic neurons use ACh as the 
dominant neurotransmitter (Darby, 2014). The parasympathetic division of the 
autonomic nervous system is illustrated in Figure 1.2. 
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Figure 1.2: Parasympathetic division of the autonomic nervous system (Buijs & Swaab, 2013). 
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Although most visceral and cranial structures are innervated by both the sympathetic 
and parasympathetic nervous system, certain structures such as smooth muscles in 
systemic blood vessels, as well as sweat glands and hair follicles, do not follow this 
rule (Chase & Clemente, 1968); they receive sympathetic innervation exclusively. 
Together, the sympathetic and parasympathetic nervous systems work in balance to 
ensure homeostasis (Darby, 2014).  
1.2. The arterial baroreflex 
The arterial baroreceptor reflex is the main mechanism through which blood pressure 
is controlled on a beat-to-beat basis. The afferent limb of the reflex involves the arterial 
baroreceptors, which are stretch receptors found in the distensible walls of the aortic 
arch and carotid sinus, at the base of the internal carotid artery, just distal to the 
bifurcation (Guyenet, 2006). These two sites are of particular importance as they 
reflect whole-body perfusion pressure and the perfusion pressure of the brain, 
respectively. A rise in arterial blood pressure increases the radial distending pressure 
and increases the firing rate of these dynamically sensitive stretch receptors (Guyenet, 
2006). The action potentials generated by the baroreceptor afferents are then conducted 
to the central nervous system via different routes: those originating in the aortic arch 
travel in the vagus nerve, while those arising from the carotid sinus travel in the 
glossopharyngeal nerve (Saper, 2002). Both routes eventually synapse in the nucleus 
tractus solitarius (NTS) in the dorsomedial medulla  (Dampney et al., 2003). Neurons 
in the NTS send a direct excitatory (glutamatergic) projection to the nucleus ambiguus 
and the dorsal motor nucleus of the vagus, sites where parasympathetic cardiac 
preganglionic neurons originate (Saper, 2002). An increase in activity within these 
second-order neurons engages the parasympathetic limb of the baroreflex, bringing 
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about an increase in cardiac vagal outflow and the release of acetylcholine at the 
sinoatrial node of the heart, and hence causes a decrease in heart rate and stroke volume 
(Dampney et al., 2003). 
 
The sympathetic limb of the baroreflex involves three synapses within the medulla. 
After synapsing onto barosensitive neurons in the NTS, excitatory projections from 
these neurons synapse onto neurons in the caudal ventrolateral medulla (CVLM), the 
terminals of which contain the inhibitory neurotransmitter gamma-aminobutyric acid 
(GABA; Benarroch, 1998). The GABAergic neurons in the CVLM in turn synapse 
onto sympathoexcitatory premotor neurons in the rostral ventrolateral medulla 
(RVLM) that innervate sympathetic vasomotor preganglionic neurons in the spinal 
cord (Dampney, 1981). The RVLM is the primary output nucleus for sympathetic 
vasoconstrictor drive to the muscle, splanchnic, and renal vascular beds, and as such 
plays an important role in the ongoing regulation of total peripheral resistance and 
hence blood pressure (Guyenet, 2006).   
 
In summary, the activation of the baroreceptors at the level of the aortic arch and 
carotid sinus cause increased parasympathetic activity to the heart, via the vagus nerve, 
and simultaneously cause the withdrawal of sympathetic excitation to the heart and 
blood vessels. The baroreflex pathway is illustrated below (see Figure 1.3). 
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Figure 1.3: Central nervous system baroreceptor pathway linking baroreceptor afferents to 
sympathetic and parasympathetic outflow. 
Plus (+) and minus (-) symbols refer to excitatory (glutamatergic) synapses and inhibitory 
(GABAergic) synapses, respectively (from Sved, 2009). 
 
This baroreflex circuitry has been extensively investigated in animals, where 
experiments in anesthetized cats have shown that excitation of RVLM neurons evoked 
increases in muscle sympathetic nerve activity and blood pressure (Dampney et al., 
2003). The majority of sympathetic premotor vasoconstrictor neurons originate in the 
RVLM and electrolytic destruction of the RVLM in rabbits results in precipitous, life-
threatening falls in blood pressure (Dampney & Moon, 1980). Because blood pressure 
is primarily influenced by changes in heart rate, stroke volume, and the degree of 
sympathetically-mediated vasoconstriction in skeletal muscles, muscle sympathetic 
nerve activity (MSNA) is understandably a major contributor to the control of total 
peripheral vascular resistance (Hart & Charkoudian, 2014).  
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1.3. Muscle sympathetic nerve activity 
Muscle sympathetic nerve activity (MSNA), which can be recorded via 
microelectrodes inserted directly into a peripheral nerve in awake human subjects, 
reflects the activity of postganglionic sympathetic neurons supplying the skeletal 
muscle vascular beds; an increase in MSNA causes vasoconstriction and thereby 
increases blood pressure (Macefield, 2013). The main role of MSNA in healthy 
individuals is to regulate acute falls in blood pressure, via the arterial baroreflex, and 
thereby maintain a constant perfusion pressure to skeletal muscle. MSNA is greatly 
influenced by the arterial (high-pressure) and cardiopulmonary (low-pressure) 
baroreceptors, as well as cardiac rhythmicity (Fagius & Wallin, 1980).  When blood 
pressure rises, baroreceptors are excited and sympathetic output to the heart and blood 
vessels is inhibited, and parasympathetic outflow to the heart increased, leading to a 
decrease in heart rate and stroke volume, and a decrease in sympathetically-mediated 
vasoconstriction (Guyenet, 2006). Through the baroreflex, MSNA exhibits strong 
cardiac rhythmicity; it is specifically the carotid arterial baroreceptors that seem to 
provide the dominant temporal coupling of MSNA to the cardiac cycle (Jänig & Häbler, 
2003). 
 
MSNA is modulated by various factors such as respiration, age, and body weight. For 
example, MSNA decreases during inspiration and increases in expiration (Eckberg et 
al., 1985; Fatouleh & Macefield, 2013; Hagbarth & Vallbo, 1968; Macefield & Wallin, 
1995; Seals et al., 1990). Increased age and body weight also raise resting levels of 
MSNA (Hart et al., 2009; Hart & Charkoudian, 2014; Joyner, Barnes, Hart, Wallin, & 
Charkoudian, 2015; Lambert et al., 2007; Sverrisdóttir, Johannsson, Jungersten, 
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Wallin, & Elam, 2001). However, MSNA remains constant in a given individual over 
many years (Fagius & Wallin, 1993). Moreover, there are inter-individual differences: 
some individuals have high levels of MSNA at rest while others have low levels; 
identical twins have similar levels, whereas the burst incidence in fraternal twins 
differs widely (Wallin, Kunimoto, & Sellgren, 1993). The effects of mental stress on 
MSNA are also well documented. Indeed, metabolic syndrome patients with anxiety 
and mood disorders have greater MSNA burst frequency at rest, compared to 
metabolic syndrome patients and controls without these psychological symptoms 
(Toschi-Dias et al., 2013). Furthermore, single unit recordings from muscle 
vasoconstrictor neurons in metabolic syndrome patients with high levels of anxiety, as 
well as in patients with panic disorder and major depressive disorder, revealed greater 
incidence of multiple firing during a burst (Lambert et al., 2006, 2008, 2010). Table 1.1 
summarizes some of the influences on MSNA.  
 
Table 1.1: Physiological and clinical influences on resting MSNA (Charkoudian & Wallin, 
2014).  
Factor Influence 
Female sex (and / or female sex hormones) Decrease (most / not all studies) 
Race Difference Pima Indian vs. white (men) 
Difference African-American vs. white (men) 
Altitude (acute and long-term) Increase 
Pregnancy Increase 
Hypertension Increase (most / not all studies) 
Heart failure Dramatic increase 
Obstructive sleep apnoea Increase 
Chronic renal failure Increase 
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Since MSNA causes vasoconstriction and is the main contributor to increasing blood 
pressure once it has dropped, it would be reasonable to think that higher levels of 
MSNA would be associated with higher blood pressure. Indeed, it is known that 
elevated levels of MSNA are associated with essential hypertension (Esler & Kaye, 
2000), renovascular hypertension (Johansson et al., 1999), and the high blood pressure 
that results from untreated obstructive sleep apnoea (Takeuchi et al., 1994; Trombetta 
et al., 2010). However, there is no relationship between MSNA and blood pressure 
among young healthy individuals. That is, a person with high MSNA can have normal 
blood pressure and vice versa (Charkoudian & Wallin, 2014). Although this does not 
hold true for people older than age 50 (Hart & Charkoudian, 2014), it should not 
undermine the importance of the baroreflex, which is important not only for transient 
blood pressure compensations, but also for setting the level of blood pressure over the 
long term (Hart & Charkoudian, 2014). 
 
The role of sympathetic activity in long-term blood pressure control is highly debated. 
Although early animal studies failed to show any alterations in blood pressure control 
upon sino-aortic denervation (Cowley et al., 1973), more recent studies have shown 
the importance of the sympathetic nervous system in long-term blood pressure control 
(Lohmeier, 2001). Indeed, stimulation of the carotid baroreflex in dogs causes 
sustained decreases in systemic blood pressure (Lohmeier et al., 2004, 2010). In 
humans, there is evidence that afferent carotid baroreceptor stimulation leads to 
sustained decreases in blood pressure, decreased central sympathetic outflow and 
increased parasympathetic tone (Heusser et al., 2010). Moreover, people with 
baroreflex failure tend to become hypertensive in the future (Heusser et al., 2005). 
Since baroreceptor afferents are conducted to the central nervous system, in particular 
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the medullary nuclei, it is vital to understand the central neural sites responsible for 
the control of MSNA. 
1.4. Supraspinal regulation of MSNA 
1.4.1. Animal studies 
Experimental animal studies have revealed that there are four classes of neurons that 
constitute the central cardiovascular pathway (Dampney, 1994). First, there are 
preganglionic autonomic motor neurons, such as vagal (Nosaka et al., 1979) and 
sympathetic (Jänig, 1985) preganglionic neurons, which control the heart, blood 
vessels, and adrenal medulla. Second, there are autonomic premotor neurons that 
project to and control the activity of these first preganglionic neurons (Dampney, 
1994). Cardiovascular sympathetic premotor neurons have their nuclei in the 
brainstem and hypothalamus (Strack et al., 1989a,b). Indeed, five specific cell groups 
– in the rostral ventrolateral medulla, rostral ventromedial medulla, caudal raphe nuclei, 
A5 noradrenergic cell group in the caudal ventrolateral pons, and the paraventricular 
nucleus (PVN) in the hypothalamus – all innervate preganglionic outflow to the 
adrenal medulla and all major sympathetic ganglia (Strack et al., 1989a,b). Third, there 
are primary afferent neurons that transmit signals from peripheral receptors, which 
influence cardiovascular function (Loewy & Spyer, 1990). Finally, there are 
interneurons that link primary afferent inputs of higher brain centres controlling 
cardiovascular function to autonomic premotor neurons, including the CVLM 
(Feldberg & Guertzenstein, 1976), the parabrachial complex (Herbert et al.,  1990), 
locus ceruleus (Elam, et al., 1984, 1986), the midbrain periaqueductal grey (PAG; 
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Carrive & Bandler, 1991), and cortical regions such as the insula (Cechetto & Chen, 
1990).  
1.4.2. Human studies 
In 2010, Macefield and Henderson were the first to record muscle sympathetic nerve 
activity in awake human subjects while performing functional Magnetic Resonance 
Imaging (fMRI) of the brainstem, in order to identify the baroreflex circuitry. Although 
it remains unclear whether fMRI signal intensity changes represent synaptic 
transmission or neuronal firing (Logothetis, Pauls, Augath, Trinath, & Oeltermann, 
2001; Mukamel et al., 2005; Viswanathan & Freeman, 2007), Macefield and 
Henderson showed that when bursts of MSNA were present, Blood Oxygen Level 
Dependent (BOLD) signal intensity was high in the RVLM, while signal intensity 
within the NTS and CVLM was low; the reverse was true when bursts were absent 
(Macefield & Henderson, 2010). These results confirmed the role of the brainstem in 
human cardiovascular control and specifically muscle sympathetic outflow. 
 
Further studies allowed the group to identify cortical structures involved in central 
cardiovascular control (James, Macefield, & Henderson, 2013). They found that signal 
intensity in certain cortical structures - such as the dorsomedial and ventromedial 
hypothalamus, the precuneus, insula, and dorsolateral prefrontal cortex - varied with 
the intensity of the concurrently recorded bursts of MSNA, which correlated with 
signal intensity of the left and right RVLM. Since the RVLM is the final output nucleus 
for MSNA, this work suggests that higher cortical areas may be involved in the 
regulation of MSNA in awake human subjects (James et al., 2013). Indeed, 
experiments involving animals have shown direct projections from the sensorimotor 
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cortex to the NTS and the RVLM (M’hamed, Sequeira, Poulain, Bennis, & Roy, 1993; 
Verberne & Owens, 1998) so that central command could potentially cause increases 
in muscle sympathetic nerve activity. Along those lines, a number of brain regions, 
including the insular cortex, amygdala, hypothalamus, PAG, parabrachial nucleus, 
NTS, and ventrolateral medulla have been proposed to make up the “central autonomic 
network” (Benarroch, 1993). These findings were more recently confirmed, with 
consistently activated regions such as the left amygdala, right anterior and left 
posterior insula, as well as the midcingulate cortices, forming the core of the central 
autonomic network (Beissner, Meissner, Bär, & Napadow, 2013). Furthermore, 
several studies have shown that damage to certain areas of the brain can lead to 
disruption of cardiovascular control. For example, reduced cardiovascular arousal 
following a stroke isolated to the anterior cingulate cortex has been reported (Critchley 
et al., 2003). Neurocardiogenic dysfunction has also been hypothesized to be the cause 
of sudden unexplained death following stroke and epileptic seizures (Scorza et al., 
2009).  
 
The role of the autonomic nervous system is vital for the homeostatic and 
physiological adjustments crucial in life (Darby, 2014). Sympathetic outflow to the 
muscle vascular bed can be altered through physiological challenges, but can also be 
increased in pathological conditions, such as heart failure or obstructive sleep apnoea 
(Charkoudian & Wallin, 2014). Little is known however, about the effects of pain on 
muscle sympathetic nerve outflow in humans, and the interaction between the 
sympathetic nervous system and pain is complex. 
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1.5. Noxious stimulation 
Intramuscular injection of hypertonic saline has been used in the study of experimental 
pain in humans for many years. It was first used in humans in 1938 by Kellgren to 
study referred pain, and shown to induce a deep and dull ache that often referred to 
distal structures (Kellgren, 1938). For example, injection of hypertonic saline solution 
in the tibialis anterior causes referred pain in the ankle (Graven-Nielsen et al., 1997a,b). 
Hypertonic saline induces pain, as it is a specific stimulus for nociceptors (Graven-
Nielsen & Mense, 2001). In 2009, Burton and colleagues used intramuscular or 
subcutaneous injections of hypertonic saline to examine the effects of deep and 
superficial pain on muscle sympathetic nerve activity (Burton, Birznieks, Bolton, 
Henderson, & Macefield, 2009) Capra and Ro (2004) induced tonic muscle pain for 
20 minutes to simulate longer-lasting musculoskeletal pain. More recently, Fazalbhoy 
and colleagues used intramuscular infusion of hypertonic saline to cause a sustained, 
steady level of pain for one hour (Fazalbhoy et al., 2012, 2014). This method of 
inducing pain offers the advantage of allowing a controlled investigation into how 
long-lasting tonic pain may modulate the cardiovascular responses. As these 
sensations closely resemble the description of pain in patients with actual chronic pain 
conditions, it may shed light on the initial mechanisms underlying the complex chain 
of physiological changes that lead to the establishment of long-lasting pain conditions.  
 
Important for survival, pain helps to avoid tissue damage, mobilizing all relevant 
homeostatic systems for a fight-and-flight response or, alternatively, promoting 
conservation of energy and thus promoting healing (Craig, 2002). In the short term, 
these physiological responses serve as a protective mechanism, preventing the 
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establishment of prolonged damage. Conversely, chronic pain, which is thought to 
arise from the activation of nociceptors initially (but can be maintained without the 
ongoing noxious stimulus) is maladaptive and can have detrimental psychological and 
physiological consequences that affect many systems (Blyth et al., 2001). One in five 
people in Australia suffers from chronic pain (Blyth et al., 2001), and there is a 
significant increase in psychological distress in people with chronic pain which 
interferes with their daily activities (Blyth et al., 2001). Furthermore, individuals with 
chronic pain are more likely to rate their health as poor compared with individuals 
without pain (Mäntyselkä et al., 2003). In terms of the cardiovascular system, chronic 
pain is associated with an increased risk of developing hypertension (Bruehl et al., 
2005). 
1.6. Pain and the sympathetic nervous system 
While the role of sustained activation of the sympathetic nervous system and its 
association with the development and maintenance of chronic pain (such as in chronic 
regional pain syndromes) is highly debated (Ali et al., 2000; Benarroch, 2006; Elam 
& Macefield, 2004; Macefield, 2010), the effects of pain on the sympathetic nervous 
system are well-documented, with changes in blood pressure, heart rate, sweat release, 
and blood flow to muscle and skin being reported in both animals and humans (Burton 
et al., 2009; Burton, Birznieks, Spaak, Henderson, & Macefield, 2009; Fazalbhoy et 
al., 2012; Horeyseck & Jänig, 1974; Kobuch, Fazalbhoy, Brown, & Macefield, 2015; 
Lewis, 1942). 
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1.6.1. Animal studies 
In animals, the effects of pain on the cardiovascular system have been extensively 
investigated. In general, the cardiovascular response seems to be dependent on the 
origin of the pain. The first experiments exploring this relationship date back to 1866 
when Lovén showed that electrical stimulation of cutaneous afferent fibres in rabbits 
decreased the activity in vasomotor neurons innervating the same area of skin as the 
afferent fibres, and increased the activity in other vasomotor neurons, leading to an 
increase in arterial blood pressure (Lovén, 1866). Further experiments have shown that 
superficial pain causes an increase in the activity of sympathetic postganglionic muscle 
fibres, in anesthetized and spinalised cats (Boczek-Funcke et al., 1992; Horeyseck & 
Jänig, 1974a, 1974b), as well as anesthetized rats (Häbler, Jänig, Krummel, & Peters, 
1994). However, noxious stimulation of skeletal muscle (but not noxious stimulation 
of the skin) in anesthetized rats has shown to inhibit muscle vasoconstrictor neurons 
(Kirillova-Woytke, Baron, & Jänig, 2014). In 1984, Sato and colleagues showed that 
manipulation of an inflamed knee joint (causing deep pain) in anesthetized cats caused 
increases in blood pressure and heart rate (Sato, Sato, & Schmidt, 1984). Finally, 
activation of group III afferent fibres through sciatic nerve stimulation is capable of 
causing increases in blood pressure and heart rate in spontaneously hypertensive rats 
(Yao, Andersson, & Thorén, 1982). 
 
Thus, the animal literature (with the exception of the study conducted by Sato and 
colleagues) suggests that generally superficial pain evokes an increase in the 
cardiovascular activity, which is probably driven by increases in MSNA. In contrast, 
pain originating from deeper structures evokes decreases in blood pressure and heart 
rate (Bandler, Carrive, & Zhang, 1991). Bandler and colleagues (1991) attribute these 
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conflicting responses to the ability of the organism to deal with the noxious stimulus. 
Indeed, the coping mechanisms to certain stressors, including pain, differ depending 
on whether that stressor is “escapable” or “inescapable” (Keay & Bandler, 2002). 
When the situation is escapable, humans and animals use a more active coping strategy, 
which evokes an increase in the fight-or-flight response. Conversely, an inescapable 
stressor is met with passive coping mechanisms, which are associated with 
sympathetic depression (Bandler et al., 1991).  
1.6.2. Human studies 
Early studies in humans suggested that cardiovascular responses to noxious inputs also 
vary according to the tissue of origin (Lewis, 1942). Lewis (1942) proposed that 
superficial pain (that arose from skin) resulted in an increase in pulse rate, which 
reflects an increase in sympathetic activity. In contrast, pain that arose from deeper 
structures showed a decrease in pulse rate and blood pressure, which is attributable to 
a decrease in sympathetic activity (Lewis, 1942). These findings were confirmed by 
Feinstein and colleagues in 1954, who found that injection of 6% hypertonic saline 
solution into the paravertebral muscles of the thorax - and rarely neck and back - was 
associated with pallor, sweating, a fall in blood pressure, and bradycardia in awake 
human subjects (Feinstein, Langton, Jameson, & Schiller, 1954). Furthermore, 
research has shown that acute noxious stimuli, such as pressure to the nail-bed and the 
trigeminal region, as well as instillation of soap solution in the eye, and mechanical 
pressure on the muscles, evoke a generalized increase in MSNA (Nordin & Fagius, 
1995; Schobel et al., 1996). Similarly, the painful physical stress during immersion of 
the hand into ice-cold water triggers increases in MSNA with parallel increases in 
blood pressure (Fagius, Karhuvaara, & Sundlöf, 1989; Kregel, Seals, & Callister, 
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1992). Burton and colleagues (2009) used intramuscular and subcutaneous injections 
of hypertonic saline to examine the effects of deep and superficial pain on muscle 
sympathetic nerve activity. They showed that both types of pain – which lasted 
between 6 and 8 minutes - increased MSNA amplitude, blood pressure, and heart rate 
in almost all subjects (Burton et al., 2009a). Therefore, in humans, the majority of 
acute painful stimuli produce an increase in MSNA. Notable exceptions have been 
shown during painful electrical stimulation to the skin, which causes a short-lasting 
decrease in MSNA (Delius, Hagbarth, Hongell, & Wallin, 1972a). 
 
Chronic pain is associated with an increased risk of developing hypertension, a 
phenomenon that is thought to originate from the alterations in the relationship 
between the cardiovascular and pain regulatory systems (Bruehl et al., 2005). However, 
little is known about the early physiological changes that accompany the establishment 
of chronic pain. Indeed, there are few studies that have investigated the changes in 
sympathetic nerve activity during chronic pain: in a single patient with chronic 
regional pain syndrome (CRPS), suspected to be sympathetically maintained because 
of the marked cutaneous vasoconstriction, there was no difference in sympathetic 
outflow to the painful limb compared to the contralateral non-painful limb (Casale & 
Elam, 1992). It may be that both limbs were affected equally - in most instances 
sympathetic outflow is distributed symmetrically to the left and right limbs. In a larger 
study involving 25 fibromyalgia patients, pain intensity was positively correlated with 
MSNA burst frequency (Zamunér et al., 2015). 
 
In order to investigate the consequences of long-lasting pain on the cardiovascular 
system, Fazalbhoy and colleagues (2012) infused hypertonic saline solution into the 
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tibialis anterior muscle of healthy subjects for ~45 minutes. They found that the 
physiological effects of longer-lasting pain produced two types of responses: one 
group of subjects showed a constant increase in burst amplitude of MSNA, blood 
pressure and heart rate, and another group showed a decrease in these parameters 
(Fazalbhoy et al., 2012). Interestingly, the subjects in that study all showed an increase 
in blood pressure and a decrease in heart rate in the first few minutes after the onset of 
pain. It was hypothesized that this initial response may represent the urge to respond 
to a noxious stimulus, and that the changes in blood pressure that followed may be 
attributed to the different coping mechanisms utilized by each individual. A 
subsequent study demonstrated that the changes in MSNA observed during long-
lasting muscle pain were consistent over time in the majority of individuals (Fazalbhoy 
et al., 2014).  
1.6.3. Supraspinal regulation 
In 1996, Schobel and colleagues observed that subjects with borderline hypertension 
had increased tolerance to pain compared to normotensive subjects. They further 
demonstrated that these changes did not correlate with changes in MSNA, or the 
baroreflex, and therefore may be attributable to central changes (Schobel et al., 1996).  
More recently, Burton and colleagues showed that a bolus injection of hypertonic 
saline in the leg muscles in people with spinal cord injury does not cause reflex 
increases in blood pressure or heart rate, or any cutaneous vasoconstriction or sweat 
release below the lesion (Burton, Brown, & Macefield, 2008). These findings therefore 
suggest that cardiovascular changes to pain in humans appear to be mediated by 
supraspinal sites. 
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It has recently been shown that supraspinal centres regulating cardiovascular activity 
overlap substantially with those receiving nociceptive input (Benarroch, 2006; Bruehl 
& Chung, 2004). These same regions, including the insula, the anterior cingulate 
cortex (ACC), the amygdala, the hypothalamus, as well as the PAG, parabrachial 
nucleus (PBN), and NTS, also contain groups of neurons that initiate autonomic, 
antinociceptive and behavioural responses to these stimuli (Benarroch, 1993; Saper, 
2002). Furthermore, it is interesting that there appears to be a relationship between the 
cardiovascular and descending pain modulation systems, since the greater the 
magnitude of cardiovascular response during the cold pressor test, the greater an 
individual’s endogenous analgesic ability (Chalaye et al., 2013).  
 
In fact, the insula receives pain and temperature information (Craig, 2003) and is 
connected to the hypothalamus, as well as brainstem autonomic regions such as the 
NTS, parabrachial nucleus, and ventrolateral medulla (Saper, 2002). Similarly, the 
ACC also receives nociceptive inputs, is involved in the affective and motivational 
components of pain sensation (Vogt, Berger, & Derbyshire, 2003), and extensively 
interacts with areas of the central autonomic network (Gabbott, Warner, Jays, Salway, 
& Busby, 2005). The amygdala provides emotional significance to the painful stimulus, 
and via its projections to the hypothalamus and brainstem, it can initiate autonomic 
responses (Davis & Whalen, 2001). At the level of the diencephalon, the lateral and 
posterior areas of the hypothalamus are involved in autonomic control as well as pain 
modulation (Abrahamson & Moore, 2001). In the brainstem, the NTS and the PAG are 
two important supraspinal structures that also receive both cardiovascular information 
as well as nociceptive input (Bruehl & Chung, 2004). As noted above, the NTS 
receives information from baroreceptor inputs and, through negative feedback, 
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provides an excitatory signal to cardiac parasympathetic neurons via the vagus nerve, 
and also reduces the excitatory drive to the RVLM (Sved, 2009). The NTS also 
receives projection neurons from spinal laminae involved in nociceptive processing 
(Bruehl & Chung, 2004). Finally the PAG is involved in the processing of noxious 
stimuli (Carrive & Bandler, 1991), and stimulation of the lateral columns (lPAG) 
preferentially evokes a fight-or-flight response, with increases in blood pressure and 
heart rate, similar to the response evoked by cutaneous pain. Conversely, stimulation 
of the ventrolateral columns of the PAG (vlPAG) promotes rest and digest, with a 
parallel decrease in blood pressure and heart rate – as seen during experimental deep 
pain in animals (Depaulis et al., 1992). 
1.7. Microneurography 
Microneurography is a method that allows the direct recording of axonal activity via a 
tungsten microelectrode inserted percutaneously into a peripheral nerve in awake 
human subjects (Vallbo, Hagbarth, & Wallin, 2004). The technique was developed in 
Sweden in the 1960s to record activity from low-threshold mechanoreceptors in 
muscle and skin, but is most often used to record activity in unmyelinated 
postganglionic sympathetic axons (Vallbo et al., 2004). Due to their accessibility, the 
common peroneal nerve or the tibial nerve in the popliteal fossa are the most 
commonly used nerves in the lower limb (Macefield, 2013). These peripheral nerves 
are particularly useful as they contain several fascicles, each separated from one 
another via the perineurium, a high impedance fibrous barrier, which prevents cross-
talk between neighbouring fascicles. Generally, close to the fascicular innervation 
zone all nerve fibres in one fascicle supply one type of tissue: either muscle or skin 
(Vallbo et al., 2004). 
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1.7.1. Sympathetic microneurography 
Sympathetic microneurography is used to record multiunit sympathetic nerve activity, 
which is characterized by bursts of impulses separated by silent periods. However, 
microneurography can also be used to record the activity from individual 
postganglionic sympathetic axons, using highly selective microelectrodes (Macefield, 
2013). An example of a multi-unit recording is shown in Figure 1.4. 
 
Figure 1.4: Spontaneous bursts of MSNA recorded via a tungsten microelectrode inserted into 
a muscle fascicle of the common peroneal nerve (from Macefield, 2013). 
 
Bursts of MSNA exhibit a tight coupling to the cardiac rhythm via the baroreflex (Jänig 
& Häbler, 2003; Macefield, Elam, & Wallin, 2002). The sympathetic nervous system, 
however, is not only involved in the baroreflex or blood vessel constriction, but also 
provides cutaneous innervation to sweat glands, hairs, and adipose tissue via 
sympathetic axons travelling in cutaneous fascicles (Chase & Clemente, 1968). 
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Therefore, it is important to distinguish the nerve fascicle carrying MSNA from the 
one carrying skin sympathetic nerve activity (SSNA; Macefield, 2013). Cutaneous 
fascicles are defined as such because intraneural stimulation through the 
microelectrode evokes radiating paraesthesia but no muscle twitches. Moreover, 
stroking over the fascicular innervation zone activates low-threshold 
mechanoreceptors in the skin.  
 
Several features differentiate bursts of MSNA from bursts of SSNA. In contrast to 
MSNA, bursts of SSNA have variable shapes and durations and do not display overt 
cardiac rhythmicity. SSNA does not exhibit a sustained increase during an inspiratory-
capacity apnoea, only generating a single burst during the inflation phase. Single bursts 
of SSNA are also evoked by a brisk sniff, as well as with arousal: a loud clap, or an 
unexpected tap on the nose will generate a burst of SSNA. Such manoeuvres have no 
effect on MSNA (Delius et al., 1972a,b). 
1.7.2. Analysis 
The standard analysis of sympathetic nerve activity involves counting the number of 
visible bursts occurring per minute (burst frequency) or per 100 heart beats (burst 
incidence), or measuring the total neural activity (the cumulative sum of burst 
amplitudes in 1 minute; Macefield, 2013). Based on single-unit recordings of 
sympathetic post-ganglionic axons, it is known that individual neurons fire primarily 
only once per burst, indicating that increases in burst amplitude are brought about 
largely through recruitment of additional neurons (Macefield et al., 2002). Burst 
amplitude, frequency, and incidence reveal slightly different features about MSNA. 
Burst amplitude reveals the strength of the signal and is dependent on the number of 
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action potentials generated during the burst and the distance between the electrode tip 
and the active fibres. Burst frequency and burst incidence, by contrast, are dependent 
on the number of bursts and cardiac cycles. Because MSNA is tightly coupled with 
cardiac rhythmicity, the higher the heart rate, the greater the potential for a burst to 
occur; this therefore influences burst frequency but not burst incidence (Charkoudian 
& Wallin, 2014).  
 
It is known that variability in the amplitude of the bursts and the number of bursts does 
occur, and that this is possibly due to two different sites in the central nervous system 
being involved in a feedback loop interacting with the arterial baroreceptors: one being 
responsible for determining the occurrence (incidence) of bursts and the other for the 
strength (amplitude) of the bursts (Kienbaum et al., 2001). According to Kienbaum’s 
model (2001), one synapse is regulated by the strength of the input from the 
baroreceptors (as well as other afferent inputs), such that a stronger withdrawal of 
baroreceptor input will lead to a stronger sympathetic burst, while the other synapse 
acts as a gate control and determines whether the burst can be passed on to the spinal 
cord and the target vasculature (Kienbaum et al., 2001).   
1.8. Imaging of central cardiovascular control 
The central circuitry underlying the baroreflex mechanism has been thoroughly studied 
in experimental animals. Few studies, however, have investigated the circuitry in 
human subjects. The first neuroimaging studies of autonomic function in humans 
involved the functional magnetic resonance imaging during respiratory challenges 
(Gozal et al., 1995, 1996; Harper et al., 1998; King, Menon, Hachinski, & Cechetto, 
1999). Further investigations of the central neural sites responsible for controlling the 
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autonomic nervous system in humans involved manoeuvres that evoke increases in 
MSNA, such as static hand grip exercise (Critchley, Corfield, Chandler, Mathias, & 
Dolan, 2000; Goswami, Frances, & Shoemaker, 2011; Macey et al., 2012; Macey, 
Kumar, Ogren, Woo, & Harper, 2014; Norton et al., 2015; Nowak et al., 1999), the 
Valsalva manoeuvre (Henderson et al., 2002, 2003; King et al., 1999; Macey et al., 
2012; Ogren et al., 2012; Wu, Bandettini, Harper, & Handwerker, 2015), immersion 
of the hand (or forehead) into ice cold water (Harper et al., 1998, 2003; Harper, Bandler, 
Spriggs, & Alger, 2000; Macey, Macey, Woo, Keens, & Harper, 2005), or lower body 
negative pressure (Goswami, Frances, Steinback, & Shoemaker, 2012; Kimmerly, 
O’Leary, Menon, Gati, & Shoemaker, 2005). For example, the Valsalva manoeuvre 
evokes a sustained increase in MSNA and arterial blood pressure, and is associated 
with increased signal intensity within multiple brain regions, including the dorsal pons 
and medulla (Harper et al., 1998; Henderson et al., 2002). Lower body negative 
pressure unloads the low-pressure baroreceptors, leading to a sustained increase in 
MSNA, and is associated with functional changes within the insula, anterior cingulate 
cortex, and orbitofrontal cortex, as well as the midbrain and thalamus (Kimmerly et 
al., 2005). Similarly, a maximal inspiratory breath-hold also increases MSNA through 
the unloading of low-pressure baroreceptors (Macefield, 1998), and causes significant 
signal intensity changes in the NTS, RVLM, and CVLM (Macefield et al., 2006). 
Although these studies have provided great insight into the central circuitry 
responsible for producing changes in MSNA, none have measured MSNA changes 
and functional brain imaging synchronously.  
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1.8.1. MSNA-coupled fMRI 
In 2010, Macefield and colleagues managed to record MSNA while simultaneously 
measuring brain activity using functional magnetic resonance imaging (fMRI). In 
order to do so, the protocol involved a scan repetition time of 8 sec, including 4 sec 
image collection period, followed by 4 sec of rest, during which MSNA was recorded 
(Macefield & Henderson, 2010). This procedure allowed one to take advantage of the 
temporal delays inherent in blood oxygen level dependent (BOLD) imaging, where 
microvascular responses to an increase in neuronal activity lag by about 5 sec 
(Logothetis et al., 2001). One second was removed in order to account for the time 
taken for a volley of MSNA to travel from the brainstem to the peripheral recording 
site at the level of the fibular head (Fagius & Wallin, 1980). Thereby, changes in 
BOLD signal intensity that are temporally coupled to MSNA reflect changes in neural 
activity with the production of the bursts of MSNA recorded 4 seconds previously.  
 
As noted in section 1.4, Macefield and Henderson were able to define the human 
baroreflex circuitry by measuring regional brainstem activity changes during 
spontaneous changes in MSNA in awake subjects (Macefield & Henderson, 2010). 
The group then explored the cortical brain regions that regulate MSNA, by extending 
the imaging to the whole brain, and identified suprabulbar regions that regulate resting 
MSNA by projecting to the RVLM (James et al., 2013).  
 
 44 
1.9. Aims & Hypotheses 
Aim 1: Investigating whether baseline physiological parameters predict the 
sympathetic responses to muscle pain. 
In this study, we set out to determine whether baseline physiological levels, including 
baseline blood pressure, heart rate, and muscle sympathetic nerve activity (MSNA), as 
well as age, sex, and BMI may be predictors of the direction of the muscle sympathetic 
response to experimental muscle pain. This material, which has been published, 
extends the work undertaken in my Bachelor of Medical Research project and 
continued during my PhD. Because of this overlap, I present this work in Appendix A 
as: Baseline physiological parameters do not determine whether muscle sympathetic 
nerve activity increases or decreases during pain. Front Neurosci 9:471. 
 
Aim 2: Investigating whether psychological parameters determine the cardiovascular 
responses to muscle pain. 
The aim of this second study was to investigate whether anxiety levels and attitudes to 
pain could account for the divergent sympathetic responses to muscle pain. We tested 
the hypothesis that subjects with higher levels of pain anxiety, and pain catastrophizing 
and vigilance, as well as state and trait anxiety scores would show increases in MSNA 
during tonic muscle pain. This published work is presented in Chapter 3 as: Inter-
individual responses to experimental muscle pain: Baseline anxiety ratings and 
attitudes to pain do not determine the direction of the sympathetic response to tonic 
muscle pain in humans. Int J Psychophysiol 104:17–23. 
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Aim 3: Understanding the processes in the brain that determine how long-lasting 
muscle pain produces sustained increases or decreases in muscle sympathetic nerve 
activity. 
In this study, we used concurrent microneurography and functional brain imaging to 
determine if known autonomic brain regions respond differently in individuals in 
whom MSNA increases to those in whom MSNA decreases. We tested the hypothesis 
that changes in MSNA during muscle pain are associated with a sustained increase or 
decrease in blood oxygen level dependent signal intensity in the dorsomedial 
hypothalamus, the periaqueductal grey and the rostroventrolateral medulla. This work 
has been published and is presented in Chapter 4 as: Central circuitry responsible for 
the divergent sympathetic responses to tonic muscle pain in humans. Hum. Brain 
Mapp. 38(2):869-881. 
 
Aim 4: To identify brain regions that are recruited during MSNA bursts during tonic 
muscle pain. 
The aim of this study was to identify brain regions that are coupled to MSNA bursts 
during rest and during tonic muscle pain. We hypothesized that in addition to areas 
known to be coupled to MSNA bursting at rest, additional regions such as the cingulate 
cortex and midbrain would be recruited during MSNA bursts during pain.  
This work has been accepted for publication and is presented in Chapter 5 as: Muscle 
sympathetic nerve activity-coupled changes in brain activity during sustained muscle 
pain. Brain & Behaviour 8: e00888 
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Aim 5: To examine the muscle sympathetic responses to experimental muscle pain 
during audio-visual distraction.  
The aim of this study was to investigate whether distraction via engagement in an 
affectively neutral stimulus could bring about changes in the muscle sympathetic and 
cardiovascular responses to experimental muscle pain. This work has been accepted 
for publication and is presented in Chapter 6 as: The effects of audio-visual distraction 
on the muscle sympathetic responses to experimental muscle pain. Experimental Brain 
Research. 236: 1919-1925 
 
 
 CHAPTER 2   General Methods 
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2.1. General procedures 
Experiments were performed on healthy university subjects. For all studies in the 
thesis, subjects responded to an advertisement that outlined the procedures to be 
undertaken, including the nerve recording, muscle pain and fMRI; all procedures were 
approved by the Human Research Ethics Committees of Western Sydney University 
and the University of New South Wales. Written consent was obtained from all 
subjects in accordance with the Declaration of Helsinki. Exclusion criteria included a 
history of cardiovascular disease or chronic musculoskeletal pain. The subjects who 
volunteered for the experiment did so knowing that they were going to have a 
microelectrode inserted into a nerve, another needle inserted under the skin, and a 
cannula inserted into a muscle. Moreover, they knew they were going to experience 
strong muscle pain during the intramuscular infusion of hypertonic saline for up to an 
hour.  
For experiments conducted in Chapters 3 and 6, the subjects were either seated in a 
comfortable reclined position with the legs supported in an extended position.  For the 
chapters involving fMRI recordings, the subjects were laying on an MRI bed with the 
legs supported by a foam cushion. For either of the protocols, the room was kept quiet 
and at a constant temperature of 22◦C. 
2.1.1. MSNA recording procedures 
For Chapters 3 and 6, the subjects were seated in a comfortable reclined position with 
the legs supported in an extended position. The course of the common peroneal nerve 
was identified via external stimulation (2–10 mA) using a 1 mm surface probe which 
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delivered 0.2 ms pulses at 1Hz from an isolated stimulator (Stimulus Isolator; 
ADInstruments, Sydney, Australia). Spontaneous bursts of muscle sympathetic nerve 
activity (MSNA) were recorded from muscle fascicles of the common peroneal nerve 
supplying the ankle or toe extensor or foot everter muscles via tungsten 
microelectrodes (FHC, Bowdoin, ME, USA) inserted percutaneously at the level of 
the fibular head. Multi-unit neural activity was amplified (gain 20 000, bandpass 0.3–
5.0 kHz) using an isolated amplifier (NeuroAmp EX, ADInstruments, Sydney, 
Australia) and stored on computer (10-kHz sampling) using a computer-based data 
acquisition and analysis system (PowerLab 16SP hardware and LabChart 7 software; 
ADInstruments, Sydney, Australia). ECG (0.3–1.0kHz) was recorded with Ag–AgCl 
surface electrodes on the chest and sampled at 2 kHz. Blood pressure was recorded 
continuously using finger pulse plethysmography (Finometer Pro, Finapres Medical 
Systems, The Netherlands) and sampled at 400 Hz. Respiration (DC-100Hz) was 
recorded using a strain-gauge transducer (Pneumotrace, UFI, Morro Bay CA, USA) 
wrapped around the chest.  
Chapters 4 and 5 involved concurrent MSNA and functional magnetic resonance 
imaging recordings. Therefore, the protocol was slightly adjusted to accommodate this 
procedure. Instead of being seated, subjects lay supine on an MRI bed in a comfortable 
position with the legs supported by a foam cushion. The external and internal 
stimulation processes were carried out in the exact same manner as in Chapters 3 and 
6. Once a stable recording was attained, MSNA was recorded continuously for 5 
minutes of rest, prior to the subjects being wheeled from the laboratory to the scanner 
with the microelectrode remaining in situ.  
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2.1.2. Noxious stimulation protocol 
For all chapters, the noxious stimulation comprised a 7% hypertonic saline solution 
which was prepared by diluting sterile, 20% hypertonic saline with sterile water. Two 
syringes of 10 ml each were filled with the 7% hypertonic saline, placed in an infusion 
pump (Harvard Instruments, USA), and connected to a three-way tap via a 75cm 
extension tubing primed with hypertonic saline. A 23-gauge butterfly needle was then 
attached to the three-way tap via a cannula, primed, and inserted 1.5 cm deep into the 
belly of the ipsilateral tibialis anterior muscle, about 5 cm lateral and 10 cm inferior to 
the tibial tuberosity. The cannula was inserted as soon as a stable recording of 
spontaneous MSNA was achieved. Infusion of the 7% hypertonic saline solution was 
started at a time unknown to the subject and was maintained for 45 min; the pain lasted 
for ∼60min. The initial rate of infusion was set at 0.25ml/min and was constantly 
adjusted to maintain a pain level of 5–6/10 on a Numerical Rating Scale (NRS). 
Subjects were asked to rate their pain continuously by sliding a linear potentiometer 
(Response Meter, ADInstruments, Sydney, Australia) that was calibrated to the NRS, 
with a rating of “0” meaning “no pain/discomfort” at all, and a rating of “10” being 
equivalent to the “worst pain the subject ever had experienced.” For the imaging 
studies, the subjects’ pain ratings were monitored continuously and adjusted according 
to each subject pressing four colour-coded buttons, each colour associated with either 
“pain onset,” “pain at 5/10,” “pain below 5/10,” or “pain above 5/10.” When the pain 
level dropped below 4/10 or rose above 6/10, the infusion rate was changed by 0.02 
ml/min accordingly. After the infusion was completed, the recording was continued 
until the pain stopped.  
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2.1.3. MSNA-coupled fMRI 
For the studies that included imaging, the brain was scanned using a 3 Tesla MRI 
scanner (Philips Achieva, 32-channel SENSE head coil). The head was immobilized 
in the head coil, and padding was added to prevent head movement. Two scans 
encompassing the whole brain were collected: a high-resolution 3D T1-weighted 
anatomical image (200 axial slices, echo time (TE)=2.5 ms, repetition time (TR)=5600 
ms, raw voxel size = 0.87 mm3), followed by a series of 250 gradient echo echo-planar 
sensitive to blood oxygen level dependent contrast (BOLD) fMRI images (46 axial 
slices, (TE)=40 ms, (TR)=8 s, raw voxel size = 1.5 x 1.5 x 3.25 mm3). During the fMRI 
scan, all axial slices were collected during the first 4 seconds of the 8 s TR. 
Functional magnetic resonance imaging (fMRI) measures changes is blood oxygen 
levels, in order to infer neuronal activity (Logothetis et al., 2001). It can be used both 
for resting state or responses to stimulation, such as noxious inputs. As mentioned 
above, the protocol for simultaneously measuring MSNA and functional magnetic 
resonance imaging, a scan repetition time of 8 sec, including 4 sec image collection 
period, followed by 4 sec of rest, during which MSNA is recorded. This procedure 
allows one to take advantage of the temporal delays inherent in blood oxygen level 
dependent (BOLD) imaging, where microvascular responses to an increase in neuronal 
activity lag by about 5 sec (Logothetis et al., 2001). One second is removed in order 
to account for the time taken for a volley of MSNA to travel from the brainstem to the 
peripheral recording site at the level of the fibular head (Fagius & Wallin, 1980). 
Thereby, changes in BOLD signal intensity that are temporally coupled to MSNA 
reflect changes in neural activity with the production of the bursts of MSNA recorded 
4 seconds previously.  
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2.2. Analytical procedures 
2.2.1. MSNA and cardiorespiratory parameters 
LabChart 7 Pro software (ADInstruments, Sydney, Australia) was used to record the 
following parameters: muscle sympathetic nerve activity (burst amplitude and 
frequency), heart rate, blood pressure, respiration, pulse pressure, heart rate variability 
(HRV), and pain ratings. Individual bursts of MSNA were displayed as a mean-voltage 
neurogram, computed as the root-mean-square (RMS) processed signal with a moving 
time average window of 200 ms. This signal was then analysed using the “Peak 
Analysis” module of the LabChart 7 Pro software to calculate the amplitude of each 
burst. The absolute values were averaged into 5-min blocks and reported as 
percentages from the “baseline” values. An average of all blocks was taken to 
determine the direction of the response. Subjects with overall average MSNA 
amplitude 10% lower than baseline were arbitrarily assigned to the decreasing group; 
averages 10% higher than baseline were considered as increasing. Baseline MSNA 
amplitude was compared to the 5-min block with the mean value calculated over the 
entire infusion period, and to the highest average for the increasing group and to the 
lowest average value for the decreasing group. Changes in mean heart rate and mean 
blood pressure were also measured in 5 min epochs, normalized to the baseline value 
prior to the infusion of hypertonic saline. 
2.2.2. fMRI  
For Chapters 4 and 5, using Statistical Parametric Mapping 12 (Wellcome Trust Centre 
for Neuroimaging, University College London, UK) the fMRI images were realigned 
and spatially normalized to the Montreal Neurological Institute (MNI) template. The 
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VBM8 toolbox DARTEL template was used, which was derived from 550 healthy 
control subjects of the IXI database (http://brain-development.org/) and is in MNI152 
space. The images were then intensity normalized to eliminate any slow drift in signal 
intensity, and bias corrected. Once realigned and spatially normalized, the images were 
then smoothed using a 6mm full-width at half-maximum Gaussian filter. A brainstem-
only analysis was also performed: it was isolated and spatially normalised using the 
Spatial Unbiased Infratentorial Template (SUIT) using the SUIT toolbox (Diedrichsen 
et al., 2011), intensity normalised, bias corrected, and smoothed using a 4mm FWHM 
Gaussian filter. Signal intensity changes were measured during the subsequent 4s (ON), 
taking into account the 5 second neurovascular coupling delay between a neuronal 
event and the peak BOLD signal (Logothetis et al., 2001) and the 1 second required 
for the burst of MSNA to travel from the brain to the peripheral recording site (Fagius 
& Wallin, 1980). Because the images were collected in a caudal to rostral direction, 
the region of the brainstem from the caudal medulla to the rostral pons was scanned in 
the 1st second, the rostral pons to the diencephalon in the 2nd second, the diencephalon 
and surrounding cortex in the 3rd second, and the remainder of the cortex in the 4th 
second. 
For Chapter 4, signal intensity changes were searched for using a box-car design, with 
a baseline period of 60 volumes (scans 16–75) and a pain period of 175 volumes (scans 
76–250). A one-sample random effects analysis was performed with all subjects in a 
single group to determine signal intensity changes associated with the pain period (p 
< .05, family wise error corrected). To determine regions in which signal intensity 
changes were different in the increasing versus decreasing MSNA group, a two-sample 
random effects analysis was performed using both the whole-brain and brainstem only 
images (p < .001, uncorrected). 
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For Chapter 5, the analysis methods differed from Chapter 4 as the aim was to identify 
brain regions that were functionally coupled to the generation of bursts of MSNA at 
rest and during pain. In each subject, and for each of the 4 s periods, the brain volumes 
during periods in which there were no bursts were averaged to create a mean “no 
MSNA burst” image. Similarly, brain volumes during periods in which there were 
MSNA bursts were averaged to create a mean “MSNA burst” image. These two images 
were created for the baseline and tonic pain periods separately. To determine brain 
areas in which signal intensity was greater during MSNA bursts compared to periods 
of no MSNA bursts, we entered these two images for the baseline period into a second 
level, random effects paired t-test for each of the 4-second periods. To determine 
changes in MSNA-coupled BOLD signal intensity evoked by tonic pain, we subtracted 
the mean “MSNA no burst” image from the mean “MSNA burst” image during the 
baseline and tonic pain periods. This resulted in a single baseline and a single tonic 
pain image for each subject, of which each voxel’s signal intensity value reflected the 
difference between periods of no bursts compared to periods of MSNA bursts. The 
percentage difference between these two images was then calculated for each voxel, 
resulting in a brain map in which each voxel’s value was the percentage change in 
MSNA-coupled signal intensity during tonic pain compared with baseline.
 CHAPTER 3   Inter-individual responses to experimental 
muscle pain: baseline anxiety ratings and attitudes to pain 
do not determine the direction of the sympathetic response 
to tonic muscle pain in humans 
 
 
 
Chapter 3 is published as: 
Kobuch, S., Fazalbhoy, A., Brown, R., Macefield, V.G. (2016): Inter-individual  
responses to experimental muscle pain: Baseline anxiety ratings and attitudes to 
pain do not determine the direction of the sympathetic response to tonic muscle 
pain in humans. Int J Psychophysiol 104:17–23. 
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3.1. Abstract 
We have recently shown that intramuscular infusion of hypertonic saline, causing pain 
lasting ~ 60 min, increases muscle sympathetic nerve activity (MSNA) in one group 
of subjects, yet decreases it in another. Across subjects these divergent sympathetic 
responses to long-lasting muscle pain are consistent over time and cannot be foreseen 
on the basis of baseline MSNA, blood pressure, heart rate or sex. We predicted that 
differences in anxiety or attitudes to pain may account for these differences. 
Psychometric measures were assessed prior to the induction of pain using the State 
and Trait Anxiety Inventory (STAI), Pain Vigilance and Awareness Questionnaire 
(PVAQ), Pain Anxiety Symptoms Scale (PASS) and Pain Catastrophizing Scale 
(PCS); PCS was also administered after the experiment. MSNA was recorded from the 
common peroneal nerve, before and during a 45-minute intramuscular infusion of 
hypertonic saline solution into the tibialis anterior muscle of 66 awake human subjects. 
Forty-one subjects showed an increase in mean burst amplitude of MSNA (172.8 ± 
10.6%) while 25 showed a decrease (69.9 ± 3.8%). None of the measured 
psychological parameters showed significant differences between the increasing and 
the decreasing groups. We conclude that inter-individual anxiety or pain attitudes do 
not determine whether MSNA increases or decreases during long-lasting experimental 
muscle pain in healthy human subjects.  
3.2. Introduction 
Similar to the sensory aspects of pain – superficial pain being perceived as sharp or 
burning, and deep pain as dull and aching (Henderson, Bandler, Gandevia, & 
Macefield, 2006) – the cardiovascular responses to noxious inputs vary according to 
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the tissue of origin. In 1942, it was shown that superficial pain (arising from skin) 
resulted in an increased pulse rate, whereas pain that arose from deeper structures 
(muscle) showed a decrease in pulse rate and blood pressure (Lewis, 1942). Feinstein 
and colleagues confirmed these findings in 1954, when they found that muscle pain 
was associated with a fall in blood pressure, as well as bradycardia, in awake human 
subjects (Feinstein et al., 1954).  
3.2.1. Pain and sympathetic nerve activity 
Over the past few years we have been using intramuscular as well as subcutaneous 
injections of hypertonic saline to examine the effects of deep and superficial pain on 
muscle sympathetic nerve activity (MSNA) in awake human subjects (Burton et al., 
2009a). Interestingly, it was shown that both types of pain – when hypertonic saline 
was injected as a bolus – caused an increase in MSNA (Burton et al., 2009a) and a 
transient increase in skin sympathetic nerve activity (SSNA; Burton et al., 2009b). 
These results support previous findings of increased cardiovascular responses to deep 
and superficial pain in animals (Boczek-Funcke et al., 1992; Horeyseck & Jänig, 
1974b; Sato et al., 1984). 
 
In more recent studies we have used intramuscular infusion of hypertonic saline to 
produce a sustained, steady-state level of pain (Fazalbhoy et al., 2012, 2014; Hall et 
al., 2012). This continuous nociceptive input has been shown to produce a transient 
increase in skin sympathetic nerve activity (SSNA) followed by a sustained decrease 
in SSNA in all subjects (Hall et al., 2012), yet divergent muscle sympathetic responses, 
such that half of the subjects experienced a sustained increase in MSNA, blood 
pressure and heart rate during tonic muscle pain, while the other half showed sustained 
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decreases (Fazalbhoy et al., 2012, 2014; Kobuch et al., 2015). Moreover, the direction 
of the sympathetic response to tonic muscle pain was reproducible (Fazalbhoy et al., 
2014). That is, subjects who had an increase in MSNA, blood pressure, and heart rate 
during the first session showed a similar response in a subsequent session, conducted 
weeks apart. This consistency was also true for the subjects experiencing a fall in 
MSNA. We recently showed that the divergent muscle sympathetic responses to 
muscle pain cannot be explained by sex or by differences in resting blood pressure, 
heart rate, heart rate variability or MSNA (Kobuch et al., 2015).  
 
So, we are left with trying to understand why these two divergent patterns of 
sympathetic response to long-lasting muscle pain come about. Here, we posit that 
psychological differences may account for the different physiological responses. In 
particular, given that increases in sympathetic nerve activity are features of the fight 
or flight response to a threatening stimulus, we speculate that subjects showing higher 
anxiety levels, or greater negative attitudes to pain, will show increases in MSNA 
during tonic muscle pain, while those who are better able to cope do not.  
3.2.2. Negative emotions and pain 
Catastrophizing – “an exaggerated negative mental set brought to bear during actual 
or anticipated painful experience” (Sullivan et al., 2001)– has been associated with 
increased distress and higher pain ratings during painful interventions (Chaves & 
Brown, 1987; Spanos, Radtke-Bodorik, Ferguson, & Jones, 1979; Sullivan, Adams, 
Rhodenizer, & Stanish, 2006). Parallel increases in catastrophic thinking and intensity 
of pain (Carter et al., 2002; Sullivan et al., 2006), as well as severity of depression and 
anxiety (Keefe, Brown, Wallston, & Caldwell, 1989; Martin et al., 1996), have also 
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been observed. Accordingly, one might expect that subjects with high catastrophizing 
scores would exhibit greater sympathetic responses to pain.  
3.2.3. Anxiety and MSNA 
It is well known that patients with anxiety have an elevated cardiovascular risk 
(Musselman, Evans, & Nemeroff, 1998; Rosengren et al., 2004). Metabolic syndrome 
patients with anxiety and mood disorders have greater MSNA burst frequency at rest, 
compared to metabolic syndrome patients and controls without these psychological 
symptoms  (Toschi-Dias et al., 2013). Moreover, single unit recordings from muscle 
vasoconstrictor neurones in metabolic syndrome patients with high blood pressure 
revealed a higher incidence of multiple firing during a burst when levels of anxiety 
were high (Lambert et al., 2010). This disturbed sympathetic firing pattern was also 
found in patients with panic disorder and major depressive disorder (Lambert et al., 
2006, 2008). Other indirect measures of sympathetic activity, such as pulse transit time 
(Richards & Bertram, 2000) and catecholamine levels (Villacres, Hollifield, Katon, 
Wilkinson, & Veith, 1987), have also been shown to reflect higher sympathetic nerve 
activity - with higher levels of anxiety in healthy participants and panic disorder 
patients. Therefore, we might expect that anxious subjects would show an increase in 
sympathetic activity during pain.  
 
Given the above, in the current study we administered questionnaires to subjects before 
and after an intramuscular infusion of hypertonic saline to test the hypothesis that 
elevated levels of anxiety, and/or negative attitudes to pain, leads to a higher 
prevalence of increases than decreases in MSNA during tonic muscle pain.  
 60 
3.3. Methods 
Experiments were carried out on 66 healthy subjects (27 females, 39 males), aged 18 
to 39 years. All subjects provided written informed consent to the experimental 
procedures, which were conducted under the approval of the Human Research Ethics 
Committee of Western Sydney University and satisfied the requirements of the 
Declaration of Helsinki. No subject had any history of cardiovascular disease, chronic 
musculoskeletal pain, or mental health disorders.  
3.3.1. Psychometric measures 
Prior to commencing the experiment, the following psychological questionnaires were 
administered: The State and Trait-Anxiety Inventory (STAI), Pain Vigilance and 
Awareness Questionnaire (PVAQ), Pain Catastrophizing Scale (PCS), and Pain 
Anxiety Symptoms Scale (PASS). The PCS was also administered after the experiment 
to assess the subject's attitudes to the pain experience during the experiment. The STAI 
is commonly used to measure state (S) and trait (T) anxiety (Spielberger et al., 1983). 
The inventory contains 20 items for assessing state anxiety, which gauges a person's 
feelings of anxiety at a particular time, and 20 items for assessing trait anxiety, which 
evaluates a person's feelings of anxiety in general. Each item is rated on a 4-point scale 
from “almost never” to “almost always,” with scores ranging from 20 to 80 for each 
subtest. Higher scores indicate greater anxiety, with a score of 39 – 40 suggesting 
clinically significant symptoms (Knight, Waal-Manning, & Spears, 1983; Spielberger, 
et al., 1983). The PVAQ (McCracken, 1997) is a 16-item questionnaire that measures 
attention to pain. The PCS encompasses three dimensions of catastrophizing: 
rumination (“I can't stop thinking about how much it hurts”), magnification (“I worry 
that something serious may happen”), and helplessness (“it's awful and I feel that it 
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overwhelms me”; Sullivan et al., 1995). The subject is asked to reflect on previous 
painful experiences, and to indicate on a 5-point scale (0 being “not at all” and 4 being 
“all the time”) the degree to which they experienced each of the 13 feelings during 
pain. Summing responses of all 13 items gives a total PCS score, ranging from 0 to 52, 
and a score ≥ 30 represents a clinically significant level of catastrophizing attitude 
towards pain (Sullivan et al., 1995). The PASS (McCracken et al., 1992) is a tool to 
measure fear of pain across “cognitive, overt behavioural, and physiological domains” 
(McCracken et al., 1992). This study incorporated the PASS-20, a short version of the 
PASS, as an instrument to assess fear avoidance behaviour of pain, which has a 
significant correlation with the suffering and disability of chronic pain (McCracken & 
Dhingra, 2002). 
3.3.2. Experimental procedures 
Once the questionnaires were completed, the subjects were seated in a comfortable 
reclined position with the legs supported in an extended position. The protocol for 
MSNA and cardiorespiratory parameters measurement, as well as noxious stimulation 
procedures were described in the general methods section. At the conclusion of the 
experiment, each subject completed a McGill Pain Questionnaire, in which the quality 
of the pain was described using a standardised set of descriptors.  
3.3.3. Statistical analysis 
Statistical analysis consisted of non-paired two tailed t-tests, paired t-tests to assess 
pain-related changes in MSNA amplitude, and linear regression. Correlation 
coefficients between psychometric measures as well as between the psychometric 
measures and MSNA were also calculated. Statistical analyses were performed using 
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Prism version 6 for Mac OS X (GraphPad software, San Diego, California, USA). All 
values are expressed as means and standard error. Probability levels of p < .05 were 
deemed significant.  
3.4. Results 
3.4.1. Subjective experience of tonic muscle pain  
Intramuscular infusion of hypertonic saline solution into the tibialis anterior muscle 
caused a sustained dull ache in the muscle belly that often extended into the ankle. The 
level of pain was kept constant, around 5 out of 10 on the Numeric Rating Scale (NRS), 
by adjusting the rate of the infusion according to the subject's feedback.  
3.4.2. Muscle sympathetic nerve activity during tonic muscle pain  
As reported previously, infusion of hypertonic saline evoked two divergent patterns of 
MSNA response: 41 subjects showed a significant increase in burst amplitude (172.8 
± 10.6%, p < .001, t-test) during the steady-state of pain, while 25 showed a significant 
decrease relative to baseline (69.9 ± 3.8%, p < .0001, t-test). This is illustrated 
graphically in Figure 3.1A. There were no significant differences between the groups 
in baseline MSNA burst frequency: 13.3 ± 1.3 bursts/min in the increasing group and 
17.1 ± 1.5 bursts/min in the decreasing group (p = .07, t-test). The average burst 
frequency during pain was 15.8 ± 1.3 bursts/min in the increasing group and 12.4 ± 
1.4 bursts/min in the decreasing group (p = .09, t-test). The difference between 
baseline and pain was not significantly different between the groups (2.5 ± 1.8 
bursts/min in the increasing group and −4.7 ± 2.1 bursts/min in the decreasing group).  
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3.4.3. Psychometric measures 
Table 3.1 shows the correlation matrix coefficients between each psychometric 
measure in the top part, and between the psychometric measures against MSNA in the 
lower part. While correlations between State Anxiety and other psychometric 
measures were low – with the exception of Trait Anxiety – it is clear that correlations 
were generally higher (indicated by bold type) between the psychometric measures 
themselves, with no strong coupling between these measures and MSNA.  
 
When the psychological parameters were compared between the group of subjects who 
showed an increase in MSNA during tonic muscle pain and the group who showed a 
decrease, there were no differences in state anxiety scores (34.0 ± 1.7 vs 33.8 ± 2.2,  
p = .92, t-test; Figure 3.1B) or trait anxiety scores (34.2 ± 1.4 vs 35.6 ± 1.7, p = .60, t-
test; Figure 3.1C). The state anxiety scores ranged from 20 to 52 in both the increasing 
and decreasing MSNA groups. The trait anxiety scores ranged from 22 to 55 in the 
increasing group, and from 21 to 49 in the decreasing group. There were no differences 
in pain vigilance and awareness scores (34.7 ± 2.0 vs 33.7 ± 2.1, p = .75, t-test; Figure 
3.1E), the scores ranging from 0 to 60 in the increasing group, and from 15 to 50 in the 
decreasing group. Pain anxiety symptoms scores were also similar between the two 
groups (29.8 ± 2.7 vs 28.3 ± 3.2, p = .74, t-test; Figure 3.1D); scores ranged between 3 
and 72 in the increasing group, and between 2 and 51 in the decreasing group. Finally, 
there were no differences between the groups in pain catastrophizing scores measured 
either before (increasing group: 12.41 ± 1.2 vs decreasing group: 13.7 ± 1.7, p = .53, 
t-test; Figure 3.1F) or after the experiment (16.65 ± 1.7 vs 18.9 ± 2.1, p = .42, t-test; 
Figure 3.1G). PCS scores before the experiment ranged between 0 and 33 in the 
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increasing group, and between 0 and 25 in the decreasing group. PCS scores after the 
experiment ranged between 1 and 39 in the increasing group and 3 and 35 in the 
decreasing group.  
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Figure 3.1: Anxiety and attitudes to pain scores for the increasing and decreasing MSNA 
groups. 
Changes in MSNA amplitude (A), state anxiety scores (B), trait anxiety scores (C), PASS 
scores (D), PVAQ scores (E), pre-experiment PCS scores (F), and post-experiment PCS scores 
(G) for each group. 
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Table 3.1: Correlation coefficients between psychometric measures and between 
psychometric measures and MSNA. 
Significant correlations are shown in bold. 
 
 State 
anxiety 
Trait 
anxiety 
PVAQ PASS PCS 
pre 
PCS post 
State anxiety 1 0,44 0,07 0,09 0,21 0,01 
Train anxiety 0,44 1 0,04 0,11 0,05 0,00 
PVQA 0,07 0,04 1 0,53 0,40 0,08 
PASS 0,09 0,11 0,53 1 0,28 0,16 
PCS pre 0,21 0,05 0,40 0,28 1 0,19 
PCS post 0,01 0,00 0,08 0,16 0,19 1 
Change in MSNA 0,00 0,01 0,00 0,00 0,05 0,02 
3.4.4. Anxiety and MSNA 
As depicted in Figure 3.2 there was no significant relationship between state anxiety 
levels and baseline MSNA burst frequency (R2 = 0.025; Figure 3.2A) or changes in 
MSNA burst amplitude (Figure 3.2B; Table 3.1). Similarly, neither trait anxiety levels 
and baseline MSNA burst frequency (R2 = 0.002; Figure 3.2C), nor trait anxiety and 
changes in MSNA amplitude (Figure 3.2D; Table 3.1) showed any correlation.  
3.4.5. Attitudes to pain vs MSNA 
There was no significant relationship between the scores recorded for the Pain Anxiety 
Symptoms Scale (PASS) and baseline MSNA frequency (R2 = 0.099), although the 
line deviated significantly from zero (Figure 3.3E), or changes in MSNA amplitude 
(Figure 3.3F; Table 3.1). Likewise, although the line deviated significantly from zero, 
there was no statistically significant relationship between the scores recorded for the 
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Pain Vigilance Anxiety Questionnaire (PVAQ) and baseline MSNA frequency (R2 = 
0.083; Figure 3.3G), and changes in MSNA amplitude (Figure 3.3H; Table 3.1).  
 
 
Figure 3.2: Relationship between state anxiety scores and MSNA. 
State anxiety scores plotted against baseline MSNA frequency (A), and against changes in 
MSNA amplitude (B). Trait anxiety scores plotted against baseline MSNA frequency (C), and 
against changes in MSNA amplitude (D). 
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Figure 3.3: PASS and PVAQ scores plotted against MSNA. 
PASS scores plotted against baseline MSNA frequency (E), and against changes in MSNA 
amplitude (F). PVAQ scores plotted against baseline MSNA frequency (G), and against 
changes in MSNA amplitude (H). 
3.4.6. PCS vs MSNA 
The Pain Catastrophizing Scale (PCS) was administered before and after the 
experiment. The scores before the experiment pertained to the subject's pain 
experience in general, the values recorded after referred to the subject's pain 
experience during the experiment reveal that there was no significant relationship 
between the PCS scores before the experiment (R2 = 0.05; Figure 3.4A) and baseline 
MSNA burst frequency, and changes in MSNA burst amplitude (Figure 3.4B; Table 
3.1). Finally, there was no statistically significant correlation between the PCS scores 
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obtained after the experiment and baseline MSNA levels (R2 = 2.922e- 006; Figure 
3.4C), or changes in MSNA amplitude (Figure 3.4D; Table 3.1).  
 
 
Figure 3.4: Relationship between PCS and MSNA. 
PCS pre-experiment scores plotted against baseline MSNA frequency (A), and against changes 
in MSNA amplitude (B). PCS post-experiment scores plotted against baseline MSNA 
frequency (C), and against changes in MSNA amplitude (D). 
3.5. Discussion 
This study adds to our body of work investigating the effects of experimental muscle 
pain on the sympathetic nervous system (Burton et al., 2009a,b; Burton et al., 2008; 
Fazalbhoy et al., 2012, 2014; Hall et al., 2012; Kobuch et al., 2015). We have shown 
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that, across subjects, the divergent cardiovascular responses to long-lasting 
experimental muscle pain are not dependent on anxiety levels. Neither did different 
attitudes to pain provide a significant prediction as to whether a subject would show 
an increase or a decrease in MSNA during muscle pain. Both the increasing and 
decreasing MSNA groups had similar scores in all psychological parameters measured 
in this study. Moreover, higher scores did not correlate with higher MSNA levels at 
rest, or with the degree of change in MSNA burst amplitude during tonic muscle pain.  
As stated in the Introduction, we had good reasons to think that anxiety levels or 
attitudes to pain may determine whether MSNA increases or decreases during tonic 
muscle pain. Chaves and Brown (1987) noticed that patients who were excessively 
negative during a dental procedure were more likely to experience distress at the time 
of the intervention. Spanos et al. (1979) interviewed subjects on the level of pain 
following a cold-pressor test and observed that individuals who engaged in 
catastrophic thinking reported the highest levels of pain. Moreover, Keefe et al. (1989) 
showed that “catastrophizers” with chronic pain had increased physical and emotional 
suffering associated with their pain condition. Higher scores have also been shown to 
predict the persistence of pain and development of chronic pain (Pavlin, Sullivan, 
Freund, & Roesen, 2005; Picavet, Vlaeyen, & Schouten, 2002), and have been linked 
to increased levels of depression, anxiety, and fear (Börsbo, Peolsson, & Gerdle, 2008; 
Drahovzal, Stewart, & Sullivan, 2006; Edwards, Smith, Kudel, & Haythornthwaite, 
2006; Leeuw et al., 2007). Furthermore, there are significant relationships between 
measures of depression, anxiety, fear, and anger, and increased pain experience 
(Leeuw et al., 2007; Sullivan & N. Neish, 1999; Rudy, Kerns, & Turk, 1988), with 
Carroll et al. (2004) suggesting that symptoms of depression might increase the 
chances of musculoskeletal pain exacerbation. Similarly, fear and avoidance of pain 
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have been shown to exhibit a tight correlation with the suffering and disability 
associated with chronic pain (McCracken & Dhingra, 2002). 
 
The influences of anxiety, panic disorder, and depression on the sympathetic nervous 
system have recently gained much attention, in particular with respect to their 
contributions to increased cardiovascular risk (Lambert et al., 2008; Musselman et al., 
1998; Rosengren et al., 2004). Altered sympathetic activity, either through distorted 
baroreflex function (Lambert et al., 2002), elevated resting MSNA (Toschi-Dias et al., 
2013), disturbed firing patterns of individual sympathetic neurons (Lambert et al., 
2006, 2010), or increased catecholamine levels (Villacres et al., 1987) have been 
reported. Nevertheless, despite the known effects of certain psychological parameters 
on MSNA and pain experience, we found no differences in these psychometric 
measures between the increasing and decreasing MSNA groups. Accordingly, we 
reject the hypothesis we set out to test. So, given that neither baseline physiological or 
psychological differences exist between the two groups of subjects, we are left with 
trying to explain why there are two divergent muscle sympathetic responses to long-
lasting muscle pain.  
 
Based on studies in experimental animals it is entertaining to speculate that differences 
may exist in the brain to account for the two patterns of response. In the brainstem the 
nucleus tractus solitarius (NTS) and the periaqueductal grey (PAG) may be two key 
players in this response, as they are two important supraspinal structures that receive 
both cardiovascular information as well as nociceptive input (Bruehl & Chung, 2004). 
While the NTS is the first synapse in the baroreflex and also receives projections from 
spinal laminae involved in nociception, the PAG processes noxious stimuli (Carrive & 
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Bandler, 1991), and mediates different patterns of autonomic activity depending on 
the stressor (Bandler et al., 2000). Indeed, stimulation of the lateral columns of the 
PAG (lPAG) preferentially induces a fight-or-flight response, with increases in blood 
pressure and heart rate, similar to the response evoked by cutaneous pain (Depaulis et 
al., 1992). Conversely, stimulation of the ventrolateral columns of the PAG (vlPAG) 
promotes rest, with a parallel decrease in blood pressure and heart rate – as seen during 
experimental deep pain in animals (Depaulis et al., 1992). Therefore, it is plausible 
that when the NTS and PAG receive information about painful stimuli from higher 
centres, parallel changes in blood pressure, heart rate, and muscle sympathetic nerve 
activity are also seen. However, in the absence of direct evidence, this remains pure 
speculation.  
3.6. Limitations 
It should be emphasized that the participants included in the study were all healthy 
volunteers willing to be exposed to 1 h of strong pain. While all participants were 
informed that they could stop the infusion at any time and withdraw from the 
experiment, no one did so. In this way, we can see that all participants coped well with 
the pain, which may well differ if we targeted a population who were recruited on the 
basis of high anxiety or pain anxiety scores. Nevertheless, the ranges of scores in each 
of the psychometric measures were sufficiently wide in the 66 participants to indicate 
that we were recruiting a representative sample of healthy subjects, some of whom 
exhibited high anxiety and some low.  
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3.7. Conclusions 
Contrary to our prediction, baseline anxiety levels or attitudes towards pain do not 
explain the divergent sympathetic responses we observe, nor do they appropriately 
predict whether a given individual shows an increase or a decrease in muscle 
sympathetic nerve activity during long-lasting muscle pain. These findings add to our 
earlier conclusions that the divergent sympathetic responses cannot be explained by 
baseline MSNA, blood pressure, heart rate or sex. Whether differences exist in the 
cortical and subcortical processing of muscle pain in the two groups remains to be seen. 
 CHAPTER 4   Central circuitry responsible for the 
divergent sympathetic responses to tonic muscle pain in 
humans 
 
 
 
 
Chapter 4 is published as: 
Kobuch, S., Fazalbhoy, A., Brown, R., Henderson, L.A., Macefield, V.G. (2017):  
Central circuitry responsible for the divergent sympathetic responses to tonic 
muscle pain in humans. Hum. Brain Mapp. 38:869-881. 
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4.1. Abstract 
Experimentally induced tonic muscle pain evokes divergent muscle vasoconstrictor 
responses, with some individuals exhibiting a sustained increase in muscle 
sympathetic nerve activity (MSNA), and others a sustained decrease. These patterns 
cannot be predicted from an individual’s baseline physiological or psychological 
measures. The aim of this study was to investigate whether the different muscle 
sympathetic responses to tonic muscle pain were associated with differential changes 
in regional brain activity. Functional magnetic resonance imaging (fMRI) of the brain 
was performed concurrently with microelectrode recording of MSNA from the 
peroneal nerve during a 40-min infusion of hypertonic saline into the ipsilateral tibialis 
anterior muscle. MSNA increased in 26 and decreased in 11 of 37 subjects during tonic 
muscle pain. Within the prefrontal and cingulate cortices, precuneus, nucleus 
accumbens, caudate nucleus, and dorsomedial hypothalamus, blood oxygen level 
dependent (BOLD) signal intensity increased in the increasing-MSNA group and 
remained at baseline or decreased in the decreasing-MSNA group. Similar responses 
occurred in the dorsolateral pons and in the region of the rostral ventrolateral medulla. 
By contrast, within the region of the dorsolateral periaqueductal grey (dlPAG) signal 
intensity initially increased in both groups but returned to baseline levels only in the 
increasing-MSNA group. These results suggest that the divergent sympathetic 
responses to muscle pain result from activation of a neural pathway that includes the 
dlPAG, an area thought to be responsible for the behavioural and cardiovascular 
responses to psychological rather than physical stressors.  
  76 
4.2. Introduction 
Research in experimental animals has revealed that noxious stimulation of different 
body tissues evokes different behavioural and cardiovascular responses. That is, 
cutaneous pain elicits fight/flight behaviours, coupled with increases in heart rate, 
blood pressure and sympathetic vasoconstrictor drive, whereas muscle and visceral 
pain bring about quiescence and decreases in heart rate, blood pressure and 
vasoconstrictor drive (Keay & Bandler, 2001). Although some clinical observations in 
humans suggested similar divergent responses (Lewis, 1942; Feinstein et al., 1954), 
we found that acute cutaneous or muscle pain, induced by bolus subcutaneous or 
intramuscular injection of hypertonic saline, both evoked transient (􏰀30 s) increases 
in skin sympathetic nerve activity (SSNA) and heart rate, with small sustained 
increases in blood pressure and muscle sympathetic nerve activity (MSNA) that 
matched the duration of pain (Burton et al., 2009a,b; Hall et al., 2012; for review see 
Burton et al., 2016). These data demonstrate that, in humans, differential sympathetic 
responses to acute cutaneous and muscle pain do not occur. Moreover, we had shown 
that these sympathetic responses are psychogenic rather than of spinal reflex origin, as 
they do not occur when noxious stimuli are delivered to the legs in individuals with 
complete spinal cord injury (Brown & Macefield, 2008).  
 
We recently found that prolonged muscle pain, induced by intramuscular infusion of 
hypertonic saline, is accompanied by two patterns of change in MSNA, with subjects 
showing either a sustained increase or a sustained decrease in MSNA (Burton et al., 
2016; Fazalbhoy et al., 2012, 2014; Kobuch et al., 2015; Kobuch, Fazalbhoy, Brown, 
& Macefield, 2016). These divergent patterns of MSNA are reproducible over time 
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(Fazalbhoy et al., 2014), and not based on sex, or differences in resting MSNA, blood 
pressure, or heart rate (Kobuch et al., 2015). Moreover, anxiety and attitudes to pain 
do not account for these divergent sympathetic responses to muscle pain  (Kobuch et 
al., 2016). Interestingly, chronic pain is associated with a significantly greater risk of 
hypertension, particularly in females, and it has been proposed that this comorbidity 
reflects fundamental alterations in the relationship between the cardiovascular and pain 
regulatory systems (Bruehl et al., 2005). Although the underlying brain circuitry 
responsible for hypertension in individuals with chronic pain is not known, it is 
possible that the divergent responses we previously found to occur in healthy 
individuals during tonic muscle pain also reflect differences in interactions between 
pain and cardiovascular circuits even in healthy subjects.  
 
As noted above, given that noxious stimuli below the lesion in patients with complete 
spinal cord injury do not evoke any changes in blood pressure, heart rate, skin blood 
flow or sweat release, the circuitry responsible for pain-related changes in MSNA must 
lie within supraspinal sites (Burton et al., 2008). Studies in the cat suggest that the 
autonomic responses to pain form part of a behavioural response mediated by neurons 
in the midbrain periaqueductal grey matter (PAG; Bandler et al., 1991, 2000). Of 
course, numerous human brain imaging studies have also revealed a “central 
autonomic network” consisting of higher brain regions such as the insular, cingulate, 
and prefrontal cortices, as well as precuneus and amygdala (Benarroch, 1993; 
(Macefield & Henderson, 2016). Furthermore, recent con- current functional magnetic 
resonance imaging (fMRI) and microneurography studies from our laboratory have 
confirmed the function of the well-described autonomic-related regions of the 
brainstem, such as the rostral and caudal ventrolateral medulla, nucleus tractus 
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solitarius and dorsolateral pons (Lundblad et al., 2014; Macefield & Henderson, 2010, 
2016). The aim of the current study was to use concurrent fMRI and microelectrode 
recordings of MSNA to determine if these autonomic regions respond differentially in 
individuals who displayed increases versus those who displayed decreases in MSNA 
during tonic muscle pain. Given that the dorsomedial hypothalamus (DMH) is part of 
the classical hypothalamic defence area, evoking increases in blood pressure and heart 
rate in the cat (Coote, Hilton, & Perez-Gonzalez, 1979), we tested the hypothesis that 
a sustained increase in MSNA during long-lasting muscle pain is associated with a 
sustained increase in BOLD signal intensity of the DMH, while a sustained decrease 
in MSNA is associated with a sustained decrease in DMH activity. And given that the 
DMH has connections with the PAG and RVLM, we tested the hypothesis that a 
sustained increase or decrease in MSNA during tonic muscle pain is associated with 
parallel increases or decreases in signal intensity of the PAG and RVLM.  
4.3. Methods 
4.3.1. Participants 
Experiments were performed on 37 healthy university subjects (11 females; mean ± 
SEM age: 21.9 ± 0.5 years), each of whom had contributed psychometric data to our 
recent study in which we examined differences in anxiety and attitudes to pain in 66 
subjects (Kobuch et al., 2016). Subjects responded to an advertisement that outlined 
the procedures to be undertaken, including the nerve recording, muscle pain and fMRI; 
all procedures were approved by the Human Research Ethics Committees of Western 
Sydney University and the University of New South Wales. Written consent was 
obtained from all subjects in accordance with the Declaration of Helsinki.  
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4.3.2. Microneurography 
The protocol for MSNA measurement, as well as noxious stimulation procedures were 
described in the general methods section. MSNA was recorded continuously for 5 
minutes of rest, prior to the subjects being wheeled from the laboratory to the scanner 
with the microelectrode remaining in situ.  
4.3.3. Cardiovascular monitoring 
Before the scanning period, 5 minutes of continuous blood pressure were recorded 
using radial arterial tonometry (Colin 7000 NIBP; Colin Corp., Aichi, Japan). 
Respiration was measured using a strain-gauge transducer (Pneumotrace, UFI, Morro 
Bay, CA, USA), and heart rate was monitored with a piezoelectric pulse transducer 
placed on the big toe. The blood pressure monitor was removed before entering the 
scanner.  
4.3.4. MRI 
Using a 3 Tesla MRI scanner (Philips Achieva, 32-channel SENSE head coil), two 
scans encompassing the whole brain were collected: a high-resolution 3D T1-weighted 
anatomical image (200 axial slices, echo time (TE)=2.5 ms, repetition time (TR)=5600 
ms, raw voxel size = 0.87 mm3), followed by a series of 250 gradient echo echo-planar 
sensitive to blood oxygen level dependent contrast (BOLD) fMRI images (46 axial 
slices, (TE)=40 ms, (TR)=8 s, raw voxel size = 1.5 x 1.5 x 3.25 mm).  
 
During the fMRI scan, all axial slices were collected during the first 4 seconds of the 
8 s TR. Two 10 ml syringes filled with hypertonic saline were placed in an infusion 
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pump (Harvard Instruments, USA), and connected to a three-way tap via a 30 cm 
length of extension tubing primed with hypertonic saline. A 23 G butterfly cannula 
was then attached to the three-way tap, primed, and inserted 1.5 cm deep into the belly 
of the right tibialis anterior muscle, approximately 5 cm lateral and 10 cm inferior to 
the tibial tuberosity. An infusion of hypertonic saline solution (7%) was commenced 
during the 50th scan (volume 50) for all subjects and was sustained throughout the 
duration of the entire scanning period. Each subject was unaware of when the 
hypertonic saline infusion was to begin. The initial rate of infusion was set at 0.25 
ml/min and was constantly adjusted to maintain a pain level of 5 out of 10 on a 
Numerical Rating Scale (NRS; 0 = no pain, 10 = most intense pain imaginable). The 
subjects’ pain ratings were monitored continuously and adjusted according to each 
subject pressing four colour-coded buttons, each colour associated with either “pain 
onset,” “pain at 5/10,” “pain below 5/10,” or “pain above 5/10.” At the completion of 
the scanning session, each subject was asked to complete a McGill Pain Questionnaire 
(Melzack, 1975) and draw the area of perceived pain on a standard diagram of the leg.  
4.4. Analysis 
4.4.1. Pain psychophysics 
Using the points at which each subject indicated the onset of pain as well as when the 
pain reached 5/10, we plotted an estimate of the average pain intensity over time for 
all subjects. We found that, on average, pain began approximately 18 volumes after 
the start of the infusion, i.e., at volume 68, and first reached a 5/10 rating at 
approximately volume 72, after which it was sustained for the remaining scanning 
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period (Figure 4.1). These pain intensity changes were similar in all subjects, whether 
they were subsequently categorized as displaying an increase or a decrease in MSNA. 
4.4.2. MSNA 
Individual bursts of MSNA were displayed as a mean-voltage neurogram, computed 
as the root-mean-square (RMS) processed signal with a moving time average window 
of 200 ms. The 4 s inter-scan (OFF) period (see below) allowed the measurement of 
MSNA bursts. Bursts were manually counted and the amplitude was measured from 
the RMS-processed nerve signal. Scans 16 to 75 were selected as the baseline period 
and scans 76 to 250 as the tonic pain period. In each subject, the absolute values for 
MSNA amplitude were averaged for the pain period and reported as percentage change 
relative to the baseline period.  
4.4.3. Functional MRI 
Using Statistical Parametric Mapping 12 (Wellcome Trust Centre for Neuroimaging, 
University College London, UK) and custom software, all fMRI images were 
realigned, spatially normalized to the Montreal Neurological Institute (MNI) template, 
intensity normalized to eliminate any slow drift in signal intensity, and bias corrected. 
Scans were then smoothed using a 6mm full-width at half-maximum (FWHM) 
Gaussian filter. In addition, we performed a brainstem-only analysis for the subjects 
for whom the acquired images extended to the bottom of the caudal medulla (n = 30). 
The brainstem was isolated and spatially normalized to the Spatial Unbiased 
Infratentorial Template (SUIT) using the SUIT toolbox (Diedrichsen et al., 2011), 
intensity normalized, bias corrected, and smoothed using a 4mm FWHM Gaussian 
filter.  
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Signal intensity changes were measured during the subsequent 4 s (ON period), taking 
into account the (1) 5 s neurovascular coupling delay between a neuronal event and 
the peak BOLD signal (Logothetis et al., 2001) and the (2) 1 s required for the burst of 
MSNA to travel from the brain to the peripheral recording site (Fagius & Wallin, 1980). 
The first 15 scans were excluded to allow for global signal equilibration. We searched 
for signal intensity changes using a box-car design, with a baseline period of 60 
volumes (scans 16–75) and a pain period of 175 volumes (scans 76–250). A 
hemodynamic delay function was not included, given that we accounted for this delay 
in our analysis design. A one-sample random effects analysis was performed with all 
subjects in a single group to determine signal intensity changes associated with the 
pain period (p < .05, family wise error corrected). To determine regions in which 
signal intensity changes were different in the increasing versus decreasing MSNA 
group, a two-sample random effects analysis was performed using both the whole-
brain and brainstem only images (p < .001, uncorrected). Significant clusters were 
overlaid onto a standard whole-brain and brainstem template in MNI space. For each 
significant cluster, the percentage changes in signal intensity were extracted by 
comparing the signal intensity of the pain period to baseline. We also performed non-
paired two sample t-tests between baseline and pain for the signal intensity changes in 
each region that was significantly different between the increasing and decreasing 
MSNA groups. In addition, we performed correlation analyses in each subject to 
determine whether there were significant linear relationships between the peak or 
trough in MSNA amplitude against the corresponding BOLD signal intensity changes 
(Pearson’s correlation, p < .05); for each subject, the average change in MSNA or 
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BOLD signal intensity was calculated over 10 volumes. All results were expressed as 
mean ± SEM.  
4.5. Results 
4.5.1. Subjective experience of tonic muscle pain 
Intramuscular infusion of hypertonic saline solution induced moderately intense pain 
that began approximately 18 volumes (144 s) following the start of the infusion and 
quickly reached a pain rating of ~5/10 within approximately 4 volumes (32 s). The 
pain intensity remained at approximately this level for the remainder of the MRI 
session. A two-sample t-test revealed that there was no significant difference in the 
mean pain intensity ratings in the increasing MSNA compared with the decreasing 
MSNA group (increasing: 5.7 ± 0.2; decreasing: 6.0 ± 0.2; p = .28). In addition, there 
was no significant group difference between the total volume of hypertonic saline 
infused in either group (increasing: 18.8 ± 2.6 ml; decreasing: 18.1 ± 0.9 ml; p = .82) 
or the area of perceived pain spread (increasing: 1054 ± 102 pixels; decreasing: 1009 
± 131 pixels; p = .80; Figure 4.2). There was also no difference in the words chosen 
from the McGill pain questionnaire to describe the ongoing pain; both groups chose 
“dull,” “aching,” and “throbbing” to describe the pain (Figure 4.3).  
4.5.2. MSNA during tonic muscle pain 
Consistent with our previous findings, tonic muscle pain induced two distinct 
sympathetic responses: 26 subjects exhibited a significant increase in MSNA burst 
amplitude (71.8 ± 26.7%), while 11 subjects showed a significant decrease (-32.5 ± 
18.6%) throughout the pain period (p < .0001, t-test; Figure 4.1). The changes in MSNA 
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began at approximately the same time as the subjects first perceived pain and were 
sustained for the duration of the infusion. 
 
 
Figure 4.1: Plots of perceived pain intensity and MSNA amplitude changes during pain. 
Plots of perceived pain intensity and MSNA amplitude changes during continuous hypertonic 
saline solution infusion into the right tibialis anterior muscle of 37 subjects. The MSNA plot 
indicates mean (±SEM) percentage change in MSNA amplitude during pain relative to the 
baseline period in the increasing (black, n=26) and decreasing groups (grey, n = 11). The 
vertical dashed line indicates the start of the hypertonic saline infusion. The grey shading 
indicates the volumes during which all subjects were in moderate pain.  
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Figure 4.2: Pain intensity, pain area, and infusion volume in subjects who displayed increases 
and decreases in MSNA. 
Plots of mean (±SEM) pain intensity, pain area, and infusion volume in subjects that displayed 
increases and decreases in MSNA. 
 
 
Figure 4.3: Frequency of words most often chosen from the McGill pain questionnaire. 
Plots of the frequency of words most often chosen by subjects from the McGill pain 
questionnaire to describe the ongoing muscle pain. Note there is no difference in any of the 
pain parameters between the increasing and decreasing MSNA groups.  
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4.5.3. Signal intensity changes 
Pain was associated with significant increases in BOLD signal intensity in a number 
of brain regions that have been previously shown to be activated during acute muscle 
pain. In all 37 subjects BOLD signal intensity increased in the left (contralateral to the 
noxious stimulus) primary somatosensory cortex and right primary motor cortex in the 
region representing the leg and foot, contralateral secondary somatosensory cortex, 
contralateral anterior and dorsal posterior insular cortex, as well as bilaterally in the 
posterior cingulate cortex and the thalamus (Figure 4.5, Table 4.1).  
 
In none of these regions (Figure 4.4, Table 4.1) were there any significant differences 
in signal intensity between subjects in whom MSNA increased compared with those 
in whom MSNA decreased. However, a two-sample analysis revealed significant 
differences in other regions (Figure 4.5, Table 4.2). Signal intensity increased in the 
increasing MSNA group and remained unchanged in the decreasing MSNA group in 
the right (ipsilateral) dorsolateral prefrontal cortex (dlPFC: % change over entire pain 
period: increasing 1.13 ± 0.08 vs. decreasing 20.29 ± 0.07), left nucleus accumbens 
(NAc: increasing 1.46 ± 0.10 vs. decreasing -0.27 ± 0.09), right subgenual anterior 
cingulate cortex (sgACC: increasing 2.71 ± 0.18 vs. decreasing -0.46 ± 0.19) and left 
dorsomedial hypothalamus (DMH: increasing 1.52 ± 0.09 vs. decreasing 0.27 ± 0.09). 
By contrast, signal intensity increased during the pain period in the increasing MSNA 
group and decreased in the decreasing MSNA group in the left orbitofrontal cortex 
(OFC: increasing 1.76 ± 0.11 vs. decreasing -0.26 ± 0.09), left caudate nucleus 
(increasing 1.08 ± 0.09 vs. decreasing -0.99 ± 0.08) and left precuneus (increasing 0.61 
± 0.10 vs. decreasing -1.01 ± 0.10).  
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In addition, in the increasing MSNA group, the signal intensity changes were 
significantly different from baseline in the following cortical regions: dlPFC (p < .001), 
left OFC (p < .001), left hypothalamus (p < .001), left caudate (p < .001), subgenual 
ACC (p < .001), precuneus (p = .002). In the decreasing group, the signal intensity 
changes were significantly different from baseline in the following cortical regions: 
dlPFC (p < .001), left OFC (p < .001), left hypothalamus (p = .02), subgenual ACC (p 
< .001), precuneus (p < .001), and left accumbens (p < .001). 
 
In no region was signal intensity lower in the MSNA increasing group relative to the 
MSNA decreasing group. In the brainstem-specific analysis (n=30), we found 
significantly different signal intensity changes in the increasing compared with the 
decreasing MSNA group (Figure 4.6, Table 4.1). Signal intensity increased in the 
increasing MSNA group and remained at baseline levels in the MSNA decreasing 
group in the right lateral medulla, within the region of the rostral ventrolateral medulla 
(RVLM: increasing 1.08 ± 0.10 vs. decreasing 0.32 ± 0.09), right dorsolateral pons 
(dlPons: increasing 1.53 ± 0.10 vs. decreasing 0.27 ± 0.08) and the left dlPons 
(increasing 1.60 ± 0.10 vs. decreasing 0.39 ± 0.07). In direct contrast, BOLD signal 
intensity was significantly greater in the MSNA decreasing group compared with the 
increasing group in the region of the midbrain encompassing the left periaqueductal 
grey matter (PAG: increasing 0.61 ± 0.17 vs. decreasing 1.45 ± 0.17). This was the 
only region in the entire brain where signal intensity was greater in the MSNA 
decreasing group.  
 
Furthermore, the following regions showed significant signal intensity changes during 
pain compared to baseline in the increasing MSNA group: left PAG (p < .001), right 
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RVLM (p < .001), left dlPons (p < .001), right dlPons (p < .001). In the decreasing 
group the signal intensity changes during pain were significantly different from 
baseline in the left PAG (p < .001) and right RVLM (p = .04).  
 
 
Figure 4.4: Signal intensity increases during pain. 
Signal intensity increases (hot colour scale) during continuous hypertonic saline solution 
infusion into the right tibialis anterior muscle in all 37 subjects. Significant clusters were 
overlaid onto a mean T1-weighted anatomical image set created from all 37 subjects. Slice 
locations in MNI space are indicated in the upper left of each image. The left side of the image 
is the side contra- lateral to the noxious stimulus. M1: primary motor cortex; PCC: posterior 
cingulate cortex; S1: primary somatosensory cortex; S2: secondary somatosensory cortex.  
  
  89 
Table 4.1: Signal intensity increases in all subjects during muscle pain. 
Location in Montreal Neurological Institute space, t values, and cluster sizes of regions in 
which signal intensity increased in all subjects during tonic muscle pain. 
 
Signal intensity increases x y z t value Cluster size 
 
Orbitofrontal cortex 
     
Left (contralateral) -10 10 -20 6.85 9 
 
Insular cortex 
     
Left -30 
-38 
-36 
18 
10 
18 
-16 
-14 
-10 
8.10 
7.12 
6.87 
74 
 
Primary somatosensory cortex 
     
Left -10 -36 46 5.95 6 
 
Secondary somatosensory cortex 
     
Left -38 -30 18 7.08 55 
 
Primary motor cortex 
     
Right (ipsilateral) 4 
4 
4 
-14 
-20 
-14 
60 
58 
54 
6.39 
6.28 
6.17 
28 
 
Posterior cingulate cortex 
     
Right 
 
Left 
2 
6 
-4 
-40 
-42 
-42 
26 
24 
26 
7.02 
6.98 
6.62 
78 
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Figure 4.5: Regions above the brainstem showing signal intensity differences between 
subjects with increasing versus decreasing MSNA. 
A: Brain regions above the brainstem in which signal intensity increases were greater (hot 
colour scale) or lower (cool colour scale) in the increasing MSNA than in the decreasing 
MSNA group during tonic muscle pain. Significant clusters were overlaid onto a mean T1-
weighted anatomical image set created from all 37 subjects. Slice locations in MNI space are 
indicated in the upper right of each image. The left side of the image is the side contralateral 
to the noxious stimulus. B: Plots of mean (±SEM) percentage signal intensity changes during 
pain relative to the baseline period for significant clusters in the increasing MSNA (orange) 
and decreasing MSNA (blue) groups. The vertical dashed line indicates the start of the 
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hypertonic saline infusion and the grey shading the pain period. ACC: anterior cingulate 
cortex; DMH: dorsomedial hypothalamus. 
 
Table 4.2: Regions above the brainstem showing signal intensity differences between subjects 
with increasing versus decreasing MSNA. 
Locations in Montreal Neurological Institute space, t values and cluster sizes of regions in 
which signal intensity was significantly different in subjects that displayed increased muscle 
sympathetic nerve activity (MSNA) compared with those that showed decreased MSNA 
during tonic muscle pain. Only regions above the brainstem are included. 
 
Signal intensity increases x y z t value Cluster size 
 
Orbitofrontal cortex 
     
Left (contralateral) -20 24 -22 3.76 24 
 
Subgenual anterior cingulate cortex 
     
Right (ipsilateral) 6 
 
18 
 
-16 
 
3.25 
 
6 
Dorsomedial hypothalamus       
Left -2 -10 -8 3.51 7 
 
Nucleus accumbens 
     
Right 
Left 
10 
-4 
-10 
10 
 0 
-6 
3.67 
3.18 
18 
5 
 
Dorsolateral prefrontal cortex 
     
Right  
 
Caudate nucleus 
Left 
32 
 
-14 
 
48 
 
8 
 
6 
 
14 
 
3.78 
 
3.69 
14 
 
22 
 
Precuneus 
     
Left -6 
 
-52 
 
66 
 
4.40 
 
22 
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Figure 4.6: Brainstem regions showing signal intensity differences between the increasing and 
decreasing MSNA groups. 
A: Brainstem regions in which signal intensity increases were greater (hot colour scale) or 
lower (cool colour scale) in the increasing MSNA (n = 20) than in the decreasing MSNA (n = 
10) group during tonic muscle pain. Significant clusters were overlaid onto a mean SUIT T1-
weighted anatomical image set created from 30 subjects. Slice locations in MNI space are 
indicated in the upper right of each image. The left side of the image is the side contralateral 
to the noxious stimulus. B: Plots of mean (±SEM) percentage signal intensity changes during 
pain relative to the baseline period for significant clusters in the increasing MSNA (orange) 
and decreasing MSNA groups (blue). The vertical dashed line indicates the start of the 
hypertonic saline infusion and the grey shading the pain period. RVLM: rostroventrolateral 
medulla; dlPons: dorsolateral pons; PAG: midbrain periaqueductal grey. 
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Table 4.3: Brainstem regions showing signal intensity differences between subjects with 
increasing versus decreasing MSNA. 
Locations in Montreal Neurological Institute space, t values and cluster sizes of regions in 
which signal intensity was significantly different in subjects that displayed increased muscle 
sympathetic nerve activity (MSNA) compared with those that showed decreased MSNA 
during tonic muscle pain. Only brainstem regions are included. 
 
Signal intensity increases x y z t value Cluster size 
 
Rostroventrolateral medulla 
     
Right (ipsilateral)  8 -40 -49 4.30 12 
 
Dorsolateral pons 
     
Right  
Left (contralateral) 
 8 
-6 
-30 
-32 
-29 
-35 
3.28 
3.60 
3 
13 
Midbrain periaqueductal grey       
Left -4 -34 -5 3.20 2 
      
 
4.5.4. Correlation with MSNA 
In addition to differences in cortical and subcortical signal intensity changes between 
the increasing and decreasing MSNA groups, we found that changes in signal intensity 
in most of these regions were correlated with the peak/trough (maximum change) in 
MSNA amplitude (Figure 4.7). Positive correlations occurred in the left OFC 
(Pearson’s, r = 0.41, p = .02), right dlPFC (r = 0.43, p = 0.01), left precuneus (r = 0.50, 
p = .002), left dlPons (r = 0.45, p = .01), and right dlPons (r = 0.51, p = .004). In 
contrast, a negative correlation between increasing MSNA and signal intensity 
increases occurred in the left dorsolateral PAG (dlPAG; r = -0.43, p = .02). We found 
no significant linear relationships in the right RVLM (r = 0.33, p = .09), left NAc (r = 
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0.32, p = .07), left caudate nucleus (r = 0.23, p = .21), right sgACC (r = 0.27, p = .14), 
or left DMH (r = 0.25, p = .15).  
 
 
Figure 4.7: Brain regions in which peak or trough MSNA amplitude during pain were 
significantly correlated with signal intensity changes. 
4.6. Discussion 
In this investigation, we revealed brain responses associated with divergent changes in 
MSNA during tonic muscle pain. Although all subjects reported similar pain intensity 
ratings, the long-lasting pain evoked robust increases in MSNA in some individuals 
and decreases in others. These divergent MSNA responses were associated with 
different signal intensity changes in a number of brain regions, namely the prefrontal 
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and cingulate cortices, precuneus and DMH, and brainstem regions such as the PAG 
and RVLM. These data suggest that, during tonic muscle pain, descending modulation 
of the brainstem circuits, which are thought to control the cardiovascular responses to 
pain, can evoke different MSNA responses in different individuals.  
 
Consistent with our previous investigations, we found that tonic muscle pain resulted 
in divergent muscle sympathetic responses (Fazalbhoy et al., 2012, 2014; Kobuch et 
al., 2015, 2016). Since these opposite MSNA responses were associated with different 
signal intensity changes in cortical regions involved in higher-order emotional and 
cognitive function, such as the prefrontal and cingulate cortices, one might expect that 
psychological differences underlie the different MSNA responses. However, we 
previously reported that pain catastrophizing, pain anxiety, and pain vigilance, as well 
as state and trait anxiety levels, did not differ between groups (Kobuch et al., 2016). 
In addition, here we report no group difference in pain parameters such as the intensity, 
spread, or quality of the pain. Although there is a well-documented relationship 
between psychological variables such as pain catastrophizing and the development of 
chronic pain (Chaves & Brown, 1987; Keefe et al., 1989; McCracken & Dhingra, 
2002; Pavlin et al, 2005; Picavet et al., 2002; Spanos et al., 1979), our findings suggest 
that these variables do not predict the MSNA response to pain and likely do not play a 
role in the development of hypertension associated with chronic pain.  
 
In almost all regions showing differences in signal intensity changes, signals increased 
in the increasing MSNA group and remained unchanged in the decreasing group. 
Moreover, most of these regions were positively correlated with maximum MSNA 
amplitude. One clear exception was the region of the dlPAG, in which the signal 
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intensity initially increased in both groups but then returned to baseline levels in the 
increasing MSNA group and continued to increase in the decreasing MSNA group. In 
addition, there was a negative correlation between signal intensity in the PAG and peak 
MSNA. It is well established in the cat that the PAG is activated by both superficial 
and deep pain and is critical for the expression of defensive behaviours (Bandler et al., 
1991; Keay & Bandler, 2001). Keay and Bandler’s review (2001)  discusses studies in 
which cutaneous pain activates the lateral PAG, and direct stimulation of this PAG 
region evokes fight/flight behaviours that are associated with behaviourally-relevant 
increases in blood pressure, heart rate, and sympathetic activity (Bandler et al., 2000; 
Carrive, Bandler, & Dampney, 1988; Carrive, Dampney, & Bandler, 1987; Hilton & 
Redfern, 1986; Meller & Dennis, 1991; Van Bockstaele, Aston-Jones, Pieribone, 
Ennis, & Shipley, 1991; Yardley & Hilton, 1986). In direct contrast, deep pain, such 
as that arising from muscle, activates the ventrolateral PAG, and stimulation of this 
PAG region evokes quiescence with decreases in blood pressure, heart rate, and 
sympathetic activity (Carrive & Bandler, 1991; Lovick, 1992). Given these data, one 
would expect that tonic muscle pain in humans would evoke decreases in MSNA in 
all individuals, and that this would be associated with signal changes in the 
ventrolateral part of the PAG, which did not occur in the current study.  
 
An alternate proposal of PAG organization is one based on whether the pain is 
interpreted as being escapable or inescapable. That is, when the situation is escapable, 
active coping strategies such as fight/flight and sympathoexcitation are evoked, 
whereas an inescapable stressor is met with passive coping mechanisms, such as a 
conservation-withdrawal response and sympathoinhibition (Keay & Bandler, 2001). 
In our experiment, the noxious stimulus is inescapable in the sense that the MRI 
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scanner is a confined environment and requires the subject to remain stationary. 
Alternatively, the stimulus could be deemed escapable - given that each individual is 
informed that they can stop both the pain and the scanning at any point. It might be 
that those individuals that deemed the stimulus inescapable displayed decreases in 
MSNA, whereas those that judged the stimulus as escapable displayed MSNA 
increases. If this were the case, one would then predict that decreased MSNA would 
be associated with increases in signal intensity in the ventrolateral PAG, and increased 
MSNA with lateral PAG signal increases, which again did not occur.  
 
It is curious that the divergent MSNA responses seen in our study during long-lasting 
muscle pain are associated with different signal intensity changes in the region of the 
dlPAG, and not the lateral or ventrolateral PAG. Although stimulation of the dlPAG 
evokes active coping behaviours, unlike the lateral and ventrolateral PAG, it does not 
receive noxious inputs from the spinal cord or brainstem but, instead, receives inputs 
from primarily prefrontal and cingulate cortices (Floyd, Price, Ferry, Keay, & Bandler, 
2000). The predominance of cortical inputs into the dlPAG has led to the suggestion 
that this region produces active coping strategies in response to psychological stressors 
(Keay & Henderson, 2010). This idea is supported by studies in the rat, which show 
active coping behaviours and dlPAG activation during threat signals such as the odour 
or sight of a cat (Canteras & Goto, 1999; Dielenberg, Leman, & Carrive, 2004). 
Furthermore, it has been shown in the rat that the dlPAG projects to, and receives input 
from the hypothalamus - which in turn receives input from the prefrontal and cingulate 
cortices (Beckstead, 1979; Domesick, 1969; Floyd, Price, Ferry, Keay, & Bandler, 
2001; Gabbott et al., 2005). Microinjection of excitatory amino acids into the dlPAG 
in the rat evokes a significant increase in sympathetic nerve activity and respiratory 
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activity (Huang, Subramanian, Balnave, Turman, & Moi Chow, 2000; Iigaya, 
Horiuchi, McDowall, & Dampney, 2010). Imaging studies in humans have 
demonstrated the role of the dlPAG in the physiological responses to psychological 
stressors, such as induced panic attack (Reiman et al., 1989), or the approach of a 
virtual predator (Mobbs et al., 2007). Moreover, stimulation of the dlPAG in humans 
can evoke increases in blood pressure (Basnayake et al., 2011; Basnayake, Green, & 
Paterson, 2012) as well as increases in MSNA burst amplitude (Sverrisdóttir et al., 
2014). Further investigations in rats have proposed that these increases are mediated 
via a pathway to the DMH (Horiuchi, McDowall, & Dampney, 2009), and since there 
is only a small direct projection from the dlPAG to the DMH (Thompson & Swanson, 
1998), it has been suggested that the dlPAG produces sympathoexcitation through 
indirect projections to the DMH via the cuneiform and/or parabrachial nuclei 
(Dampney, Furlong, Horiuchi, & Iigaya, 2013; Fulwiler & Saper, 1984; Lam & 
Verberne, 1997). The DMH then projects directly to the RVLM and/or raphe pallidus, 
where it can excite sympathetic premotor neurons and increase sympathetic output, as 
shown in the rat (Fontes, Tagawa, Polson, Cavanagh, & Dampney, 2001). 
 
Consistent with this proposed dlPAG output pathway and descending inputs, we found 
that in subjects in whom MSNA increased, signal intensity also increased in the dlPFC, 
sgACC, DMH, dorsolateral pons, and RVLM. The increased signal intensity in DMH 
and RVLM in the increasing MSNA group supports our hypothesis. Interestingly, 
within the dlPAG, signal intensity increased during the initial period of pain but then 
decreased towards baseline levels for the remainder of the scanning period whilst 
MSNA remained elevated. It has been suggested the dlPAG control of sympathetic 
activity may involve a facilitatory summation of inputs from the dlPAG and DMH 
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(Dampney et al., 2013; de Menezes, Zaretsky, Fontes, & DiMicco, 2009). This raises 
the possibility that, following the initial period of muscle pain, facilitatory effects of 
the dlPAG on the DMH, in combination with descending inputs from the prefrontal 
and cingulate cortices - which also project to the DMH (Beckstead, 1979; DiMicco, 
Samuels, Zaretskaia, & Zaretsky, 2002; Domesick, 1969; Floyd et al., 2001; Gabbott 
et al., 2005) - are adequate to maintain increased sympathetic drive without increased 
dlPAG activity.  
 
Intriguingly, dlPAG signal increased and remained elevated during the entire pain 
period in individuals who displayed a fall in MSNA. In these subjects, signal intensity 
did not change in the prefrontal or cingulate cortices, DMH, dorsolateral pons or 
RVLM. Indeed, the only regions besides the dlPAG that showed signal changes were 
the precuneus and caudate nucleus, which displayed robust decreases in signal 
intensity. It is possible that in these subjects, inputs onto the dlPAG from the precuneus 
and caudate over-ride the pathway described above and, instead, elicit decreased 
dlPAG output and reduced muscle sympathetic activity. In fact, the dlPAG contains a 
high concentration of receptors for the inhibitory neurotransmitter gamma-
aminobutyric acid (GABA; Barbaresi, 2005, 2010) and the blockade of these receptors 
elicits strong increases in sympathetic and respiratory activity (Iigaya et al., 2012). 
Given this, increased dlPAG signal intensity in the decreasing MSNA group could 
reflect increased excitation of tonic local GABAergic activity, resulting in a decrease 
in MSNA. Additionally, the dlPAG contains high concentrations of NADPH 
diaphorase and nitric oxide synthase (NOS; Bandler & Shipley, 1994; Herbert & Saper, 
1992; Onstott, Mayer, & Beitz, 1993). Blocking NOS in the dlPAG evokes an increase 
in mean arterial pressure, and injection of nitric oxide donating compounds can evoke 
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hypotensive responses (Hall & Behbehani, 1997, 1998). Why differences in the effects 
of higher centres, such as the prefrontal and cingulate cortex, or precuneus and caudate 
nucleus, on the dlPAG occur in some individuals and not others remains unknown.  
Finally, it is important to emphasize that, although we used a physical stressor (tonic 
muscle pain), we did not find differential signal changes in the region of the lateral or 
ventrolateral PAG, but instead found such changes in the dlPAG. Although this 
difference may reflect inter-species variability, we suggest instead that the natural 
behavioural-coupled cardiovascular responses to the physical stressor were not 
expressed due to the need for the individual to remain still. We speculate that the 
MSNA changes and associated changes in brain activity reflect differences in 
individuals’ psychological stress responses to the unpleasant painful event. If this is 
true, it significantly alters the interpretation of brain imaging studies that explore PAG 
activity during physical stressors, since natural behavioural responses and their 
associated changes in cardiovascular control and even analgesic responses may not be 
properly expressed. Nevertheless, this experimental method of inducing pain provides 
insight as to how pain may modulate MSNA and its underlying central circuitry. 
However, in order to interpret these changes in chronic pain patients, one would need 
to know their baseline levels prior to the development of chronic pain.  
4.7. Limitations  
As with our previous studies on the sympathetic responses to muscle (or cutaneous) 
pain, it may be that there was a form of selection bias in our subjects. While we did 
not knowingly introduce a bias, one must recognize that those subjects who 
volunteered for the experiment did so knowing that they were going to have a 
microelectrode inserted into a nerve, another needle inserted under the skin, and a 
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cannula inserted into a muscle. Moreover, they knew they were going to experience 
strong muscle pain during the intramuscular infusion of hypertonic saline for up to an 
hour. As such, subjects with a needle phobia, or a morbid fear of pain, would not 
volunteer for this type of experiment. None of the subjects we did study reported 
having a fear of needles, and none fainted during the course of the experiment 
(although they were supine). Of course, it may well be that had we actively selected 
those with a needle phobia, or those with a tendency to faint, we may have uncovered 
further differences, but it is fair to say that all our subjects were essentially normal. 
Another potential limitation is that we always recorded MSNA from the right common 
peroneal nerve, ipsilateral to the intramuscular infusion of hypertonic saline. 
Accordingly, we must be circumspect in any consideration of the lateralization of the 
changes in BOLD signal intensity we uncovered, but it is fair to say that changes in 
MSNA are usually distributed symmetrically to muscles on either side of the body. 
The most significant limitation of this study is the spatial resolution of imaging 
brainstem structures such as the PAG. Whilst we argue that the differential signal 
intensity changes within the midbrain were located in the region of the dlPAG, given 
the relatively poor spatial resolution of human brain imaging at 3 T, it is possible that 
these changes were indeed located in other PAG columns. Recent developments in 
MRI at higher field strengths, such as 7 T, offer to provide superior spatial acuity and 
will provide greater confidence in the spatial accuracy of future imaging studies.
 CHAPTER 5   Muscle sympathetic nerve activity-coupled 
changes in brain activity during sustained muscle pain 
 
 
 
Chapter 5 is published as: 
Kobuch, S., Fazalbhoy, A., Brown, R., Macefield, V.G, Henderson, L.A. (2017):  
Muscle sympathetic nerve activity-coupled changes in brain activity during 
sustained muscle pain. Brain & Behaviour 8: e00888  
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5.1. Abstract 
Long-lasting experimental muscle pain elicits divergent muscle sympathetic responses, 
with some individuals exhibiting a persistent increase in muscle sympathetic nerve 
activity (MSNA), and others a decrease. These divergent responses are thought to 
result from sustained functional changes in specific brain regions that modulate the 
cardiovascular responses to pain. The aim of this study was to investigate brain regions 
that are functionally coupled to the generation of an MSNA burst at rest and to 
determine their behaviour during tonic muscle pain. Functional magnetic resonance 
imaging of the brain was performed concurrently with microelectrode recording of 
MSNA from the common peroneal nerve during a 40min infusion of hypertonic saline 
into the ipsilateral tibialis anterior muscle of 37 healthy human subjects. At rest, blood 
oxygen level dependent signal intensity coupled to bursts of MSNA increased in the 
rostral ventrolateral medulla, insula, dorsolateral prefrontal cortex, posterior cingulate 
cortex, and precuneus, and decreased in the region of the midbrain periaqueductal grey. 
During pain, MSNA-coupled signal intensity was greater in the region of the nucleus 
tractus solitarius, midbrain periaqueductal grey, dorsolateral prefrontal, medial 
prefrontal, and anterior cingulate cortices, than at rest. Conversely, MSNA-coupled 
signal intensity decreased during pain in parts of the prefrontal cortex. These results 
suggest that multiple brain regions are recruited in a burst-to-burst manner and the 
magnitude of these signal changes is correlated to the overall change in MSNA 
amplitude during tonic muscle pain. 
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5.2. Introduction 
Investigations in experimental animals have revealed that pain arising from the skin 
(cutaneous pain) evokes increases in blood pressure, heart rate, and sympathetic 
vasoconstrictor drive, whereas pain arising from muscle (deep pain) evokes decreases 
in these parameters (Keay & Bandler, 2001). These distinct autonomic responses are 
mediated by neurons in the midbrain periaqueductal grey matter (PAG), which are 
themselves under the influence of higher brain centres (Bandler et al., 2000). In 
humans, the sympathetic vasoconstrictor drive is revealed through either skin or 
muscle sympathetic nerve activity (SSNA or MSNA), which can be recorded via 
microelectrodes inserted directly into a peripheral nerve in awake human subjects, a 
technique called microneurography. MSNA, which is tightly coupled to cardiac 
rhythmicity, reflects the activity of postganglionic sympathetic neurons supplying the 
skeletal muscle vascular beds. An increase in MSNA causes vasoconstriction and 
thereby increases blood pressure (Macefield, 2013). Whilst distinctive cardiovascular 
responses to pain originating from different tissues have been observed in humans 
(Feinstein et al., 1954; Lewis, 1942), we recently reported that experimentally induced, 
transient (~6 minutes) cutaneous and muscle pain did not evoke such distinct 
cardiovascular responses. Cutaneous pain, elicited by subcutaneous injection of 
hypertonic saline solution, evoked increases in muscle sympathetic nerve activity 
(MSNA), blood pressure (BP) and heart rate (HR). On the other hand, muscle pain, 
elicited by intramuscular injection - on average - also evoked significant increases in 
these cardiovascular parameters (Burton et al., 2009). We speculated at the time that 
this unexpected pattern of change during acute muscle pain may be a characteristic of 
the short-lasting nature of the stimulus and the associated novelty. 
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We have since shown that prolonged (~45 minutes) muscle pain in humans evokes a 
mixed cardiovascular response, with some individuals showing a sustained MSNA 
increase, and others a sustained decrease (Fazalbhoy et al., 2012, 2014; Kobuch et al., 
2015, 2016, 2017). These individual differences are reliable across multiple 
experimental sessions in individuals (Fazalbhoy et al., 2014), and are not influenced 
by sex, age, anxiety levels, attitudes to pain, or resting MSNA, blood pressure, or heart 
rate levels (Kobuch et al., 2015, 2016). Using concurrent functional magnetic 
resonance imaging (fMRI) and microneurography, we recently found that areas of the 
prefrontal, cingulate and precuneus cortices, hypothalamus, midbrain, and medulla 
displayed sustained increases in blood oxygen level dependent (BOLD) signal 
intensity in those individuals who displayed sustained increases in MSNA compared 
with those who displayed sustained decreases (Kobuch et al., 2017). That study 
explored continuous signal intensity changes throughout the whole scanning period, 
with subjects separated into two groups according to whether they exhibited an 
increase or a decrease in MSNA during pain (Kobuch et al., 2017). However, while 
investigating overall signal intensity changes associated with sustained increases or 
decreases in MSNA responses during tonic muscle pain, it did not explore MSNA-
coupled changes in BOLD signal intensity, i.e. regions in which signal intensity 
increased or decreased during each MSNA burst. This is important, since sustained 
signal changes may be providing persistent modulatory inputs onto other brain regions 
that are actually driving each MSNA burst. This chapter is a separate burst-burst 
analysis of the same data presented in the previous chapter (Chapter 4).  
 
For example, at rest, signal intensity within the prefrontal, insular and precuneus 
cortices, hypothalamus, and medulla are tightly coupled to each MSNA burst (see 
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Macefield & Henderson, 2016 for review). It is unknown whether, during sustained 
muscle pain, signal intensity within these areas remains coupled to MSNA, and/or 
whether other brain regions react in a similar manner. This is an important question 
since it is not known whether, in humans, there is an invariant set of brain regions in 
which activity is coupled to MSNA, or whether other brain regions are recruited during 
various autonomic challenges. 
 
The aim of the current study was to identify brain regions that are functionally coupled 
to the generation of bursts of MSNA, both at rest and during tonic muscle pain. We 
hypothesized that, in addition to areas shown to be coupled to MSNA bursts at rest, 
additional regions, such as the cingulate cortex and midbrain, would also exhibit 
coupling to MSNA during pain, and that increases in BOLD signal intensity in these 
areas would parallel an increase in MSNA burst amplitude. 
5.3. Methods 
5.3.1. Participants  
Experiments were performed on 37 healthy subjects (11 females; mean±SEM age: 
21.9±0.5 years, range: 18-31 years). The subjects were recruited through an 
advertising flyer at the Western Sydney University School of Medicine. Exclusion 
criteria included a history of cardiovascular disease or chronic musculoskeletal pain. 
The subjects who volunteered for the experiment did so knowing that they were going 
to have a microelectrode inserted into a nerve, another needle inserted under the skin, 
and a cannula inserted into a muscle. Moreover, they knew they were going to 
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experience strong muscle pain during the intramuscular infusion of hypertonic saline 
for up to an hour. All experiments were conducted at 2pm, and the subjects were 
instructed to abstain from any strenuous exercise and from drinking caffeine. None of 
the subjects took any medication for cardiovascular disease or pain relief. Most 
participants were part of a larger study (Kobuch et al., 2016) that included the 
completion of the following questionnaires: Pain Catastrophizing Scale (PCS; Sullivan 
et al., 1995), Pain Vigilance and Awareness Questionnaire (PVAQ; McCracken, 1997), 
Pain Anxiety Symptoms Scale (PASS-20; McCracken & Dhingra, 2002), and the State 
and Trait Anxiety Inventory (STAI; Spielberger et al., 1983). 
 
All procedures were approved by the Human Research Ethics Committees of Western 
Sydney University and the University of New South Wales. Written consent was 
obtained from all subjects in accordance with the Declaration of Helsinki. 
5.3.2. Microneurography  
The protocol for MSNA and cardiorespiratory parameters measurement were 
described in the general methods section.  
5.3.3. MRI scanning and stimulus  
Using a 3 Tesla MRI scanner (Philips Achieva, 32-channel SENSE head coil), two 
scans encompassing the whole brain were collected: a high-resolution 3D T1-weighted 
anatomical image (200 axial slices, echo time (TE)=2.5ms, repetition time 
(TR)=5600ms, raw voxel size=0.87mm3), followed by a series of 250 gradient echo 
echo-planar blood oxygen level dependent functional magnetic resonance images 
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(fMRI: 46 axial slices, TE=40ms, TR = 8 s, raw voxel size=1.5x1.5x3.25mm3). All 46 
axial slices in each of the 250 fMRI brain volumes were collected during the first 4 
seconds of the 8 second TR, which allowed for 4 seconds of clean MSNA recording 
per brain volume, i.e. without the potential for scanner artefact. 
 
The noxious stimulation protocol was described in the general methods section. An 
infusion of hypertonic saline was commenced during the 50th volume of the fMRI scan 
at the rate of 0.25ml/min using an infusion pump (Harvard Instruments, USA), and 
this rate was constantly adjusted to maintain a pain level of 5 out of 10 on a Numerical 
Rating Scale (0 = no pain, 10 = most intense pain imaginable). Subjects knew they 
were going to experience pain, but they were not informed as to the start time of the 
infusion. Throughout the entire scanning period, subjects gave feedback about their 
pain level by pressing 4 colour-coded buttons; each colour was associated with either 
“pain onset”, “pain at 5/10”, “pain below 5/10”, “pain above 5/10.” At the completion 
of the scanning session, each subject was asked to complete a McGill Pain 
Questionnaire (Melzack, 1975) and draw the area of perceived pain on a standard 
diagram of the leg. This was then placed into ImageJ to determine the total area of 
spread (reported in number of pixels). 
5.4. Analysis 
5.4.1. MSNA 
Individual bursts of MSNA were displayed as a mean-voltage neurogram, computed 
as the root-mean-square (RMS) processed signal with a moving time average window 
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of 200ms. The 4 seconds inter-scan OFF period (see below) allowed the measurement 
of MSNA bursts. This 4s period was divided into 1s increments; for each second, 
bursts were manually counted and the amplitude was measured from the RMS-
processed nerve signal (Figure 5.1B, Figure 5.2A). 
5.4.2. Brain image processing  
Using SPM12 (Friston, 1994) and custom software, all fMRI images were realigned, 
and co-registered to each individual’s T1-weighted image set. The T1 image was then 
spatially normalized to the Montreal Neurological Institute (MNI) template, and the 
normalization parameters applied to all fMRI images. We used the VBM8 toolbox 
DARTEL template. This template was derived from 550 healthy control subjects of 
the IXI database (http://brain-development.org/) and is in MNI152 space. In all 
subjects, no pain was reported to occur during the first 70 brain volumes (or 9.33 
minutes) and thus we selected this period to be the baseline period. In contrast, we 
found that between volumes 181 and 250, subjects reported sustained pain, and there 
was a significant change in MSNA; we selected this 70-volume (9.33 minutes) period 
as the tonic pain period. These periods were selected and separated so that they could 
then be detrended separately, in order to remove the potential influence of sustained 
changes in overall intensity within each voxel. The 70 volumes in each baseline and 
tonic pain period were then linearly detrended, bias corrected, and spatially smoothed 
using a 6mm full-width at half-maximum (FWHM) Gaussian filter. In addition, we 
performed a brainstem-specific analysis in subjects for whom we acquired images that 
extended to the caudal medulla (n=30). In each subject, the brainstem was isolated 
from the T1-weighted anatomical image and the parameters applied to the coregistered, 
realigned, and detrended fMRI images. The T1 images set was normalized to a 
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brainstem template in MNI space using the SUIT toolbox and the parameters applied 
to the fMRI images sets (Diedrichsen et al., 2011). These fMRI brainstem image sets 
were then spatially smoothed using a 4mm FWHM Gaussian filter. 
 
As mentioned above, during the fMRI scan, all axial slices were collected during the 
first 4 s of the 8 s TR. Signal intensity changes were measured during the subsequent 
4 s (ON period), taking into account the (+) 5 s neurovascular coupling delay between 
a neuronal event and the peak BOLD signal (Logothetis et al., 2001), and the (-) 1 s 
required for the burst of MSNA to travel from the brain to the peripheral recording site 
(Fagius & Wallin, 1980). Because the images were collected in a caudal to rostral 
direction, the region of the brainstem from the caudal medulla to the rostral pons was 
scanned in the 1st second, the rostral pons to the diencephalon in the 2nd second, the 
diencephalon and surrounding cortex in the 3rd second, and the remainder of the cortex 
in the 4th second (Figure 5.1A). 
 
In each subject, and for each of the 4 s periods, the brain volumes during periods in 
which there were no bursts were averaged to create a mean no MSNA burst image. 
Similarly, brain volumes during periods in which there were MSNA bursts were 
averaged to create a mean MSNA burst image. These two images were created for the 
baseline and tonic pain periods separately (Figure 5.1B). This resulted in a total of 4 
images for all 4 seconds for each subject. For each of the 4 seconds: (1) burst image 
for baseline, (2) no burst image for baseline, (3) burst image for pain, (4) no burst 
image for pain. 
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To determine brain areas in which signal intensity was greater during MSNA bursts 
compared to periods of no MSNA bursts, we entered these two images for the baseline 
period into a second level, random effects paired t-test for each of the 4-second periods. 
An initial threshold of p < .001, uncorrected was used to display regional changes. We 
then performed cluster correction (family wise error p < .05) to limit the prospects of 
Type II errors (Woo, Krishnan, & Wager, 2014). Clusters were overlaid onto a mean 
whole-brain and brainstem T1-weighted anatomical image calculated from all subjects 
in the study. 
 
 
Figure 5.1: MSNA-coupled fMRI. 
A: Sagittal section of the brain showing the location of functional magnetic resonances 
imaging (fMRI) scans collected during the 4 s period. Images were collected in a caudal to 
rostral direction, enabling the analysis to target specific brain regions by only using the input 
of muscle sympathetic nerve activity (MSNA) that occurred in the 1st (yellow), 2nd (red), 3rd 
(green), and 4th (blue) second of the 4 second interscan interval. B: Recording of MSNA in a 
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subject while performing fMRI of the brain. The filtered neurogram is shown in the top trace, 
the root-mean-square processed signal in the bottom trace. The black areas represent scanning 
artefacts during the 4 s “ON” periods when fMRI images were being acquired. The red shading 
corresponds to the 2nd second of the interscan interval. The signal intensity values for the 
highlighted brain region (orange rectangle) are schematically plotted as the orange line. The 
MSNA-coupled signal intensity change was calculated for images in each second by averaging 
signal during an MSNA burst and subtracting the signal during period of no bursts. MSNA: 
muscle sympathetic nerve activity; RMS: root-mean-square. 
 
In addition, to determine changes in MSNA-coupled BOLD signal intensity evoked 
by tonic pain, we subtracted the mean MSNA no burst image from the mean MSNA 
burst image during the baseline and tonic pain periods. This resulted in a single 
baseline and a single tonic pain image for each subject, for each of the 4 seconds. 
Thereby, each voxel’s signal intensity value reflected the difference between periods 
of no bursts compared to periods of MSNA bursts.  
The percentage difference between these two images was then calculated for each 
voxel, resulting in a brain map in which each voxel’s value was the percentage change 
in MSNA-coupled signal intensity during tonic pain compared with baseline. These 
brain maps were placed into a second level random effects analysis, where 
relationships between percentage change in MSNA-coupled signal intensity and 
percentage change in MSNA amplitude during tonic pain were determined (p < .001, 
uncorrected). Significant clusters were overlaid onto a mean whole-brain and 
brainstem T1-weighted anatomical image, calculated from all subjects in the study. 
Finally, for each significant cluster, the percentage differences in MSNA-coupled 
signal intensity changes during pain compared with baseline were extracted and 
plotted against the overall change in MSNA amplitude during pain. 
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5.5. Results 
5.5.1. Participants  
The resting mean blood pressure was 86.3±2.0 mmHg (range: 68.7-105.5mmHg), 
resting mean heart rate was 66.4±1.7 beats/min (range: 50-85 beats/min), resting 
MSNA frequency 12.0±1.5 bursts/min (range: 2-35 bursts/min), MSNA amplitude 
change for the last pain period was +42.7±16.6% (range: -91.7 to +388.1%), PCS: 
12.0±1.2 (range: 0-27), PASS: 28.8±2.8 (range: 2-72), PVAQ: 34.7±1.6 (range: 16-
49), state anxiety: 31.4±1.9 (range: 20-52), and trait anxiety: 35.1±1.4 (range: 24-50); 
see Table 5.1 below. 
 
Table 5.1: Subject information. 
Age, sex, resting mean BP, resting HR, resting MSNA frequency, MSNA amplitude change 
during pain, PCS, PASS, PVAQ, and STAI averages of all participants. 
 
 Mean SEM 
Sex 11F, 26M  
Age 22.0 0.5 
Mean BP (mmHg) 86.3 2.0 
HR (beats/min) 66.4 1.7 
Resting MSNA (bursts/min) 14.3 1.7 
MSNA amplitude during pain (% change) 42.7 16.6 
PCS 12.0 1.2 
PASS 28.8 2.8 
PVAQ 34.7 1.6 
State anxiety 31.4 1.9 
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 Mean SEM 
Trait anxiety 35.1 1.4 
 
5.5.2. Psychophysics  
In all subjects, intramuscular infusion of hypertonic saline elicited continuous muscle 
pain, which began, on average, 22 volumes (176 seconds) after the start of the infusion 
(i.e. at volume 72) and continued at a mean pain intensity of 5.8±0.1 (range: 5-7) for 
the remainder of the fMRI scan. The mean volume of infusion was 18.6±1.4 ml. The 
mean pain spread depicted on the McGill pain questionnaire involved an area of 
1039±80 pixels (as measured from the area of pain subjects drew on an image of a leg). 
The most frequent descriptors chosen from the McGill pain questionnaire to describe 
the tonic pain were “dull”, “aching”, and “throbbing”.  
5.5.3. MSNA rest vs pain:  
The mean percentage change during the last 70 volumes of pain compared to the 70 
volumes of baseline was +42.7±16.6%. The amplitude change during this period 
ranged between -91.7% and +388.1% across the 37 subjects (Figure 5.2B). 
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Figure 5.2: MSNA recording and percentage changes. 
A: Extract of an MSNA recording from the common peroneal nerve in a subject in whom 
MSNA amplitude increased during intramuscular infusion of hypertonic saline into the tibialis 
anterior muscle (grey shading, right), compared to baseline (left). Grey shading indicates the 
tonic pain period. B: Plot of the mean percentage change in MSNA amplitude for the last 70 
volumes of pain compared to baseline in 37 subjects. MSNA: muscle sympathetic nerve 
activity; RMS: root-mean-square; uV: microvolts. 
5.5.4. MSNA-coupled signal intensity changes 
5.5.4.1. Baseline  
During the baseline period, increases in MSNA-coupled signal intensity occurred in 
the rostral medulla encompassing the area of the left rostroventrolateral medulla 
(RVLM; mean±SEM percent change burst versus no burst: 0.34±0.14), left mid-insula 
(0.17±0.03), right mid-insula (0.17±0.05), left posterior cingulate cortex (PCC; 
0.14±0.04), left dorsolateral prefrontal cortex (dlPFC; 0.22±0.07) and left precuneus 
(0.27±0.07; Figure 5.3, Table 5.2). In contrast, decreases in MSNA-coupled signal 
intensity occurred in only one region, in the rostral midbrain encompassing the region 
of the left midbrain periaqueductal grey matter (PAG; -0.25±0.07).  
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Figure 5.3: Signal intensity increases and decreases during MSNA bursts compared to periods 
of no bursts at rest. 
Signal intensity increases (hot colour scale) and decreases (cool colour scale) during MSNA 
bursts compared to periods of no bursts, at rest in all 37 subjects. Significant clusters were 
overlaid onto a mean T1-weighted anatomical image set created from all 37 subjects. Slice 
locations in Montreal Neurological Institute space are indicated in the top right of each image. 
The left side is the side contralateral to the side of microneurography recording. The inset on 
the left represents the results from a brainstem-specific analysis. dlPFC: dorsolateral prefrontal 
cortex; PAG: periaqueductal grey; PCC: posterior cingulate cortex; RVLM: rostral 
ventrolateral medulla. 
 
Table 5.2: Brain regions showing signal intensity increases or decreases during MSNA bursts 
compared to no bursts at rest. 
Locations in Montreal Neurological Institute space, t values, and cluster sizes of regions in 
which signal intensity increased or decreased during muscle sympathetic nerve activity bursts 
compared with periods of no MSNA bursts while the subject was at rest. 
 
Signal intensity increases x y z t value Cluster size 
Dorsolateral prefrontal cortex 
Left 
 
-22 
 
54 
 
24 
 
3.41 
 
6 
Insular cortex      
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Signal intensity increases x y z t value Cluster size 
Left 
Right 
-34 
38 
2 
6 
0 
2 
5.07 
3.62 
65 
15 
Posterior cingulate cortex 
Left  
 
-6 
 
-22 
 
44 
 
3.84 
 
13 
Precuneus 
Left 
 
-12 
 
-52 
 
70 
 
3.55 
 
7 
Rostral ventrolateral medulla 
Left 
 
-2 
 
-40 
 
-43 
 
2.58 
 
4 
Signal intensity decreases x y z t value Cluster size 
Periaqueductal grey 
Left 
 
-8 
 
-26 
 
-11 
 
2.84 
 
18 
 
5.5.4.2. Tonic Pain  
During tonic pain, a number of brain regions displayed significant correlations 
between percentage changes in MSNA-coupled signal intensity and MSNA-amplitude 
(Figure 5.4, Figure 5.5, Figure 5.6, Table 5.3). It can be seen in Figure 5.5 and Figure 5.6 
that one subject had a very high MSNA value, accordingly we have performed 
statistical analyses with and without the outlier. Significant positive relationships 
occurred in the dorsal closed medulla in the region of the right nucleus tractus solitarius 
(NTS; r = 0.46, p = .01; r = 0.43, p = .02 without outlier), right midbrain in the region 
of the ventrolateral PAG (r = 0.41, p = .03; r = 0.57, p = .001 without outlier), left 
insula (r = 0.65, p < .001; r = 0.48, p = .004 without outlier), left medial prefrontal 
cortex (mPFC; r = 0.64, p < .001; r = 0.28, p = .10 without outlier), right dlPFC (r = 
0.59, p < 0.001; r = 0.42 p = .01 without outlier) and the right anterior cingulate cortex 
(ACC; r = 0.57, p < .001; r = 0.28, p = .11 without outlier). Significant negative 
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relationships occurred in the left dlPFC (r = -0.55, p < .001; r = -0.55, p < .001 without 
outlier) and the left mPFC (r = -0.58, p < .001; r = -0.32, p = .06 without outlier). After 
excluding the outlier, significant positive relationships were still apparent for the NTS, 
PAG, left insula, and significant negative relationships for the right dlPFC and left 
mPFC.   
 
 
Figure 5.4: Brain regions in which MSNA-coupled signal intensity changes are significantly 
correlated with MSNA amplitude. 
Brain regions in which muscle sympathetic nerve activity (MSNA) -coupled signal intensity 
changes were significantly positively (hot colour scale), or negatively (cool colour scale) 
correlated with MSNA amplitude change in 37 subjects. Significant clusters were overlaid 
onto a mean T1-weighted anatomical image set created from all 37 subjects. Slice locations in 
Montreal Neurological Institute space are indicated in the top right of each image. The inset 
on the left represents the results from a brainstem-specific analysis. ACC: anterior cingulate 
cortex; dlPFC: dorsolateral prefrontal cortex; mPFC: medial prefrontal cortex; NTS: nucleus 
tractus solitarius; PAG: periaqueductal grey. 
  119 
  
 
Figure 5.5: Relationship between MSNA-coupled signal intensity changes and MSNA 
amplitude change during pain. 
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Figure 5.6: Relationship between MSNA-coupled signal intensity changes and MSNA 
amplitude change during pain (cont’d.) 
Plots of the muscle sympathetic nerve activity (MSNA)-coupled signal intensity changes 
against MSNA amplitude change during tonic pain in all 37 subjects. In all regions, there is a 
significant linear relationship between MSNA burst-to-burst signal changes during tonic pain 
compared with baseline with the overall change in MSNA amplitude. PAG: periaqueductal 
grey. 
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Table 5.3: MSNA-coupled signal intensity changes during tonic pain compared to rest. 
Locations in Montreal Neurological Institute space, t values, and cluster sizes of regions in 
which muscle sympathetic nerve activity (MSNA) coupled signal intensity changes during 
tonic muscle pain were significantly different to those at rest. 
 
Signal intensity increases x y z t value Cluster size 
Anterior cingulate cortex 
Right 
 
15 
10 
 
50 
34 
 
0 
16 
 
3.74 
3.81 
 
3 
4 
Dorsolateral prefrontal cortex 
Right 
 
38 
 
36 
 
14 
 
3.64 
 
4 
Insular cortex 
Left 
 
-40 
-36 
 
-18 
6 
 
14 
12 
 
4.05 
4.07 
 
37 
27 
Medial prefrontal cortex 
Left 
 
-6 
 
64 
 
8 
 
5.04 
 
45 
Midbrain periaqueductal grey 
Right 
 
4 
 
-32 
 
-7 
 
2.33 
 
1 
Nucleus tractus solitarius 
Right 
 
2 
 
-44 
 
-57 
 
2.66 
 
2 
Signal intensity decreases x y z t value Cluster size 
Dorsolateral prefrontal cortex 
Left 
 
-40 
 
52 
 
2 
 
4.21 
 
5 
Medial prefrontal cortex 
Left 
 
-8 
 
56 
 
4 
 
4.07 
 
27 
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5.6. Discussion 
In this study, we reveal MSNA-coupled signal intensity changes produced by tonic 
muscle pain. Although many previous investigations have explored changes in signal 
intensity associated with changes in overall MSNA during various challenges, this is 
the first to compare signal intensity changes during MSNA bursts at baseline and 
during a challenge such as tonic muscle pain. We found that during tonic pain MSNA-
coupled signal intensity changes were positively correlated to MSNA amplitude in 
areas of the brainstem known to regulate the cardiovascular responses to pain, such as 
the PAG. In addition, we found both positive and negative correlations between 
MSNA-coupled signal changes and MSNA amplitude in higher order association areas, 
such as the insular, cingulate, and prefrontal cortices. Some of these regions also 
showed MSNA-coupled signal changes at rest, as we had shown previously (James et 
al., 2013; Lundblad et al., 2014), indicating that they are modulated during tonic pain 
to evoke an overall change in MSNA. 
 
Hypertonic saline infusion into the tibialis anterior muscle induced pain that was 
described as dull, aching and throbbing. Consistent with our previous investigations, 
we found that tonic muscle pain evoked increases in MSNA amplitude in some 
individuals and decreases in others (Fazalbhoy et al., 2012, 2014; Kobuch et al., 2015, 
2016, 2017). These changes began approximately 20 volumes (160 seconds) after the 
start of the hypertonic infusion, at approximately the same time as subjects began to 
perceive pain and remained fairly stable for the duration of the pain period. Importantly, 
and unlike any previous investigation, we have determined brain regions that influence 
MSNA amplitude in a burst-to-burst (MSNA-coupled) manner rather than in a 
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sustained manner during a cardiovascular challenge. Previous studies investigating 
brain activation patterns during various cardiovascular challenges have explored 
gradual signal intensity changes associated with sustained changes in BP, HR, MSNA, 
or other autonomic variables (Beissner et al., 2013 for review; Harper et al., 2003 (cold 
pressor); Henderson et al., 2002 (Valsalva)). Although these studies are valuable, they 
are unable to explore signal intensity changes in brain regions that directly drive each 
MSNA burst. We find in this study a series of brain regions that are only revealed 
through such an analysis, which provides a basis for exploring regions that may be 
recruited only during various cardiovascular challenges and only in a burst-to-burst 
manner. 
 
Consistent with our previous studies, we found that at rest, signal intensity changes 
coupled to MSNA bursts occurred in the region of the RVLM, insula, cingulate, 
prefrontal cortex, and precuneus (James et al., 2013; Lundblad et al., 2014; Macefield 
and Henderson, 2010). These results were consistent despite a subtle difference in the 
analysis methods, i.e. signal intensity changes coupled to MSNA burst pattern, versus 
mean signal during MSNA bursts compared with no bursts. One region that was 
different between this and our previous investigations was the PAG; we previously 
reported positive signal coupling with MSNA, whereas in this study we found 
decreased MSNA-coupled signal intensity in the PAG at rest (Lundblad et al., 2014). 
Why this disparity occurs is not clear, however it is possible that it arises from 
differences in methodological approaches. In addition to the PAG, tonic pain evoked 
MSNA-coupled signal changes associated with MSNA amplitude in other regions, 
which also display MSNA-coupled signal changes at rest, such as the NTS, and the 
insular, cingulate, and prefrontal cortices. This suggests that these regions are not 
  124 
necessarily recruited during tonic pain itself, but instead are modulated so that their 
activities drive either increases or decreases in MSNA amplitude. 
 
Consistent with this idea, we found that the PAG, the right dlPFC, and the right ACC 
each displayed both burst-to-burst and sustained signal intensity changes during tonic 
muscle pain (Kobuch et al., 2017). Indeed, we previously found that the dorsolateral 
PAG (dlPAG) displayed sustained increases in signal intensity during tonic pain that 
were negatively correlated to MSNA amplitude, i.e. the greater the signal change, the 
lower the MSNA amplitude change (Kobuch et al., 2017). In contrast, in the current 
study we found that positively correlated MSNA-coupled signal changes during 
muscle pain occurred in the region of the ventrolateral PAG (vlPAG).  
 
The PAG is arranged in a columnar fashion, based on histological and functional 
differences (Keay & Bandler, 2001). In animals, it is well established that the PAG is 
activated by both superficial and deep pain. Indeed, superficial pain activates the 
lateral PAG column, and direct stimulation of this column of the PAG elicits active 
behavioural responses that are coupled with increases in blood pressure, heart rate, and 
sympathetic activity (Bandler et al., 2000; Carrive et al., 1987; Carrive et al., 1988; 
Hilton & Redfern, 1986; Meller & Dennis, 1991; Van Bockstaele et al., 1991; Yardley 
& Hilton, 1986). In contrast, deep pain activates the ventrolateral column of the PAG, 
and direct stimulation of this column evokes passive, quiescent coping behaviours, and 
decreases in BP, HR, and sympathetic activity (Carrive & Bandler, 1991; Lovick, 
1992). Further, unlike the vlPAG, which receives noxious muscle and visceral inputs 
from the spinal cord and brainstem, the dlPAG receives inputs from primarily 
prefrontal and cingulate cortices (Floyd et al, 2000). This difference in input patterns 
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has led to the suggestion that the dlPAG produces active coping strategies in response 
to psychological stressors, whereas the vlPAG produces passive coping responses in 
response to deep physical stressors (Keay & Henderson, 2010). This idea is consistent 
with our own findings; although overall signal intensity within the vlPAG did not 
change during tonic muscle pain, MSNA-coupled signal intensity changed in a manner 
consistent with each individual’s overall MSNA response. Increases in MSNA-
coupled signal intensity in the vlPAG paralleled increases in MSNA amplitude, and 
MSNA-coupled signal intensity decreases in the vlPAG were accompanied by 
decreases in MSNA amplitude. It is possible that the vlPAG is involved in driving the 
change in MSNA burst amplitude on a burst-to-burst basis, whereas the dlPAG may 
provide more of a tonic modulatory role during tonic muscle pain. 
 
Similar to the PAG, the ACC and dlPFC displayed MSNA-coupled signal intensity 
changes, which paralleled MSNA amplitude changes: increases in MSNA amplitude 
were accompanied by increases in MSNA-coupled signal intensity in these regions and 
decreases in MSNA amplitude were accompanied by decreases in MSNA-coupled 
signal intensity in these regions. Further, we previously showed that these two regions 
displayed sustained intensity increases during tonic muscle pain in a pattern that 
matched the increase in MSNA amplitude (Kobuch et al., 2017). A role for these 
regions in mediating changes in autonomic function has been recognized for some time. 
For example, the ACC and dlPFC are both activated during cardiovascular challenges 
such an inspiratory capacity apnoea (Kimmerly et al., 2013; Macefield et al., 2006). 
Furthermore, we have shown that these regions display MSNA-coupled signal changes 
even at rest. 
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In our previous study, we found that the insular cortex did not display sustained signal 
intensity changes coupled to sustained changes in MSNA during tonic muscle pain 
(Kobuch et al., 2017). This is surprising given the growing body of literature 
describing insular cortex changes during various cardiovascular challenges (Beissner 
et al., 2013; Butcher & Cechetto, 1995; Harper et al., 2003; Henderson et al., 2002; 
Macefield et al., 2006; Macey et al., 2003). However, we found in the current study 
that the left insula displayed robust changes in MSNA-coupled signal intensity that 
were indeed associated with overall changes in MSNA. Consistent with previous 
findings, the left and right insula exhibited MSNA-coupled signal intensity increases 
at rest (Fatouleh et al., 2014; James et al., 2013). During tonic pain, this MSNA-
coupled signal change was located more dorsally in mid- and anterior insula and only 
on the left side, contralateral to the noxious stimulus. We have previously reported that 
intramuscular injection of hypertonic saline into the right tibialis anterior muscle 
causes sustained signal increases in the contralateral posterior insula and ipsilateral 
anterior insula and not in the contralateral anterior insula (Henderson et al., 2007). It 
has been proposed that these regions are involved in the link between sensory and 
emotional aspects of pain processing (Craig, 2011). The data presented here reveals 
that the contralateral mid- and anterior dorsal insula display MSNA-coupled signal 
changes during pain and are thus likely involved in mediating the cardiovascular aspect 
of pain. Interestingly, it has been revealed that the mid- and anterior insula are 
activated during a range of autonomic challenges such as the Valsalva manoeuvre, 
handgrip and cold pressor test, whereas the posterior insula is not (Macey et al., 2012).  
This raises the prospect that different insula regions may be preferentially involved in 
mediating the sensory, affective and cardiovascular response to sustained muscle pain. 
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In direct contrast to the above-mentioned regions, in which the magnitudes of MSNA-
coupled signal changes alter during tonic muscle pain, a number of important brain 
regions did not display pain-related changes. For example, although we found that the 
RVLM and precuneus displayed MSNA-coupled signal changes at rest, consistent 
with our earlier studies (James et al., 2013; Macefield & Henderson, 2010), these 
signal intensity increases did not change in magnitude during each burst of MSNA 
during tonic muscle pain. However, both of these regions displayed sustained signal 
intensity increases in the increasing MSNA group, and decreases in the decreasing 
MSNA group (Kobuch et al., 2017). Therefore, the RVLM and precuneus are not 
recruited to fire either more or less in a burst-to-burst fashion during tonic muscle pain, 
but instead may provide a tonic modulatory role. 
 
Finally, it is important to note that the areas identified in this study overlap with regions 
thought to be involved in descending pain modulation (Millan, 2002). Furthermore, it 
is interesting that there appears to be a relationship between the cardiovascular and 
descending pain modulation systems, since the greater the magnitude of cardiovascular 
response during the cold pressor test, the greater an individual’s endogenous analgesic 
ability (Chalaye et al., 2013). Our findings that MSNA-related regions overlap with 
those involved in endogenous analgesia further support the idea that the two systems 
are intertwined.   
5.7. Limitations 
As with all studies there are limitations to the technique and methods of analysis. 
Whilst the brainstem is small relative to the spatial resolution obtained in most fMRI 
investigations, one of the major limitations of brainstem analysis is accurate spatial 
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normalization. To overcome this issue, we used a brainstem-specific toolbox, which 
isolates the brainstem; we then manually selected the brainstem in each individual 
subject. This was then used to spatially normalize the image sets, which creates greater 
consistency between subjects with respect to their brainstems’ final location in MNI 
space. Given this we are confident that the changes we report in this study, particularly 
those in the brainstem, are accurate. Another limitation relates to the number of 
volumes chosen for the baseline and tonic pain periods. We collected 70 brain volumes 
prior to the onset of pain and, to be consistent, we chose 70 volumes during the tonic 
pain period, when the level of pain was stable. A greater number of volumes in both 
periods would have been desirable, to increase reliability, and in future investigations 
we aim to collect longer baseline periods. We did, however, find consistent MSNA-
coupled signal changes at rest when compared to our previous studies in which we 
analysed 200 brain volumes, so we are confident that the results presented are indeed 
accurate.  
 
Finally, we acknowledge that the regional hemodynamic response curve has a wide 
range, and therefore using a fixed 4-s ON and 4-s OFF protocol prevents us from taking 
into account individual variations. However, we have used this same protocol in many 
previous investigations where we concurrently recorded MSNA and fMRI, and have 
demonstrated that the BOLD signal intensity is temporally coupled to the bursts of 
MSNA recorded peripherally. Indeed, MSNA-coupled fMRI allows one to identify 
regions that are temporally coupled to the firing of an MSNA burst, which (with the 
exception of certain pathophysiological states) do not occur in every heartbeat. In our 
previous investigations, we had shown that both increases and decreases in BOLD 
signal occurred. Importantly, these were not general changes in BOLD intensity, 
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which one would expect from physiological noise related to ongoing cardiac (and 
respiratory) pulsations within the brain, but discrete. In this study we were not able to 
filter out potential physiological noise (Brooks, Faull, Pattinson, & Jenkinson, 2013) 
since we were exploring MSNA-coupled signal intensity changes, and MSNA bursts 
are tightly coupled to the cardiac rhythm. Removing frequencies (or their harmonics) 
that represent cardiac pulsatile signals would also remove MSNA-coupled signal 
changes. Since periods in which there were no MSNA bursts also contain cardiac beats, 
any potential effect of physiological noise would be equivalent during both periods. 
Furthermore, given that the discrete areas of increase or decrease in BOLD signal were 
localised to cortical and subcortical regions known to contribute to cardiovascular 
regulation in experimental animals, the most parsimonious explanation is that the 
observed changes in BOLD signal intensity reflect proxy markers of functional 
changes in neuronal activity, rather than physiological artefact. 
5.8. Conclusions 
For the first time, we have shown brain regions in which MSNA-coupled signal 
intensity changes are altered during a challenge that affects sympathetic outflow to the 
muscle vascular bed. Whilst it is important to understand brain regions that are 
associated with sustained changes in sympathetic drive, we show here that signal 
intensity changes in numerous brain regions occur only in a burst-to-burst manner. We 
provide evidence that some regions display both sustained and burst-to-burst changes 
whereas others display one or the other. These data are consistent with the idea that 
changes in MSNA result from a combination of sustained and burst-to-burst changes 
in activity in various brain regions. Whether these changes persist during chronic pain 
remains unknown. However, investigating these potential changes in chronic pain 
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would require knowing the baseline parameters prior to the development of chronic 
pain. 
 CHAPTER 6   The effects of audio-visual distraction on 
the muscle sympathetic responses to experimental muscle 
pain 
 
 
 
Chapter 6 is published as: 
Kobuch, S., Henderson, L.A., Macefield, V.G., Brown, R. (2018): The effects of  
audio-visual distraction on the muscle sympathetic responses to  
experimental muscle pain. Experimental Brain Research 236: 1919-1925 
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6.1. Abstract 
Pain elicited by intramuscular infusion of hypertonic saline solution causes muscle 
sympathetic nerve activity (MSNA) to increase in some subjects, yet decrease in others. 
Although the direction of the response is not predictable based on baseline 
physiological and psychological parameters, we know that it results from sustained 
functional changes in specific brain regions that are responsible for the behavioural 
and cardiovascular responses to psychological stressors, as well as those involved in 
attention. The aim of this study was to investigate whether MSNA responses to 
experimental muscle pain in humans could be altered with an audiovisual stimulus that 
served to distract them from the pain. MSNA was recorded from the left common 
peroneal nerve of 20 young healthy individuals during a 45-minute intramuscular 
infusion of hypertonic saline solution into the ipsilateral tibialis anterior muscle. The 
distracting stimulus commenced 15 minutes after the start of the infusion and lasted 
for 15 minutes. Fifteen subjects showed an increase in mean burst amplitude of MSNA 
(to 176.4±7.9% of baseline), while 5 showed a decrease (to 73.1±5.2% of baseline); 
distraction had no effect on these profiles. These results indicate that even though the 
subjects were attending to the audiovisual stimulus, and were presumably distracted 
from the pain, it failed to alter the MSNA responses to muscle pain.  
6.2. Introduction 
The sympathetic nervous system contributes importantly in generating physiological 
responses to pain, with recent work in human subjects having characterized the 
changes in sympathetic outflow to muscle and skin during delivery of noxious stimuli 
to muscle or skin (for review see Burton et al., 2017). We recently demonstrated that 
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a prolonged (~45min) infusion of hypertonic saline into a leg muscle, which induces 
muscle pain for ~1 hour, causes a sustained increase in muscle sympathetic nerve 
activity (MSNA) amplitude in some subjects but a sustained decrease in others 
(Fazalbhoy et al., 2012, 2014; Kobuch et al., 2015, 2016, 2017). We cannot explain 
these inter-individual differences by sex, age, anxiety levels, attitudes to pain, or levels 
of resting MSNA, blood pressure, or heart rate (Kobuch et al., 2015, 2016). Moreover, 
they are reproducible over two experimental sessions, suggesting that there is 
something “hard-wired” in a given subject’s pattern of response (Fazalbhoy et al., 
2014). Using concurrent recordings of MSNA and functional magnetic resonance 
imaging (fMRI) of the brain, we recently found that certain cortical areas (precuneus, 
prefrontal, cingulate), as well as the hypothalamus, midbrain and medulla, displayed 
sustained differences in BOLD (blood oxygen level dependent) signal intensity in the 
two groups of subjects, despite the reported pain levels, and quality of pain, being 
statistically identical in the group of subjects in whom MSNA increased and the group 
in whom MSNA decreased (Kobuch et al., 2017, 2018). We suggested that the 
divergent sympathetic responses to an identical noxious input resulted from the 
activation of a neural pathway that included the dorsomedial hypothalamus and 
dorsolateral periaqueductal grey – which are thought to be responsible for the 
behavioral and cardiovascular responses to psychological stressors (Keay & 
Henderson, 2010). Furthermore, differences in BOLD signal intensity in the precuneus 
lead us to believe that attention to the noxious stimulus may influence the sympathetic 
response to muscle pain. Indeed, the precuneus is known to form part of the default 
mode network, which comprises specific areas of the brain that display high levels of 
activation when an individual is at rest with eyes closed but exhibit inactivation during 
an attention-demanding or goal-directed task (Fransson, 2006; Raichle et al., 2001). 
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The effects of distraction from a physical stimulus on the physiological responses to 
the stimulus has had mixed results. For example, some studies have shown that 
distraction reduces distress during pain (Eccleston, 1995; McCaul & Haugtvedt, 1982; 
Wack & Turk, 1984), while others have found no physiological or behavioral changes  
(Leventhal et al., 1979; McCaul et al., 1992). A study conducted by Terkelsen and 
colleagues showed that mental stress - but not attention to the stimulus - inhibited pain 
perception and resulted in changes in heart rate variability (Terkelsen et al., 2004). 
Furthermore, it has been reported that distraction can lead to dampening of the 
cardiovascular responses to anger recall and rumination (Gerin et al., 2006; Glynn et 
al., 2002; Neumann et al., 2004). 
 
In this study, we set out to assess whether distraction – via engagement in an 
affectively neutral competing task (i.e. an audiovisual stimulus) – could influence the 
muscle sympathetic responses to muscle pain. Specifically, we tested the hypothesis 
that distraction would reduce the increase in MSNA in those subjects in whom MSNA 
increased during tonic muscle pain.  
6.3. Methods 
6.3.1. Participants 
From the inception of the study we had decided to limit the number of experiments to 
twenty healthy individuals, reasoning that if distraction did have a significant effect on 
the pattern of sympathetic response it should be clear with 20 participants. We adopted 
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a gender-balanced design: 10 females and 10 males, with a mean age of 25.0±1.9 years. 
All participants provided written informed consent to the experimental procedures, 
which were conducted under the approval of the Human Research Ethics Committee 
of Western Sydney University and satisfied the requirements of the Declaration of 
Helsinki. No subject had any history of cardiovascular disease or chronic 
musculoskeletal pain.   
6.3.2. Microneurography 
The protocol for MSNA and cardiorespiratory parameters measurement were 
described in the general methods section. 
6.3.3. Noxious stimulation 
The protocol for the noxious stimulation has been described in detail in the general 
methods section. 
6.3.4. Procedure 
After 5 min of recording resting activity, the infusion was started, at a time unknown 
to the subject, at an initial rate of 0.25 ml/min; the infusion rate was adjusted 
throughout the duration of the experiment in order to maintain a pain level of 5-6/10 
on a visual analog scale (VAS). Once a stable rating of 5-6/10 pain was reached, the 
physiological parameters were recorded continuously for 15 min (pain period 1). Then, 
while the infusion was continuing, an audiovisual stimulus – a documentary of the 
Australian landscape – was displayed via a video projector for 15 min (pain period 2). 
The documentary was chosen as it was deemed an emotionally neutral stimulus. 
During this time, the subjects were asked to focus on the documentary and to stop 
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rating the pain. The participants were told to notify the investigator if the pain reached 
a level that was higher than 5-6/10. This did not occur in any of the experiments. When 
the 15-minute audiovisual stimulus was finished, the infusion was maintained for 
another 15 min, and subjects were asked to resume rating the pain (pain period 3).  
6.3.5. Analysis 
Bursts of MSNA were displayed as a mean voltage neurogram, computed as the root-
mean-square (RMS) processed signal with a moving time average window of 200ms. 
The signal was analysed using the Peak Parameters module of the LabChart 7 Pro 
software (ADInstruments, Sydney, NSW, Australia) to calculate the amplitude of each 
burst. The absolute values were averaged into 5min blocks, normalized to the baseline 
and reported as percentage change from baseline (100%). The average of all 5min 
blocks was taken in order to determine the direction of the MSNA amplitude response. 
Subjects in whom overall MSNA amplitude change was greater than 10% during pain 
were classified as ‘increasing’, and vice versa for the ‘decreasing’ group. Statistical 
analysis was performed using Prism version 6 for Mac OS X (GraphPad Software, San 
Diego, CA, USA). For normally distributed data we used a repeated-measures one-
way analysis of variance (rmANOVA), coupled with Dunnett’s multiple comparisons 
test, to determine changes over time; for non-normally distributed data we used 
Friedman’s ANOVA, coupled with Dunn’s multiple comparison test. Otherwise, the 
paired t-test or Wilcoxon signed-rank test was used. All data were expressed as means 
plus standard error of the mean (SEM). Probability levels of p<0.05 were deemed 
significant.  
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6.4. Results 
6.4.1. Subjective experience of pain 
The pain rating remained constant at 5-6 out of 10 throughout the duration of the 
infusion. Although the subjects were asked not to rate the pain during the distraction 
task, when asked afterwards no subject reported changes in their perception of pain 
intensity while watching the documentary.  
 
Table 6.1: Subject information. 
Subject characteristics, resting MSNA burst frequency and incidence, and cardiovascular 
parameters. 
 
Variable Increasing MSNA 
Group (n=15) 
Decreasing MSNA 
Group (n=5) 
p value 
Sex 9F, 6M 1F, 4M  
Age 25.5±1.8 23.6±2.9 .6 
Body mass index (kg/m2) 27±2 21±1 .08 
MSNA burst frequency (burst/min) 17±1 20±3 .5 
MSNA burst incidence (bursts/100 heart beats) 24±2 31±5 .4 
Systolic arterial pressure (mmHg) 137±6 141±3 .7 
Diastolic arterial pressure (mmHg) 71±3 75±3 .5 
Mean arterial pressure (mmHg) 91±3 95±4 .5 
Heart rate (beats/min) 72±3 72±4 1.0 
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6.4.2. Effects of pain and distraction on cardiovascular parameters: 
population response
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Figure 6.1 shows the pooled data, sampled every 5 minutes, for normalised MSNA, 
mean arterial pressure (MAP) and heart rate (HR). It can be seen that for the whole 
sample of 20 subjects, normalised MSNA increased during tonic muscle pain 
(  
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Figure 6.1A). On average, MAP (Figure 6.1B) and HR 
(  
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Figure 6.1C) also increased significantly during the first 15 minutes of muscle pain 
(pain period 1). The 15-minute audiovisual stimulus, presented during pain period 2, 
had no significant effect on the trajectory of the MSNA response. Interestingly, there 
was a slight fall in MAP and HR while subjects were watching the documentary, which 
– while not statistically significant overall – would fit with them being engaged with 
the documentary. At the very least, the fact that neither MAP nor HR increased during 
the audiovisual stimulus, suggests that the documentary content was relaxing. By 
limiting the analysis to the first 5-min epoch of pain period 2 with the preceding 5-min 
epoch of pain period 1, heart rate was the only parameter to show a significant fall (p 
= .048; paired-test). 
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Figure 6.1: Mean MSNA amplitude changes during pain. 
Mean (±SEM) changes in muscle sympathetic nerve activity (MSNA) burst amplitude, mean 
arterial pressure and heart rate at rest (white columns) and during tonic muscle pain – before 
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(pain period 1), during (pain period 2) and following (pain period 3) an audiovisual distraction 
task. Data from 20 subjects.  *p < .05, **p < .01, ***p < .001. 
 
6.4.3. Effects of pain and distraction on cardiovascular parameters: 
group responses 
As we had shown previously, tonic muscle pain elicited a divergent muscle 
sympathetic response: the normalized mean burst amplitude increased in a sustained 
fashion in 15 subjects (to 176.4±7.9 % of baseline, p < .001, paired t-test), while five 
subjects showed a decrease (to 73.1±5.2% of baseline, p < .001, paired t-test). The fact 
that more subjects showed an increase in MSNA in this cohort of subjects explains 
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why the mean MSNA increased overall in 
 
Figure 6.1 
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Table 6.1 provides baseline data for the two groups of subjects. It can be seen that, apart 
from differences in body mass index (although not statistically significant) between 
the increasing MSNA and decreasing MSNA groups (there were fewer females in the 
latter), there were no differences in MSNA burst frequency, MSNA burst incidence, 
or in systolic, diastolic or mean arterial pressures and heart rate. Moreover, there was 
no difference in the total volume of hypertonic saline infused in the two groups during 
the induction of tonic muscle pain (19 ± 1 vs 19 ± 1 ml).  
Mean changes in MSNA normalized burst amplitude, MAP and HR are shown 
graphically in Figure 6.2. Overall, in either group, the distraction task had no effect on 
MSNA. The changes in mean normalised burst amplitude, and absolute changes in 
MSNA burst frequency, MSNA burst incidence, and systolic, diastolic and mean 
arterial pressure and heart rate during pain periods 1, 2 and 3 are shown for both groups 
of subjects in Table 6.2. 
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Figure 6.2: Changes in MSNA, MAP, and HR for both groups. 
Mean (±SEM) changes in normalized muscle sympathetic nerve activity (MSNA) burst 
amplitude, mean arterial pressure and heart rate after separating the data of Figure 6.1 into an 
increasing MSNA group (n=15) and a decreasing MSNA group (n=5). There was insufficient 
data in the decreasing group to perform statistical analysis. *p < .05, **p < .01, ***p < .001. 
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Table 6.2: Changes during tonic pain. 
Mean changes in MSNA normalised burst amplitude and absolute changes in cardiovascular 
variables during tonic muscle pain. MSNA: muscle sympathetic nerve activity. *Significantly 
different from baseline. p values refer to differences between pain periods 1, 2, and 3. 
 
Variable Increasing MSNA group (n=15) Decreasing MSNA group (n=15) 
 Pain 1 Pain 2 Pain 3 p-value Pain 1 Pain 2 Pain 3 p-value 
MSNA burst 
amplitude (%) 
174±14* 180±13* 180±6* .95 93±6 75±9 45±7* .02 
MSNA burst 
frequency ( 
bursts/min) 
5±1* 5±1* 5±1* .69 -1±1 -3±1 -9±1* .06 
MSNA burst 
incidence ( 
bursts/100 
heart beats) 
5±1* 7±1* 6±1* .54 -5±2 -7±2 -14±3* .16 
Systolic 
arterial 
pressure ( 
mmHg) 
9±2* 7±1 18±0* .37 7±5 7±3* 13±0* .42 
Diastolic 
arterial 
pressure ( 
mmHg) 
4±0* 3±0 6±0* .69 2±1 3±0 7±1* .12 
Mean arterial 
pressure ( 
mmHg) 
5±0* 4±0 8±0* .69 3±2 4±1 8±1* .18 
Heart rate ( 
beats/min) 
2±0 0±1 1±0 .38 1±0 1±0 1±1 .95 
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6.5. Discussion 
We have shown that the divergent muscle sympathetic responses to tonic muscle pain 
are not affected through distraction using an audiovisual stimulus. However, that heart 
rate fell slightly during the audiovisual task suggests that the subjects were engaged, 
and presumably distracted from the painful stimulus. It is known that novel stimuli can 
lead to decreases in HR, coupled with an increase in sweat release, as part of the 
orienting response (Bradley, 2009), so it is possible that the slight fall in heart rate can 
be explained in similar terms. Although we have previously reported significant 
differences in blood pressure (mean, systolic, and diastolic) between subjects in whom 
MSNA amplitude increases compared with those in whom MSNA amplitude 
decreases (Kobuch et al., 2015), as well as differences in heart rate (Fazalbhoy et al., 
2012), here we did not find significant differences between the two groups. It is 
possible that the increase in blood pressure in both the increasing and decreasing 
MSNA groups in this study is driven by nociceptor activation. 
Recent research in our laboratory has shed light on the neurophysiological mechanisms 
through which experimental muscle pain elicits divergent sympathetic responses in 
healthy human subjects. By performing fMRI at the same time as recording MSNA 
we have reported signal intensity differences between the increasing and decreasing 
MSNA groups in distinct brain regions, such as the prefrontal and cingulate cortices, 
as well as the dorsomedial hypothalamus, dorsolateral periaqueductal grey (dlPAG), 
and the precuneus (Kobuch et al., 2017). It remains unknown as to why these patterns 
of activation in the brain are associated with either increases or decreases in MSNA 
during tonic muscle pain. The contribution of higher-order cortical regions, such as the 
prefrontal and cingulate cortices, which are involved in emotional cognitive functions, 
indicates the possibility of underlying emotional differences between the groups. 
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However, we have recently reported that state and trait anxiety levels, as well as pain 
catastrophizing, pain anxiety, and pain vigilance did not determine the direction of the 
response (Kobuch et al., 2016).  
The contribution of the PAG and the precuneus hints towards the involvement of 
psychological stress and engagement. Indeed, research in cats has shown that direct 
stimulation of the lateral PAG evokes a fight-or-flight response associated with 
behaviourally-relevant increases in sympathetic activity, blood pressure, and heart rate 
(Bandler et al., 2000; Carrive et al., 1987; Keay & Bandler 2001). Furthermore, this 
column of the PAG receives input predominantly from cortical regions, which suggests 
that it produces active coping responses to psychological rather than physiological 
stressors (Keay & Henderson, 2010). Conversely, the precuneus is part of a network 
of brain regions which exhibits a uniform pattern of deactivation upon initiation of a 
goal-directed behaviour but is otherwise active when an individual is at rest (Raichle 
et al., 2001). Therefore, in this study, we had good reasons to investigate whether 
distraction from the noxious stimulus, and attention to an emotionally neutral stimulus, 
could modulate the sympathetic response. 
Distraction techniques have been used in many experimental procedures as a means of 
pain reduction – using cognitive strategies ranging from emotion-centred tasks (Avia 
& Kanfer, 1980; Berntzen, 1987) to attentional tasks. Attentional tasks can require the 
subjects to either focus on the pain sensation (Leventhal, et al., 1979; McCaul & 
Haugtvedt, 1982; Ahles et al., 1983), or conversely, to engage in an affectively neutral 
competing task (Barber & Cooper, 1972; Beers & Karoly, 1979; Devine & Spanos, 
1990). Most studies have found that distraction is effective in reducing the distress 
associated with the painful experience in healthy participants (Eccleston, 1995; 
McCaul & Haugtvedt, 1982; Wack & Turk, 1984). However, some studies have found 
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distraction not to reduce physiological or behavioral responses (Leventhal and 
Everhart, 1979; McCaul et al., 1992). Furthermore, it has been proposed that attention 
to physical sensations may enhance the perceived strength of those sensations, whereas 
distraction may minimize the perceived intensity of the sensation (Pennebaker & 
Lightner, 1980). We also know that mental stress increases MSNA in some subjects 
but not in others (Carter & Ray, 2009), and our own work has shown that this depends 
on the rate of rise in blood pressure (El Sayed, Macefield, Hissen, Joyner, & Taylor, 
2016). Accordingly, one should not be surprised at inter-individual variability in 
responsiveness to a given stressor. 
The fact that distraction from the ongoing noxious stimulation did not have an effect 
on the muscle sympathetic response to muscle pain is important, as it demonstrates 
that the response is independent of the subject’s attention to the pain. This further 
demonstrates that the neurophysiological response to the noxious input is prioritized 
over the conscious attentional input. Nevertheless, given that we observed a slight 
slowing of heart rate during the audiovisual stimulus, this supports our contention that 
the subjects were adequately distracted from their pain by attending to the audiovisual 
stimulus. Of course, it may be that a greater deceleration would have occurred in the 
absence of pain, even though such cardiodeceleration is only in the order of 2-3 beats 
per minute (Bradley, 2009).  
The main limitation of this chapter is the low number of subjects in whom MSNA 
decreased during pain. 
6.6. Conclusions 
We had posited that distraction would reduce the increase in MSNA during tonic 
muscle pain but found no such attenuation. Moreover, we saw no change in the group 
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of subjects in whom MSNA decreased during pain, although we had very few subjects 
in this group. Nevertheless, we conclude that the muscle sympathetic responses to 
experimental muscle pain does not depend on the attentional state of an individual.  
  
 CHAPTER 7   Conclusions  
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The aim of this thesis was to investigate the neurophysiological basis of the divergent 
sympathetic responses to long-lasting experimental muscle pain in humans. This 
chapter will summarize the main findings of each investigation, discuss the 
implications of these findings, and finally, provide recommendations for future 
research based on the questions that arose in this thesis. 
7.1. Main findings 
The first study exploring the basis of the divergent muscle sympathetic response to 
muscle pain, presented in Appendix A, revealed that the baseline physiological 
parameters measured do not predict whether an individual exhibits an increase or 
decrease in MSNA during long-lasting muscle pain. Indeed, both the direction of the 
response and the magnitude of change were independent of baseline MSNA, heart rate, 
blood pressure, heart rate variability, as well as age and body mass index. Furthermore, 
sex did not play a role in determining the direction of response to muscle pain. 
However, this study revealed a fairly even split in the propensity of subjects in whom 
MSNA and blood pressure increased, and those in whom MSNA decreased during the 
noxious stimulation. Importantly, an increase in MSNA was associated with 
significantly greater increases in blood pressure during muscle pain.  
 
Having been unable to demonstrate the influence of baseline physiological parameters 
in Appendix A, Chapter 3 focused on psychological factors. This study tested the 
hypothesis that elevated anxiety levels and negative attitudes towards pain lead to a 
higher prevalence of increases than decreases in MSNA during tonic muscle pain. The 
psychological parameters were measured with the State and Trait Anxiety Inventory 
(Spielberger et al., 1983), the Pain Catastrophizing Scale (Sullivan et al., 1995), the 
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Pain Anxiety Symptoms Scale (McCracken & Dhingra, 2002), and the Pain Vigilance 
and Awareness Questionnaire (McCracken, 1997) in 66 subjects in whom MSNA was 
measured during a 45-minute infusion of hypertonic saline solution. None of these 
explained the divergent sympathetic responses, nor did they appropriately predict 
whether a given individual shows an increase or a decrease in muscle sympathetic 
nerve activity during long-lasting muscle pain.  
 
In Chapter 4, the muscle sympathetic responses to muscle pain were recorded 
concurrently with functional brain imaging to investigate whether the responses were 
associated with differential changes in regional brain activity. The study tested the 
hypothesis that a sustained increase in MSNA during long-lasting pain is associated 
with sustained increases in blood oxygen level in important autonomic brain regions.  
This investigation revealed that the divergent MSNA responses were associated with 
different signal intensity changes in a number of brain regions, namely the prefrontal 
and cingulate cortices, precuneus, and dorsomedial hypothalamus, and brainstem 
regions such as the periaqueductal grey and rostroventrolateral medulla. These results 
suggest that, during tonic muscle pain, descending modulation of the brainstem circuits, 
which are thought to control the cardiovascular responses to pain, can evoke different 
MSNA responses in different individuals.  
 
The findings of the fMRI investigation documented in Chapter 4 prompted questions 
regarding the influence of specific brain areas on the MSNA response, particularly 
which regions would show a change in signal intensity during each MSNA burst, rather 
than a sustained signal change as seen in Chapter 4. It is known that at rest, signal 
intensity within the prefrontal, insular and precuneus cortices, hypothalamus, and 
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medulla are tightly coupled to each MSNA burst (Macefield & Henderson, 2016). The 
aim of this study was to investigate whether during sustained muscle pain, signal 
intensity within these areas remains coupled to MSNA, and/or whether other brain 
regions react in a similar manner. The hypothesis to be tested was that in addition to 
areas shown to be coupled to MSNA bursts at rest, other regions, such as the cingulate 
cortex and midbrain, would also exhibit coupling to MSNA during pain, and that 
increases in blood oxygen level dependent signal intensity in these areas would parallel 
an increase in MSNA burst amplitude. Results of the investigation revealed that 
multiple brain regions, including the nucleus tractus solitarius, PAG, prefrontal and 
cingulate cortices are recruited in a burst-to-burst manner, and that the magnitude of 
these signal changes correlates with the overall change in MSNA amplitude during 
muscle pain. 
 
The final study of this thesis (Chapter 6) described an exploration into whether 
distraction from the painful stimulus could influence the direction of the MSNA 
response. Since certain brain regions involved in attention (i.e. precuneus), as well as 
regions involved in the response to psychological stressors (i.e. PAG) had shown 
differences in activity in Chapter 4, the aim was to explore the effects of audio-visual 
distraction on the MSNA response to tonic muscle pain. The hypothesis was that 
distraction via an engagement in an affectively neutral competing task could bring 
about changes in the MSNA responses to tonic muscle pain. The hypothesis was not 
supported, and the findings indicate that audio-visual distraction does not appear to 
influence the muscle sympathetic response to muscle pain. 
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7.2. Implications  
The findings of this thesis indicate that, despite the work outlined here, relatively little 
is known about the physiological and psychological basis of the divergent muscle 
sympathetic response to long-lasting experimental muscle pain, but that differential 
central pathways are implicated in this response. Questions remain as to why these 
divergent responses occur, and whether there are predicting factors that dictate whether 
an individual will have a sustained increase in MSNA and blood pressure during pain, 
or a sustained decrease. Furthermore, whether these changes in MSNA amplitude 
persist once chronic pain is established remains unknown.  
 
Animal and human studies had extensively explored the effects of acute noxious 
stimuli on the cardiovascular system (Burton et al., 2008, 2009a,b,2016; Feinstein et 
al., 1954; Horeyseck & Jänig, 1974; Lewis, 1942; Nordin & Fagius, 1995; Sato et al., 
1984), suggesting that the cardiovascular responses to a noxious stimulus were 
dependent on the origin of the pain (Keay & Bandler 2001; Feinstein et al., 1954; 
Lewis, 1942). Few however, had focused on a longer lasting stimulus, until Fazalbhoy 
and colleagues discovered the divergent MSNA response to long-lasting experimental 
muscle pain (Fazalbhoy et al., 2012, 2014). Extensive work was then necessary in 
order to understand the basis of this phenomenon. Appendix A provides the first in-
depth understanding that this response cannot be attributed to the age, sex, or BMI of 
an individual, or his/her baseline heart rate, blood pressure, and MSNA levels (Kobuch 
et al., 2015). As previously reported (Fazalbhoy et al., 2012), in the group of subjects 
in whom MSNA increased there was also a significant increase in blood pressure. This 
is an important finding as it raises the question as to whether the rise in MSNA and the 
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associated increase in blood pressure in certain people is responsible for the 
development of hypertension that is seen in many chronic pain patients (Bruehl et al., 
2005).  
 
Since the physiological parameters presented in Appendix A were not implicated in 
determining the direction of the MSNA response to long-lasting experimental muscle 
pain, the next step was to determine whether high anxiety levels and negative attitudes 
towards pain could be associated with an increase in MSNA. There has been growing 
evidence that patients with anxiety are at greater risk for cardiovascular disease 
(Musselman et al., 1998; Rosengren et al., 2004), and disturbed sympathetic firing 
patterns in these patients have been reported (Lambert et al., 2006,2008,2010). 
Furthermore, in 2002, Keay and Bandler showed that the autonomic responses to a 
noxious stimulus were also associated with a specific behavioural reaction, depending 
on whether the stimulus was deemed escapable or inescapable. Indeed, an escapable 
situation is associated with sympathoexcitation and a fight/flight behaviour – whereas 
one that is inescapable is met with sympathoinhibition and a conservation-withdrawal 
response (Keay & Bandler, 2002). Since there were no differences in the anxiety levels 
and attitudes to towards pain in our subjects, it may well be that certain individuals 
identified the stressor as escapable and thereby showed an increased sympathetic 
response, while others found it inescapable, and therefore was met with passive coping 
mechanisms, which are associated with sympathetic depression (Keay & Bandler, 
2002). However, this is difficult to assess in this study, as the noxious stimulus is 
inescapable in the sense that the microneurography with or without the MRI scanner 
depicts a restricted environment and requires the subjects to remain immobile, but 
could be deemed escapable in the sense that the subjects knew they had the option to 
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opt out. Furthermore, the fact that distraction from the noxious stimulus did not elicit 
changes in MSNA amplitude during pain implies that the reactions may be 
representative of defensive reactions rather than conscious attentional effort. Research 
in humans has shown that defensive reactions are associated with a variety of existing 
personality constructs (Perkins et al., 2010). For example, increased fear is correlated 
with the tendency to orient oneself away from the threat (Perkins & Corr, 2006). A 
questionnaire investigating perceived threat intensity may provide some answers to the 
psychological stress that may be associated with the MSNA response to pain. 
 
Keay and Bandler (2002) showed the importance of different columns of the midbrain 
periaqueductal grey as being the sites in the CNS responsible for either of the 
autonomic and behavioural responses to pain. In humans, the PAG has been shown to 
be involved in the physiological responses to psychological stressors (Reiman et al., 
1989; Mobbs et al., 2007), and stimulation of particular columns can evoke changes in 
blood pressure and MSNA (Basnayake et al., 2011, 2012; Sverrisdottir et al., 2014).  
 
The results presented in Chapters 4 and 5 revealed that multiple brain regions are 
responsible for the sustained changes in MSNA amplitude during pain. Specifically, 
the results indicate that the PAG is playing a crucial role in this response. It would be 
interesting to investigate the activity of the specific columns of the PAG during other 
stressors which are known to elicit sympathoexcitation or inhibition in humans using 
magnetic resonance imaging. Furthermore, the concurrent microneurography and 
imaging studies presented in Chapters 4 and 5 provide evidence that several brain 
regions (including the PAG), known to be associated with changes in sympathetic 
drive, are recruited both in a sustained and burst-to-burst manner during a painful 
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stimulus. Whether other stressors elicit similar patterns of activity in autonomic brain 
regions is an interesting question and worthy of exploration.  
7.3. Future research 
If the effects of long-lasting pain on the sympathetic nervous system are to be fully 
understood, the first priority is to conduct experiments with a longer noxious stimulus. 
Indeed, one hour of muscle pain produced by infusion of hypertonic saline solution 
does not truly reflect the chronic nature of pain, and such a model is not applicable to 
draw conclusions on the physiological responses to persistent pain. Therefore, it would 
be interesting to see whether the changes in MSNA are sustained with ongoing pain, 
such as delayed onset muscle soreness. Furthermore, since the sustained activation of 
the sympathetic nervous system is thought to be associated with the development and 
maintenance of chronic pain (Ali et al., 2000; Benarroch, 2006), it would be interesting 
to see whether the subjects who showed an increase in MSNA are more prone to 
develop chronic pain than the subjects in whom MSNA decreased. This could involve 
a simple questionnaire exploring the pain history of the participants involved in the 
studies that contributed to this thesis. Furthermore, it would be useful to measure the 
blood pressure of individuals who have developed chronic pain, and compare it to 
those who have not, as it is known that patients with post-surgical chronic pain have 
nearly twice the prevalence of clinical hypertension than medical patients without pain 
(Bruehl et al., 2005). Accordingly, we could postulate that a person who consistently 
exhibited increases in MSNA and blood pressure during experimental muscle pain 
may - if he or she developed chronic pain - go on to develop hypertension. 
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Few studies have measured MSNA in chronic pain conditions, and the results are 
conflicting. In a study involving a single patient with chronic regional pain syndrome 
(CRPS), no difference in the sympathetic outflow was found between the painful and 
non-painful limb (Casale & Elam, 1992). In contrast, pain intensity in 25 fibromyalgia 
patients was positively correlated to MSNA frequency levels (Zamunér et al., 2015). 
It would be interesting however, to measure the MSNA levels of chronic pain patients, 
and repeat a measurement after chronic pain has ceased. Although, it may be difficult 
to draw conclusions on the MSNA amplitude levels, as these are dependent on the 
distance of the tip of the electrode and active fibres, and therefore vary between 
multiple measurements of MSNA at rest. However, burst frequency and burst 
incidence are reproducible; arterial pressure may also be an important indirect measure 
to investigate.  
 
Finally, the studies presented in Chapters 4 and 5 provide a precedent for future 
concurrent functional brain imaging and microneurography studies during autonomic 
challenges. It is important to note that brain regions can show sustained or MSNA-
burst-coupled activation during an autonomic challenge, or both. Therefore, it is 
essential to including both a model that detects sustained signal intensity changes and 
MSNA burst-coupled signal intensity changes when eliciting a continuous autonomic 
response. 
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A.1. Abstract 
We have previously reported that there are inter-individual differences in the 
cardiovascular responses to experimental muscle pain, which are consistent over time: 
intramuscular infusion of hypertonic saline, causing pain lasting ∼60min, increases 
muscle sympathetic nerve activity (MSNA)—as well as blood pressure and heart 
rate—in certain subjects, but decrease it in others. Here, we tested the hypothesis that 
baseline physiological parameters (resting MSNA, heart rate, blood pressure, heart rate 
variability) determine the cardiovascular responses to long-lasting muscle pain. 
MSNA was recorded from the common peroneal nerve, together with heart rate and 
blood pressure, during a 45-min intramuscular infusion of hypertonic saline solution 
into the tibialis anterior of 50 awake human subjects (25 females and 25 males). 
Twenty-four subjects showed a sustained increase in mean amplitude of MSNA (160.9 
± 7.3%), while 26 showed a sustained decrease (55.1 ± 3.5%). Between the increasing 
and decreasing groups there were no differences in baseline MSNA (19.0 ± 1.5 vs. 
18.9 ± 1.2 bursts/min), mean BP (88.1 ± 5.2 vs. 88.0 ± 3.8 mmHg), HR (74.7 ± 2.0 vs. 
72.8 ± 1.8 beats/min) or heart rate variability (LF/HF 1.8 ± 0.2 vs. 2.2 ± 0.3). 
Furthermore, neither sex nor body mass index had any effect on whether MSNA 
increased or decreased during tonic muscle pain. We conclude that the measured 
baseline physiological parameters cannot account for the divergent sympathetic 
responses during tonic muscle pain.  
A.2. Introduction 
Pain is important for survival by helping to avoid tissue damage, mobilizing all 
relevant homeostatic systems for a fight-and-flight response or, alternatively, 
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promoting conservation of energy, and thus promoting healing (Craig, 2002). It is well 
known that pain originating in deep structures may evoke very different behavioural 
and cardiovascular responses than pain originating in superficial structures. Indeed, 
Lewis (1942) observed that pain originating in skin evokes “a rise of pulse rate” and a 
“sense of invigoration” whereas pain originating in deep structures evokes quiescence, 
a “slowing of the pulse” and “falling of the blood pressure” (Lewis, 1942). Subsequent 
studies confirmed Lewis’ findings that muscle pain was associated with a fall in blood 
pressure and bradycardia in awake human subjects (Feinstein et al., 1954). However, 
since these early observations by Lewis and Feinstein, very few studies have examined 
the effects of pain on the cardiovascular system in awake human subjects.  
 
We have been using subcutaneous or intramuscular injection of hypertonic saline—a 
specific stimulus for nociceptors (Graven-Nielsen & Mense, 2001)—to study the 
effects of acute pain on the cardiovascular system in awake human subjects. We 
showed that a bolus (0.5 ml) injection of hypertonic saline into the tibialis anterior 
muscle caused a sustained increase in muscle sympathetic nerve activity (MSNA), and 
a modest increase in blood pressure and heart rate (Burton et al., 2009a), while there 
was only a transient increase in skin sympathetic nerve activity (SSNA)—the latter 
being consistent with an arousal rather than reflex response (Burton et al., 2009b). 
More recently, we used intramuscular infusion to produce a sustained, steady-state, 
level of pain lasting for approximately 1h (Fazalbhoy et al., 2012, 2014). We showed 
that about half of the subjects showed a sustained increase in MSNA, blood pressure, 
and heart rate during tonic muscle pain, while the other half showed sustained 
decreases (Fazalbhoy et al., 2012, 2014).  
 
 201 
These data call into question the idea that noxious stimuli produce invariant responses 
and raise the prospect that these differential responses may be related to an individual’s 
particular traits, which may be reproducible over time. That is, in some individuals 
muscle pain always evokes increases in MSNA, blood pressure and heart rate, whereas 
in others it consistently evokes decreases. Indeed, we recently showed that subjects 
who generate increases in MSNA, blood pressure and heart rate during one session 
also show increases in a second session; the same is true for those who show parallel 
decreases in MSNA, blood pressure and heart rate (Fazalbhoy et al., 2014). Moreover, 
we showed that there were no differences in resting MSNA, blood pressure or heart 
rate between the two recording sessions (Fazalbhoy et al., 2014), but we do not know 
whether differences in these baseline physiological parameters across individuals 
determine whether MSNA increases or decreases during tonic muscle pain. Indeed, in 
our first study we showed that resting levels of MSNA were higher in the group that 
showed an increase in MSNA than in the group that showed a decrease, but these 
differences failed to reach statistical significance—presumably because of the low 
subject numbers (n = 12). Against this background, the aim of the current study was 
to determine whether baseline physiological parameters—including resting MSNA, 
blood pressure and heart rate—could account for the divergent MSNA responses to 
tonic muscle pain. Our earlier studies (Fazalbhoy et al., 2012, 2014) were based on 
small subject numbers and were not sex-balanced. Here, we have studied a larger 
sample (n = 50), comprising 25 males and 25 females.  
A.3. Methods  
Experiments were performed on 25 female and 25 male healthy subjects, aged 18–39 
years. Data from 35 new participants were pooled with those from 15 participants 
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reported previously (Fazalbhoy et al., 2014). All subjects provided informed written 
consent to the experimental procedures, which were conducted under the approval of 
the Human Research Ethics Committee of the University of Western Sydney and 
satisfied the requirements of the Helsinki Declaration. No subject had a history of 
cardiovascular disease or former chronic musculoskeletal pain. Prior to 
commencement height, weight, body mass index (BMI), and total muscle mass were 
measured for each subject using a body-composition analyser (SA165A, Tanita, 
Japan).  
A.3.1. Experimental procedures 
The subjects were seated in a comfortable reclined position with the legs supported in 
an extended position. The room was kept quiet and at a constant temperature of 22◦C. 
The course of the common peroneal nerve was identified via external stimulation (2–
10 mA) using a 1 mm surface probe which delivered 0.2 ms pulses at 1Hz from an 
isolated stimulator (Stimulus Isolator; ADInstruments, Sydney, Australia). 
Spontaneous bursts of muscle sympathetic nerve activity (MSNA) were recorded from 
muscle fascicles of the common peroneal nerve supplying the ankle or toe extensor or 
foot everter muscles via tungsten microelectrodes (FHC, Bowdoin, ME, USA) inserted 
percutaneously at the level of the fibular head. Multi-unit neural activity was amplified 
(gain 20 000, bandpass 0.3–5.0 kHz) using an isolated amplifier (NeuroAmp EX, 
ADInstruments, Sydney, Australia) and stored on computer (10-kHz sampling) using 
a computer-based data acquisition and analysis system (PowerLab 16SP hardware and 
LabChart 7 software; ADInstruments, Sydney, Australia). ECG (0.3–1.0kHz) was 
recorded with Ag–AgCl surface electrodes on the chest and sampled at 2 kHz. Blood 
pressure was recorded continuously using finger pulse plethysmography (Finometer 
 203 
Pro, Finapres Medical Systems, The Netherlands) and sampled at 400 Hz. Respiration 
(DC-100Hz) was recorded using a strain-gauge transducer (Pneumotrace, UFI, Morro 
Bay CA, USA) wrapped around the chest.  
A.3.2. Noxious stimulation 
A 7% hypertonic saline solution was prepared by diluting sterile, 20% hypertonic 
saline with sterile water. Two syringes of 10 ml each were filled with the 7% 
hypertonic saline, placed in an infusion pump (Harvard Instruments, USA), and 
connected to a three-way tap via a 75cm extension tubing primed with hypertonic 
saline. A 23 gauge butterfly needle was then attached to the three-way tap via a cannula, 
primed, and inserted 1.5 cm deep into the belly of the ipsilateral tibialis anterior muscle, 
about 5 cm lateral and 10 cm inferior to the tibial tuberosity. The cannula was inserted 
as soon as a stable recording of spontaneous MSNA was achieved. Prior to infusion of 
the saline solution, a 5 min baseline recording of MSNA, blood pressure, respiration, 
and heart rate was obtained. Infusion of the 7% hypertonic saline solution was started 
at a time unknown to the subject, and was maintained for 45 min; as described 
previously (Fazalbhoy et al., 2012, 2014), the pain lasted for ∼60min. The initial rate 
of infusion was set at 0.25ml/min and was constantly adjusted to maintain a pain level 
of 5–6/10 on a Numerical Rating Scale (NRS). Subjects were asked to rate their pain 
continuously by sliding a linear potentiometer (Response Meter, ADInstruments, 
Sydney, Australia) that was calibrated to the NRS, with a rating of “0” meaning “no 
pain/discomfort” at all, and a rating of “10” being equivalent to the “worst pain the 
subject ever had experienced.” When the pain level dropped below 4/10 or rose above 
6/10, the infusion rate was changed by 0.02 ml/min accordingly. After the infusion 
was completed, the recording was continued until the pain stopped. At the conclusion 
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of the experiment, each subject completed a McGill Pain Questionnaire, in which 
subjects described the quality of the pain using a standard set of descriptors.  
A.3.3. Analysis 
LabChart 7 Pro software (ADInstruments, Sydney, Australia) was used to record the 
following parameters: muscle sympathetic nerve activity (burst amplitude and 
frequency), heart rate, blood pressure, respiration, pulse pressure, heart rate variability 
(HRV), and pain ratings. Individual bursts of MSNA were displayed as a mean-voltage 
neurogram, computed as the root-mean-square (RMS) processed signal with a moving 
time average window of 200 ms. This signal was then analysed using the “Peak 
Analysis” module of the LabChart 7 Pro software to calculate the amplitude of each 
burst. The absolute values were averaged into 5-min blocks and reported as 
percentages from the “baseline” values. An average of all blocks was taken to 
determine the direction of the response. Subjects with overall average MSNA 
amplitude 10% lower than baseline were arbitrarily assigned to the decreasing group; 
averages 10% higher than baseline were considered as increasing. Baseline MSNA 
amplitude was compared to the 5-min block with the mean value calculated over the 
entire infusion period, and to the highest average for the increasing group and to the 
lowest average value for the decreasing group. Changes in mean heart rate and mean 
blood pressure were also measured in 5 min epochs, normalized to the baseline value 
prior to the infusion of hypertonic saline. HRV was assessed over a 5-min steady state 
period before the infusion, and then again over 5 min when the subject experienced a 
steady-state level of pain during the infusion. The parameters of HRV that were 
analysed included the low frequency (LF) and high frequency (HF) power, as well as 
the Root Mean Square Successive Difference of cardiac intervals (RMSSD). Statistical 
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analysis—non-paired two-tailed t-tests for normally distributed data and Mann-
Whitney tests for non-normally distributed data—was performed using Prism version 
6 for Mac OS X (GraphPad software, San Diego, California, USA). All values are 
expressed as means and standard error. Probability levels of p < .05 were deemed 
significant.  
A.4. Results 
A.4.1. Subjective experience of muscle pain 
In all subjects, intramuscular infusion of hypertonic saline induced a steady state level 
of muscle pain in the tibialis anterior muscle. The level of pain was kept constant, 
typically around 5 out of 10—throughout the period of infusion by adjusting the rate 
of infusion according to the subject’s tracking of the pain level. The mean pain rating 
was 4.9 ± 0.1. Using the McGill Pain Questionnaire, 36 of the 50 subjects (72%) 
described the pain as “aching,” 48% described it as “heavy” and 48% as “dull.” After 
these, “throbbing,” “cramping,” “hurting,” “discomforting,” and “continuous” were 
the most frequent descriptions used.  
A.4.2. Muscle sympathetic nerve activity during tonic muscle pain 
Experimental records from two subjects are shown in Figure A-1 and Figure A-2. 
Muscle sympathetic nerve activity (MSNA) increased during tonic pain in the subject 
depicted in Figure A-1; it is apparent that blood pressure also increased. Conversely, 
the subject illustrated in Figure A-2 exhibited a sustained decrease in MSNA and blood 
pressure during the infusion.  
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As expected, when all subjects were analysed according to their pattern of MSNA 
response to muscle pain two distinct groups of responses emerged: 24 subjects (48%) 
showed a significant increase in burst amplitude over the entire infusion period (132.6 
± 6.1% p < .0001, t-test), while 26 subjects (52%) showed a significant decrease (72.6 
± 3.0%, p < .0001, t-test), relative to baseline. The peak changes in the increasing and 
decreasing groups, measured over 5 min, were 160.9 ± 7.3% and 55.1 ± 3.5% 
respectively; these were significantly different from baseline (p < .0001, t-test). The 
time at which the peak increase in MSNA occurred (29 ± 3 min) in the increasing 
group, and the time at which the peak fall occurred (32 ± 3 min) in the decreasing 
group, were not significantly different (p = .5077, Mann-Whitney test). There was no 
significant difference in the mean pain rating in the increasing and decreasing groups 
(4.7 ± 0.2 vs. 5.1 ± 0.2, respectively; p = .18, t-test).  
 
 
Figure A-1: Subject in whom MSNA increased during intramuscular infusion of hypertonic 
saline. 
Baseline is shown in the left panel (A) while the right panel (B) shows a sample at which 
MSNA was at its maximum. 
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Figure A-2: Subject in whom MSNA decreased during intramuscular infusion of hypertonic 
saline. 
Baseline is shown in the left panel (A), while the right panel (B) shows a sample at which 
MSNA was at its minimum. 
A.5. Blood pressure and heart rate during tonic muscle pain 
Interestingly, those subjects who showed an increase in MSNA showed a significantly 
larger increase in blood pressure than those in whom MSNA decreased. Systolic 
pressure increased from 132.0 ± 5.5 (baseline) to 159.9 ± 5.8 mmHg (steady level of 
pain) in the increasing group but from only 133.0 ± 4.7 to 142.7 ± 5.3 in the decreasing 
group. Diastolic pressure increased from 70.2 ± 5.2 (baseline) to 86.6 ± 4.5 mmHg 
(steady level of pain) and from 75.1 ± 4.2 to 76.7 ± 4.3 in the increasing and decreasing 
groups, respectively. Relative changes in blood pressure, heart rate and MSNA in the 
two groups are presented in Figure A-3. In the increasing group, data from two subjects 
were excluded from the calculated mean of all parameters as they showed much larger 
increases in amplitude of MSNA (396 and 520%), as defined by running an Outliers 
Test (Prism, GraphPad software), which would have skewed the results.  
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Figure A-3: Peak changes in blood pressure, heart rate, and MSNA for the increasing 
and decreasing MSNA groups. 
Systolic and diastolic blood pressures were significantly higher in the increasing group, as 
depicted by the asterisk. Results are compared to baseline levels (i.e. 100%). 
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A.6. Resting levels of MSNA and BP 
When comparing the increasing and decreasing groups, there were no differences in 
baseline MSNA (19.0 ± 1.5 vs 18.9 ± 1.2 bursts/min; p = .99, t-test) that could account 
for these divergent responses. Moreover, as shown in Table A-1 there were no 
differences in resting blood pressure parameters, heart rate or heart rate variability, and 
no effect of body mass index or total muscle mass.  
 
Table A-1: Baseline data for both MSNA groups. 
Baseline data for the group showing an increase in MSNA (n=24) during tonic muscle pain 
and the group showing a decrease (n=26). 
 Increasing MSNA  
 
Decreasing MSNA P-value 
Number of subjects 
Number of subjects 
11 female, 13 male 
25 
14 female, 12 male 
25 
.78 
Age (years) 22.1±1.3 22.4±0.9 .34 
Height (cm)  168.7±1.6 170.1±2.1 .60 
Weight (kg) 65.7±2.6 68.0±2.9 .56 
BMI (kg/m2) 23.1±1.0 23.4±0.8 .65 
Muscle mass (kg) 49.5±2.2 48.7±2.3 .80 
Pain rating (/10) 4.7±0.2 5.1±0.2 .18 
MSNA (bursts/min) 19.0±1.5 18.9±1.2 .99 
SAP (mmHg) 132.0±5.5 133.0±4.7 .52 
DAP (mmHg) 70.2±5.2 75.1±4.2 .32 
MAP (mmHg) 88.1±5.2 88.0±3.8 .78 
HR (beats/min) 74.7±2.0 72.8±1.8 .44 
LF HRV (nu) 56.9±3.8 59.4±4.0 .80 
HF HRV (nu) 38.4±3.4 35.6±3.7 .58 
LF/HF HRV 1.8±0.2 2.2±0.3 .38 
RMSSD HRV (ms) 40.5±4.1 40.8±4.0 .99 
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A.7. Sex differences 
Of the 24 subjects in whom MSNA increased, 11 were female and 13 were male, while 
there were 14 females and 12 males in whom MSNA decreased. These data indicate 
that there was no difference in the propensity of males or females to exhibit an increase 
or decrease in MSNA during long-lasting muscle pain (p = .78, Fisher’s Exact test). 
Moreover, the data illustrated in Figure A-4 show that there were no differences in the 
peak magnitude of change in MSNA between females and males in either the 
increasing group (158.0 ± 11.3% vs. 163.2 ± 10.0%; p = .40, Mann-Whitney) or the 
decreasing group (44.1 ± 4.7% vs. 46.4 ± 5.4%; p = .77, Mann-Whitney). There was 
no significant difference in the mean pain rating between females and males (4.9 ± 0.2 
vs. 4.9 ± 0.2, respectively; p = .87, t-test).  
 
There were no statistically significant differences in resting MSNA between the female 
and male subjects (18.8 ± 1.5 vs. 20.2 ± 1.5 bursts/min; p = .19, unpaired Mann-
Whitney test), and no significant differences in any of the other baseline cardiovascular 
parameters (Table A-2). The only statistically significant differences between males 
and females were in BMI and muscle mass, both of which were significantly higher in 
the males (p =  0.05 and p < .0001, respectively), and age (p < .01)—on average, the 
females were one year older, though this is of no consequence because ages were not 
significantly different in the increasing and decreasing groups (cf Table A-1).  
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Figure A-4: Changes in MSNA in females and males during tonic muscle pain. 
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Table A-2: Baseline data for males and females 
Age, BMI, total muscle mass, MSNA frequency (normalized to baseline), systolic arterial 
pressure (SAP), diastolic arterial pressure (DAP), mean arterial pressure (MAP), heart rate 
(HR) and specific components of heart rate variability (HRV) at baseline, divided by sex. Nu 
(normalized units). 
 Females Males P-value 
Number of subjects 
Number of subjects 
25 
25 
25 
25 
 
Age (years) 22.8±0.8 21.8±1.5 <.01 
Height (cm)  164.0±1.1 175.0±1.7 <.0001 
Weight (kg) 61.5±2.7 72.6±2.2 <.02 
BMI (kg/m2) 22.9±1.0 23.4±0.5 .05 
Muscle mass (kg) 43.3±0.8 57.8±2.1 <.0001 
Pain rating (/10) 4.9±0.2 4.9±0.2 .87 
MSNA (bursts/min) 18.8±1.5 20.2±1.5 .19 
SAP (mmHg) 131.7±6.3 133.3±3.3 .96 
DAP (mmHg) 72.7±5.4 72.7±3.9 .69 
MAP (mmHg) 89.5±5.5 86.6±3.3 .96 
HR (beats/min) 75.0±1.9 72.3±1.9 .32 
LF HRV (nu) 61.7±3.5 57.4±3.2 .21 
HF HRV (nu) 33.8±3.2 37.2±3.0 .16 
LF/HF HRV 2.2±0.3 1.8±0.3 .15 
RMSSD HRV (ms) 39.0±3.9 41.9±4.5 .64 
 
A.8. Discussion 
This study extends the recent work conducted in our laboratory on the effects of 
experimental muscle pain on the sympathetic nervous system (Burton et al., 2008, 
2009a,b; Fazalbhoy et al., 2012, 2014; Hall et al., 2012). In our first study of 12 
subjects we found that tonic muscle pain, produced by intramuscular infusion of 
hypertonic saline for 45min created divergent changes in muscle sympathetic outflow: 
one group (n = 7) showing an increase in MSNA and another (n = 5) showing a 
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decrease (Fazalbhoy et al., 2012). In a second study of 15 subjects, we had reported 
that 11 subjects showed consistent increases (n = 5) or decreases (n = 6) in MSNA 
when assessed on two occasions at least 2 weeks apart (Fazalbhoy et al., 2014). Here 
we have confirmed the findings of divergent sympathetic responses to long-lasting 
muscle pain, but with a much larger sample size (n = 50): one group of people (n = 24) 
showed an increase in MSNA and another group (n = 26) showed a decrease.  
A.8.1. Baseline physiological parameters 
The findings of the current study suggest that the cardiovascular responses to long-
lasting muscle pain are not determined by our measured baseline physiological levels; 
both the direction of the response and the magnitude of change were independent of 
baseline MSNA, heart rate, blood pressure, heart rate variability, as well as age, sex, 
and BMI. This is consistent with studies showing comparable control and sensitivity 
of the sympathetic baroreflex in young men and young women (Tank et al., 2005; 
Studinger et al., 2009; Hart et al., 2011). Whether, these findings remain with 
increasing age is beyond the scope of this study. However, it would be interesting to 
know whether the pattern of response remains unchanged with age.  
 
In this larger sample of subjects, we found no correlation between MSNA and heart 
rate, unlike the parallel changes observed in the smaller data sets reported previously 
(Fazalbhoy et al., 2012, 2014). Because of the dual innervation of the heart, it may 
well be that the increase in sympathetic outflow to the vascular bed in muscle is 
matched by a parallel increase in cardiac sympathetic drive, which would increase 
heart rate, but that a competing parasympathetic influence via the vagus nerve 
counteracts this.  
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A.8.2. MSNA and blood pressure 
Although, there was no difference in the changes in heart rate and the change in MSNA 
between the two groups, in the group of subjects in whom MSNA increased during 
tonic muscle pain blood pressure was significantly higher than in the group in whom 
MSNA decreased. This suggests that the increase in MSNA was driving the increase 
in blood pressure, as an increase in blood pressure should, via the baroreflex, lead to a 
fall in MSNA. Indeed, the latter mechanism may explain why in some subjects MSNA 
fell despite an increase in blood pressure: in these cases, it would appear that the 
increase in blood pressure was causing a baroreflex-mediated reduction in MSNA, 
while in other instances a reduction in both blood pressure and MSNA could be the 
result of a nociceptor-driven withdrawal of MSNA. However, for those subjects in 
whom both MSNA and blood pressure increased during tonic muscle pain, we would 
like to suggest that nociceptor-driven increases in blood pressure could potentially be 
a risk factor for the development of clinically significant high blood pressure in the 
future, given that some individuals with chronic pain go on to develop hypertension. 
Indeed, patients with post-surgical chronic pain have nearly twice the prevalence of 
clinical hypertension than medical patients without pain (Bruehl et al., 2005). 
Accordingly, we could postulate that a person who consistently exhibited increases in 
MSNA, blood pressure, and heart rate during experimental muscle pain may—if he or 
she developed chronic pain from an injury in the future—go on to develop 
hypertension.  
A.8.3. Heart rate variability 
Heart rate variability is widely reported to reflect the degree of sympathetic and 
parasympathetic control over the heart. The LF band is proposed to represent 
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(primarily) sympathetic cardiac activation (Malliani et al., 1991), while the HF band 
is proposed to reflect vagal cardiac control (Bernston et al., 1997). Subsequently, the 
LF/HF ratio has been suggested as an index of the sympathovagal balance (Cohen et 
al., 2000; Martinez-Lavin, 2004; Staud, 2008; Reyes del Paso et al., 2011). The value 
of HRV in distinguishing between cardiac sympathetic and parasympathetic outflow 
is debatable (Goldstein et al., 2011). However, that there was no difference between 
any HRV parameters at either baseline or during tonic pain indicates that HRV is not 
related to whatever is responsible for the divergent sympathetic responses to muscle 
pain seen in this study.  
A.9. Limitations 
The intramuscular infusion of hypertonic saline occurred at a time unknown to the 
subject, who was asked to continuously report the development of pain, as a rating out 
of 10, via the linear potentiometer provided. Infusion rates were titrated—by 
increasing or decreasing the rate of infusion in increments of 0.02ml/min—to maintain 
a constant level of pain. Although we did not routinely record either the rate of infusion, 
or the total volume infused, in each subject, we never exceeded 20 ml (as noted in 
Methods we used two syringes of 10ml each). Nevertheless, there were no differences 
in total muscle mass in the group in whom MSNA increased and the group in whom 
MSNA decreased and, given that the infusion caused a notable distension of the 
muscle belly in both groups, it is reasonable to assume that any changes in plasma 
osmolality were limited to the muscle compartment and that comparable 
depolarization of small-diameter axons by the hypertonic saline occurred in the two 
groups. In other words, the noxious sensory input was the same in the two groups, as 
reflected in the fact that there were no significant differences in mean pain ratings 
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between the two groups. The same was true when we separated the cohort into males 
and females: the only significant differences here being the higher BMI and lower total 
muscle mass in the females, both of which are expected. Of course, one could argue 
that the intramuscular infusion of hypertonic saline would have a greater effect in a 
smaller muscle (in the females), but in our experience, we see no differences in mean 
pain ratings in small muscles (e.g., intrinsic muscles of the hand) and large muscles 
(e.g., flexor carpi radialis, deltoid, tibialis anterior), and pain ratings were the same in 
males and females.  
A.10. Implications 
We have shown, in a large sample of subjects (n = 50), that the baseline physiological 
parameters measured here do not predict whether an individual exhibits an increase or 
decrease in MSNA during long-lasting muscle pain. Furthermore, sex appears to play 
no role in determining the direction of response to muscle pain. Unlike the short-
lasting pain we had previously induced by bolus injections (Burton et al., 2009a,b), we 
believe the physiological responses to tonic pain will more closely replicate episodes 
during which chronic pain patients are suffering and coping with their pain. Persistent 
deep pain in experimental animals has been shown to provoke a passive coping 
response—i.e., conservation/withdrawal (Keay & Bandler, 2002). Of course, while 
tonic muscle pain lasting only 20 min has been used as a model for chronic 
musculoskeletal pain (Capra & Ro, 2004), we should stress that this only reflects 
continuous nociceptive pain and not the neuropathic pain typically associated with 
chronic pain. Nevertheless, this method of inducing pain offers the advantage of 
allowing a controlled investigation into how pain may modulate MSNA, blood 
pressure, and heart rate. Conversely—assuming everything else is equal—one would 
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need to know the level of MSNA in a person prior to the development of chronic pain 
in order to interpret any changes in muscle sympathetic outflow. Microelectrode 
recordings of sympathetic nerve traffic in human subjects have found no differences 
in sympathetic outflow to a painful limb compared to the contralateral non-painful 
limb in patients with complex regional pain syndrome, suspected to be sympathetically 
maintained because of the marked cutaneous vasoconstriction (Casale & Elam, 1992). 
In order to understand the neurophysiological basis of the divergent sympathetic 
responses to experimental muscle pain, further investigations are needed, as the current 
results fail to demonstrate that baseline physiological parameters, BMI or sex, play a 
role in the cardiovascular responses to long-lasting muscle pain in humans.  
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